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Nothing in life is to be feared, it is only to be understood.  
Now is the time to understand more, so that we may fear less. 
  
  
 
 
Abstract 
Taxol is one of the most notorious examples in the use of naturally occurring compounds as 
the basis of modern medications and has been recognized as one of the best anticancer drugs 
in the 21st century. Nowadays, Taxol and its derivatives are the largest selling anticancer drugs 
generating a revenue of more than three billion dollars annually. Due to its structural complexity, 
Taxol has been one of the main targets for synthetic chemists around the world and several total 
and formal synthesis have been published. Two different synthetic efforts toward a formal 
synthesis of Taxol are presented in this thesis.  
 
Initially, a ring-closing dialkene alkyne metathesis (RCDEYM) is studied to form the Taxol 
skeleton. The primary target is the intermediate described by Holton during his synthesis of 
Taxol. The formation of the ABC tricyclic core by a cascade RCDEYM reaction constitutes 
the key step of this approach. On the other hand, the target molecule in the second route is a 
C7 deoxygenated tricyclic core and a relay ring-closing methatesis (RRCM) was envisioned for 
the construction of the B ring. Installation of the tether would be possible by a Julia Kocienski 
olefination  
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Chapter 1: Introduction 
1.1 Taxol 
1.1.1 Generalities on Taxol  
Taxol (Figure 1.1) is one of the most notorious examples in the use of naturally occurring 
compounds as the basis of modern medications.1 Ever since the elucidation of its structure in 
1971 and its later approval by the Food and Drugs Administration (FDA) in 1994,2 Taxol has 
been widely employed in the treatment of breast3 and ovarian cancer2, 4 as well as non-small cell 
lung cancer.5 It is recognised as one of the most effective and top selling anticancer drugs 
generating a revenue of more than three billion dollars annually.3  
 
Figure 1.1: Structure of Taxol 
As shown in Figure 1.1, Taxol´s skeleton is formed by four fused rings in a 6-8-6-4 configuration 
and a lateral chain located at the C13 carbon with a total of eleven stereocentres. It shows a 
diterpenic skeleton where the A rings adopts a deformed boat conformation due to the presence 
of an alkene in a bridgehead position (C11-C12). The 8-membered ring B sits in a chair-boat 
conformation and shares a trans junction with the six membered C ring (half chair 
conformation). Moreover, nine of its eleven stereogenic centres are in the 6-8-6 tricyclic bridge 
skeleton, including the C8 all carbon quaternary centre. Due to its structural complexity, Taxol 
has been a challenging target for synthetic chemists around the world. Indeed, there have been 
more than 200 published papers describing studies towards its total and formal synthesis.   
All compounds of the taxane family can be classified in four groups taking into account the 
functional group at the C4 position (Figure 1.2):  
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➢ Group A: Exocyclic alkene at C4-C20 (Taxine B) 
➢ Group B: Epoxide at C4-C20 (baccatin I) 
➢ Group C: Oxetane ring C4-C5 (Taxol)  
➢ Group D: 6-10-6 tricyclic core (taxine A) 
 
Figure 1.2: Structures of taxine B, baccatin I and taxine A 
1.1.2 Discovery of Taxol  
Efforts from the National Cancer Institute (NCI) and the United States Department of  
Agriculture (USDA) towards the discovery of new, naturally occurring, anticancer compounds 
from plants led to the discovery of Taxol’s bioactivity.6 In 1963 Taxus brevifolia bark extracts 
collected by Arthur Barclay showed cytotoxic activity against KB cells. Later recollection of bark 
extracts done by Wall and coworkers at the Research Triangle Institute (RTI) in North Carolina 
in 1965 confirmed in vivo cytotoxic activity against mouse leukaemia.7  
Pure Taxol was isolated in 1969 in a 0.01% yield from the bark of the tree (the needles and 
wood contained much less Taxol). Subsequently, the elucidation of its structure took place in 
1971 by making significant use of 1H NMR as well as X-ray studies on methyl N-
benzophenylisoserine 1.1 and 10-deacetylbaccatin III 1.2 (Scheme 1.1). However, low extraction 
yields and poor water solubility as well as the modest in vivo activity against various carcinomas 
and leukaemia were not very encouraging.8 
 
Scheme 1.1: Cleavage of the side chain 
Despite this, some additional bioassays were conducted by the NCI in the early 1970s showed 
a significant activity against a B16 mouse model melanoma and resulted in the selection of Taxol 
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as a development candidate in 1977. Activity shown against the then new MX-1 and CX-1 
mammary and colon xenografts in nude mice were also proved. The interest in this compound 
increased significantly in 1979 when Schiff and Horwitz discovered its mechanism of action as 
a promoter of tubulin assembly.9 By then Taxol was the only known compound capable of 
disrupting the dynamic equilibrium of microtubules and monomeric tubulin, and its cytotoxic 
activity was considered towards the development of an anticancer drug. After completion of 
toxicology studies and preclinical formulation in 1982, Taxol entered phase I clinical studies in 
1984 and phase II trials in 1985. As a result, in 1994, the FDA granted the approval of its use 
for the treatment of breast and ovarian cancer. 
Regardless of its remarkable biological activity, Taxol has a major inconvenience: its availability. 
Taxus brevifolia is primarily found in United States of America, but several other yew species can 
be found around the word, especially in temperate climates.10 Taxol content is different in each 
species, with T. yunnanensis (Burma, South China) being the one that contains the highest 
concentration of Taxol in the mature tree’s bark. However, the presence of the Taxol analogue 
cephalomannine does not allow a high yielding industrial separation. T. media (Canada) proved 
to be the most practical yew for Taxol extraction from the leaves and branches of 3 to 5 years 
old specimens (0.02 - 0.04% yield). These poor yields obtained, in addition to the ecological 
impact of the extraction, confirm the need of a sustainable source of Taxol. 
The first attempt at solving this problem was conducted by Rhône-Poulenc and the group of 
Pierre Potier from l’Institut de Chimie des Substances Naturelles of Gif-sur-Yvette in 1988 
when a semisynthetic route from 1.2, isolated in relatively large quantities from the needles of 
T. baccata, was published.11 In the same study, Taxotere™ (Figure 1.3) was also identified as a 
more active compound in the treatment of breast, lung, prostate and gastric cancer. The free 
hydroxyl group located at C10 position caused Taxotere to be more water soluble than Taxol. 
 
Figure 1.3: Structure of the Taxotere™ 
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1.1.3 Bioactivity 
As previously mentioned, in 1977 Susan Horwitz carried out the first experiments on Taxol’s 
mechanism of action. Her results showed that nanomolar concentrations of Taxol inhibited the 
replication of HeLa cells. Further examination proved that Hela cells exposed to Taxol (250 
nM) for at least 18h had replicated the DNA and had a tetraploid DNA content but were 
blocked in the metaphase.12 As shown in Figure 1.413 the modal positions of cells containing 
diploids (2C) and tetraploids (4C) did not change significantly during the experiment, proving 
that Taxol blocks cell division, thus causing cellular death. In her research, Horwitz highlighted 
Taxol’s effect on cellular division as a microtubule bundle poison. Even though colchicine, 
vincristine, and vinblastine, among some other anticancer drugs, also blocked cells in the mitotic 
cycle, only cells treated with Taxol could reorganize their microtubules. 
 
Figure 1.4: Taxol blocking cells during mitosis 
Microtubules are considered to be one of the major basic structural elements of the cytoskeleton 
and are in charge of transporting the genetic material from the mother cell to the daughter cells 
in the cellular cycle. As shown in Figure 1.5, tubulin is a heterodimer formed by two different 
subunits (α and β). The longitudinal head to tail self-assembly of tubulin dimers promoted by 
GTP biding results in the formation of protofilaments that constitute the wall of microtubules 
(13 dimers of tubulin per turn). These microtubules display an extremely dynamic behaviour 
that results in the rapid exchange of tubulin dimers at the microtubules ends.14  
  
6 
 
 
Figure 1.5: Formation of microtubule15 
Generally, microtubule bundle poisons were associated with their binding of the β-subunit, thus 
preventing the polymerisation of microtubules. In contrast, Taxol does not prevent this 
polymerisation but promotes it. Moreover, Taxol stops the depolymerisation towards the 
microtubules and is capable of polymerising tubulin, even at low temperatures (4°C) in the 
absence of GTP, inhibiting the required equilibrium for correct cell replication.12  In addition, in 
1981, it was proved that Taxol has its maximum effect when using a stoichiometric ratio to the 
tubulin dimer concentration.16 This novel mechanism of action has a major repercussion on 
carcinogenic cells (considered to duplicate faster than normal cells), and thus Taxol was 
considered a promising candidate in anticancer drug development. 
1.2 Syntheses of  Taxol 
1.2.1 Biosynthesis 
Understanding the biosynthesis of Taxol is the first step for the pharmaceutical industry to offer 
a viable commercial production pathway free from the current environmental problems. The 
biogenesis of Taxol can be divided into three conceptually different processes: the construction 
of the taxane skeleton, the addition of eight oxygenated functional groups and the later assembly 
of the C13 side chain. 
Firstly, enzymatically catalysed cyclisation of the geranylgeranyl diphosphate skeleton by 
taxadiene synthase (TS) results in the formation of the taxane skeleton via verticillenyl and 
taxenyl cations (Scheme 1.2).17 
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Scheme 1.2: Biosynthesis of ABC tricyclic core of taxol 
Since every taxane has an oxygenated function at C5, subsequent oxidation of this position by 
the taxoid oxygenase enzyme taxadiene-5α-hydroxylase (CYP725A4) is proposed (Scheme 
1.3).18 Chemical and biological studies support an epoxidation-based mechanism followed by a 
non-selective breakdown of the epoxide intermediate.19 Further oxidations and acetylations 
leads to 2α,7β-dihydrotaxusin.  
 
Scheme 1.3: Oxidation of C5 carbon 
As shown in Scheme 1.4, latter oxetane ring formation is attributed to an oxomutase reaction 
via a transferase type mechanism. The oxidation of the exo cyclic alkene is possibly due to the 
intramolecular exchange of the C5α-acetoxy group and the C4β -oxide function. 
 
Scheme 1.4: Oxidation of C5 carbon 
The final step is the assembly of C13 side chain. Reaction of natural α-phenylalanine with 
Peptidylglycine Alpha-amidating Monooxygenase (PAM) produces β-phenylalanine (Scheme 
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1.5). Coupling between β-phenylalanine and baccatin III catalysed by coenzyme A and further 
hydroxylation of C2´and benzoylation of C2 lead to Taxol. 
 
 
Scheme 1.5: Oxidation of C5 carbon 
1.2.2 Total syntheses of Taxol 
To date, seven total syntheses of Taxol have been published. In this section only the key points 
of each synthesis will be discussed. 
1.2.2.1 Holton´s synthesis 
The first total synthesis of Taxol was published in 1994 by Holton and co-workers.20 This 
synthesis uses a natural product as starting material and has a linear approach. Starting from β-
patchoulene oxide, silylated homoallylic alcohol 1.3 was obtained over four steps in 69% yield 
(Scheme 1.6). A tandem epoxidation-Grob fragmentation followed by a TBS protection of the 
secondary alcohol yielded the desired AB bicyclic core 1.4. For the construction of the C ring, 
1.4 was transformed in cyclic carbonate 1.5, which was then submitted to Chan rearrangement 
providing lactone 1.7. Dieckmann condensation of 1.8 afforded ABC tricyclic core 1.9 in 84% 
yield. After 18 steps involving the decarboxylation and selective oxidation of C5, the 
introduction of the final missing carbon atom at C4 and its transformation to an exocyclic alkene 
was followed by the installation of the oxetane ring; advanced intermediate 1.10 was isolated. 
Addition of the Ojima lactam 1.11 to alcohol 1.10 was followed by global deprotection affording 
Taxol in 0.6 % overall yield over 56 steps. 
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Scheme 1.6: Holton´s total synthesis  
1.2.2.2 Nicolaou´s synthesis  
Simultaneously to Holton’s synthesis, the Nicolaou group was working on a convergent 
approach to Taxol.21 Starting from dihydroxybutene 1.12 and the -carbonyl unsaturated ester 
1.17, the C ((±)1.16) and A (1.18) rings were successfully synthesised. Interestingly, the presence 
of phenylboronic acid favoured complexation with the two hydroxyl groups via intermediate 
1.14, leading to a single diastereomer of the Diels-Alder product ((±)1.15). Coupling of 
fragments (±)1.16 and 1.18 by a Shapiro reaction gave AC bicycle core (±)1.19 as a single 
diastereomer. The C1 hydroxyl group was installed by a regioselective epoxidation followed by 
a ring-opening epoxide reaction. Further transformations afforded dialdehyde (±)1.20 that was 
then submitted to a McMurry cyclisation and a resolution of the racemate product via its 
diastereomeric camphanate esters at C9, constructing the desired ABC tricyclic core 1.21. After 
installation of the oxetane ring the tetracyclic core 1.22 was transformed into Taxol in a 0.02% 
overall yield over 44 steps.  
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Scheme 1.7: Nicolaou´s total synthesis  
1.2.2.3 Danishefsky´s synthesis  
In 1996, the Danishefsky group published its convergent synthesis of Taxol.22 Interestingly, this 
synthesis is the only approach in which the D ring is installed in an early step. Starting from the 
Wieland-Miescher ketone 1.23, the C7 stereocentre was successfully installed and 1.24 was 
isolated after 9 steps (Scheme 1.8). The ketone motif at C4 was used to install the oxetane ring 
giving 1.25 and further transformations afforded advanced intermediate 1.26. Separately, the 
synthesis of the A ring was successfully accomplished. Starting from diketone 1.27, vinyl iodide 
1.28 was obtained after a hydrazone iodination at C1 followed by a cyanohydrin formation at 
C11.  
Coupling of the two fragments (1.26 and 1.28) yielded the ACD tricyclic core 1.29 as a single 
diastereomer. Construction of the B ring was possible by a very high-yielding intramolecular 
Heck coupling between the terminal olefin and the triflate in 1.30. Once the ABCD tetracyclic 
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core 1.31 was obtained, Taxol was finally isolated in 0.03% overall yield over 53 steps via 
intermediate 1.32 and baccatin III. 
 
Scheme 1.8: Danishefsky´s total synthesis  
1.2.2.4 Wender´s synthesis  
In 1997 Wender and co-workers published a linear total synthesis of Taxol.23 As shown in 
Scheme 1.9, air oxidation of pinene afforded verbenone. The AB core was obtained after a 
chemoselective epoxidation of the double bond at 1.33 followed by a DABCO induced Grob 
fragmentation (via transition state 1.34). Subsequent protection of the free alcohol with TIPS 
afforded the desired bicyclic system 1.35. After installation of the C1 hydroxyl group and further 
functionalisation at the C3 chain, the advanced intermediate 1.36 was obtained. Construction of 
the C ring 1.37 was achieved through an intramolecular aldol reaction. Once the oxetane ring 
was formed from 1.38 and the lateral chain was installed Taxol was isolated over 37 steps in 
total with a 0.09% overall yield. 
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Scheme 1.9: Wender´s total synthesis  
1.2.2.5 Kuwajima´s synthesis  
In 1998 Kuwajima and co-workers published their convergent synthesis of Taxol.24 In a similar 
strategy to the one used by Nicolaou, Kuwajima´s work involves the synthesis of A and  C rings. 
After connecting these two fragments and closing the B ring, the oxetane D ring was installed. 
The Ojima lactam was once again employed for the tail addition. Starting from the protected 
propargyl alcohol 1.40, E-silyl enol ether 1.41 was obtained in 34% yield after 8 steps (Scheme 
1.10). An asymmetric dihydroxylation was performed affording the α-hydroxy aldehyde 1.42 in 
90% ee. Once the pivalate was transformed to its corresponding silyl enol ether and a Peterson 
olefination was conducted, ring A 1.43 was successfully isolated. Condensation of vinyl lithium 
ring C 1.45, obtained from 2-bromocyclohexenone 1.44, afforded the AC bicyclic diol 1.46 as a 
single diastereomer. A vinylogous Mukaiyama aldol addition to the acetal motif was then 
performed for the closure of the B ring (1.47). Selective oxidations of the olefins at C4 and C7 
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and removal of the thiol yielded advanced intermediate 1.48. Incorporation of the oxetane ring 
and addition of the lateral chain gave Taxol in 0.007% overall yield over 59 steps. 
 
Scheme 1.10: Kuwajima´s total synthesis  
1.2.2.6 Mukaiyama´s synthesis  
One of the most recent total synthesis of Taxol was published in 1999 by Mukaiyama et al.25 In 
this linear approach, the eight membered B ring was firstly synthesised. Using L-Serine as 
starting material, aldehyde 1.49 was successfully synthesised after several Mukaiyama-type aldol 
reactions were performed (Scheme 1.12). Ring B 1.50 was formed using a SmI2-mediated 
cyclisation followed by the formation of the acetate and its elimination. Installation of the C 
ring was possible using a Michael addition and an aldol-type reaction as key steps, thus BC 
bicycle 1.53 was isolated with the correct configuration at C7 and C8 via intermediates 1.51 and 
1.52.  
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Scheme 1.11: Mukaiyama´s total synthesis  
Further transformations yielded diene 1.54 that was then subjected to a Wacker oxidation to 
transform the terminal double bond into a ketone; this was then followed by an intramolecular 
pinacol coupling. Deprotection of the benzyl and silyl protecting groups then provided ABC 
tricyclic core 1.55. After formation of the oxetane ring, Baccatin III was finally isolated. 
Interestingly, this synthesis employs a different connection with the side chain. Starting from 
benzaldehyde and silyl enol ether 1.56, an asymmetric aldol reaction afforded alcohol 1.58 with 
99% anti selectivity and 96% ee in the presence of 1.57. Following the installation off the alkyl 
side chain (1.59), Taxol was obtained in 0.05% overall yield over 52 steps. 
1.2.2.7 Baran´s synthesis  
In 2012, Baran and co-workers published a scalable enantioselective synthesis of taxanes.26 This 
route was further optimised to afford more than 100 g of the tricyclic core 1.60 in a simple batch 
protocol after performing a Diels Alder reaction that affords the desired diastereomer in 22% 
yield .27 A sequence of selective oxidations are the key steps for the transformation of 1.60 into 
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Taxol. Initially, a Cr(V)-based oxidation at C13 followed by a selective bromination at C5 
afforded the advanced intermediate 1.61 in 55% yield over two steps. Further transformations 
furnished the stable epoxide 1.62 in 8% yield after 8 steps. A stereoselective functionalisation 
of C7 was achieved in a one pot reaction via intermediates 1.63a-c. Treatment of 1.62 with 
TBAI/BF3·OEt2 followed by addition of 2-fluroropyridine, TMS-imidazole and DMDO 
afforded the desired olefin 1.64, which was further oxidized to the epoxy-taxane 1.65 in 43% 
yield. The tertiary alcohol 1.65 was isolated after Ti-mediated epoxide reduction followed by a 
BOM protection. Subsequent Burgess dehydration-TMS deprotection sequence afforded the 
allylic alcohol 1.67 in 18% yield over 4 steps. After formation of the oxetane ring and installation 
of the lateral chain at C13, Taxol was finally isolated in a 0.0014 % overall yield over 39 steps.  
 
Scheme 1.12: Baran´s total synthesis 
1.2.2.8 Total syntheses overlook 
As mentioned before, the preparation of the highly functionalised ABC system is the key part 
of Taxol´s total syntheses reported to date. Table 1 summarises the sequence in which the Taxol 
skeleton was constructed as well as the number of steps and the overall yields.   
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Table 1.1: Taxol’s total syntheses 
Group (year) Approach Steps Yield Sequence 
Holton (1994) Linear 56 0.6%* A→AB→ABC→ABCD 
Nicolaou (1994) Convergent 44 0.02% A+C→AC→ABC→ABCD 
Danishevsky (1996) Convergent 53 0.03% A+CD→ACD→ABCD 
Wender (1997) Linear 37 0.09% A→AB→ABC→ABCD 
Kuwajima (1998) Convergent  59 0.007% A+C→AC→ABC→ABCD 
Mukaiyama (1998) Linear  52 0.05% B→BC→ABC→ABCD 
Baran (2020) Linear 39 0.0014 % A→ABC→ABCD 
* From a 18 step prepared precursor 
 
1.2.3 Formal syntheses 
To date, three formal syntheses of Taxol have been reported. In this section only the key steps 
of each one will be discussed. Interestingly, the construction of the highly sterically hindered B 
ring represents the biggest synthetic challenge.   
1.2.3.1 Takahashi´s synthesis 
In 2006, Takahashi and co-workers reported a racemic synthesis of baccatin III.28 Remarkably, 
all the synthesis was accomplished by a single PhD student and several synthetic steps were 
performed in automatic synthesisers. Starting from geraniol 1.68, both A and C ring were 
successfully synthesised (1.69 and 1.70 respectively, Scheme 1.13). The coupling of both 
fragments afforded homoallylic alcohol 1.71 in 78% yield. A selective epoxidation followed by 
the reductive opening of the epoxide allowed the installation of the hydroxyl group at C1 (1.72). 
A sequence of protections, deprotections, oxidations and cyanohydrin formation yielded 1.73 
in 15% yield over 6 steps. Treatment of 1.73 with LiHMDS under microwave irradiation 
delivered the ABC tricycle core 1.74 in 49% yield. After installation of the D ring, baccatin III 
was isolated as a racemic mixture via intermediate 1.75. 
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Scheme 1.13: Takahashi´s formal synthesis  
1.2.3.2 Sato-Chida´s synthesis  
In 2015 Sato, Chida and co-workers published a formal synthesis of Taxol isolating  Takahashi´s 
intermediate 1.75.29 Ring C 1.77 was synthesised from known ketone 1.76 and then coupled with 
known hydrazone 1.79 by a Shapiro reaction affording 1.78 in 92% yield (Scheme 1.14). After 
further functionalisation, aldehyde 1.80 was isolated. Formation of the B ring using a samarium 
mediated cyclisation afforded ABC tricyclic core 1.81, which was then transformed into the 
Takahashi intermediate 1.75. This compound was synthesised in 0.07% overall yield over 38 
steps.  
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Scheme 1.14: Sato-Chida´s formal synthesis  
1.2.3.3 Nakada´s synthesis  
The most recent formal synthesis of Taxol was reported by Nakada and co-workers in 2015.30 
(Scheme 1.15). Three different approaches were explored towards the synthesis of the A-ring 
1.85-I (Scheme 1.15). Initially, using 1.82 as stating material, 1.85-I was synthesised in 48% yield 
after 14 steps via the silicon-tethered intermediate 1.84 (Scheme 1.15a). Notably, an 
enantioselective reduction of the ketone in the presence of baker´s yeast is used to set the 
stereochemistry in 1.83. The second approach involved the use of an enantioselective 
organocatalytic reaction starting from aldehyde 1.86-I and going via intermediate 1.89-I (Scheme 
1.15b). The final approach involved the synthesis of brominated fragment A 1.92-Br using a 
Sharpless asymmetric dihydroxylation of silyl enol ether 1.91-Br (Scheme 1.15c).   
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Scheme 1.15: Nakadas´s synthetic approaches to the A ring of Taxol 
In a parallel fashion, C-ring 1.97 was successfully synthesised (Scheme 1.16). Starting from 
diketone 1.93, protected alcohol 1.94 was isolated in 64% yield. 31 An enantioselective reduction 
catalyzed by baker´s yeast resulted in the correct stereocentres at C7 and C8. Later 
transformations yielded 1.97 via 1.96. Coupling of the two fragments via a halogen-lithium 
exchange reaction yielded 1.99-I and 1.99-Br in 95% and 80%, respectively. After further 
functionalisation, the eight-membered ring 1.101 was obtained by a palladium-catalysed 
alkelynation of methyl ketones 1.100-I and 1.100-Br. Subsequent transformations allowed the 
synthesis of Nicolaou´s intermediate 1.22.  
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Scheme 1.16: Nakadas´s formal synthesis of Taxol 
1.2.4 Additional synthetic efforts towards the Taxane skeleton 
In 1990 Swindell and coworkers published a stereoselective construction of the taxinine AB 
system (Scheme 1.17).32 Starting from enamine 1.102, an intramolecular [2+2] photoaddition 
reaction afforded 1.103 in 71% yield. Further transformations resulted in ketone 1.104 that was 
reduced and then mesylated. A fragmentation-elimination of the mesylate group gave 1.105, 
which after hydrolysis and elimination of the imine, reduction of the ketone at C2 and alkylation 
at C1 afforded alcohol 1.107. Once the epoxide 1.109 was obtained, a tandem aldol-Payne 
rearrangement annulation gave the desired AB bicyclic core 1.110 of taxinine in 70% yield. 
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Scheme 1.17: Stereoselective construction of the taxinine AB system 
In 2001, Tony Shing´s group accomplished the synthesis of Taxol´s CD ring system using a 
diasteroselective Diels Alder reaction to set up the correct configuration of the quaternary 
methyl group at C8 (Scheme 1.18).33 Starting from S-(+)-Carvone, an intermolecular Diels Alder 
reaction with isoprene followed by ketone protection, dihydroxylation and selective terminal 
cleavage oxidation furnished 1.111 in 61% yield. Further transformations afforded ketone 1.112 
that was then submitted to an Oppenaurer oxidation followed by a Meerwein-Ponndorf-Verley 
reduction yielding 1.113. Mesylated alcohol 1.114 was used as starting material for the formation 
of the D ring. Deprotection of the benzyl group and acetylation of the free alcohol afforded the 
desired CD bicyclic system 1.115.    
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Scheme 1.18: Synthesis of Taxol´s CD system by Shing´s group 
More recently, in June 2019, Inoue and co-workers reported a radical-based strategy for the total 
synthesis of 1-hydroxytaxinine 1.125 (Scheme 1.19).34 The key step of this approach is the 
connection of chiral A ring 1.117 and achiral C ring 1.120 using a decarbonylative radical 
coupling reaction. As shown in Scheme 1.19, A ring 1.117 was prepared in 9 steps form diketone 
1.116 and methyl acrylate. Treatment of 1.117 with Et3B in the presence of oxygen promoted a 
homolytic cleavage of the C-Te bond generating acyl radical 1.118. After spontaneous release of 
carbon monoxide, the α-alkoxy radical 1.119 was obtained. Interestingly, the acetonide protected 
1,2-diol redefines the stereochemistry at C9 since 1.120 can only approaches from the opposite 
side of the bulky C10-substituent in a 1,4-radical addition manner. After oxidation of boron 
enolate 1.121, enone 1.122 was obtained as a single enantiomer. Further transformations 
afforded keto-aldehyde 1.123 that was submitted to a pinnacol coupling thus forming the desired 
8- membered ring (1.124). Overall, 1-hydroxytaxinine 1.125 was prepared from ketone 1.116 in 
26 steps. 
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Scheme 1.19: Total synthesis of 1-hydroxytaxinine 1.125 
1.3 Olefin metathesis  
Olefin metathesis is one of the most used reaction in carbon-carbon bond formation. All its 
variations have been successfully employed in natural product synthesis and polymer industry 
due to its tolerance to several functional groups. In this section only a small background on this 
reaction will be provided, with an emphasis on the construction of the taxane skeleton.  
1.3.1 Generalities on the metathesis reaction 
Developed over 40 years ago, olefin metathesis is a transalkylidenation reaction that allows the 
exchange of substituents of two different olefins by forming a new carbon-carbon bond using 
transition metals as catalysts. Due to its numerous applications, in 2005 Yves Chauvin, Robert 
Grubbs and Richard Schrock received the Nobel Prize for their work in this field.35 Depending 
on the nature of the olefins employed as starting materials, the reaction can be either 
intermolecular or intramolecular (Scheme 1.20). The intermolecular process involves the use of 
two separate substrates and is refereed as cross metathesis (CM) while in an intramolecular 
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transformation, where the two olefins are on the same molecule, it is denoted as ring-closing 
metathesis (RCM). 
 
Scheme 1.20: Olefin metathesis 
In 1971 Yves Chauvin proposed the currently accepted mechanism of olefin metathesis by 
studying RCM of 1,7-octadiene.36 As shown in Scheme 1.21, the first step is the formation of 
the metallacyclobutane intermediate 1.127 by the [2+2] cycloaddition of a metal methylene 
complex 1.131. Even though this [2+2] cycloaddition is forbidden by symmetry and has a high 
activation energy, interactions with the metal catalyst d-orbital lower the activation energy 
enough for the reaction to proceed at room temperature. The formation of a new carbene 
complex 1.128, with the release of ethylene, drives the reaction towards the desired product 
1.130 and allows the recovery of the catalytic species 1.131. 
 
Scheme 1.21: Olefin metathesis mechanism 
After fortuitous discovery of nickel’s capabilities as a catalyst for this reaction, different efforts 
were made to look for more effective catalysts. In 1984 Richard Schrock synthesised the first 
catalyst, molybdenum complex S (Scheme 1.22), capable of carrying out this transformation.37 
Nevertheless, the lack of versatility towards highly functionalised olefins, especially those 
containing protonated heteroatoms, limited the use of this complex. In 1992, Grubbs 
discovered that ruthenium complexes were more tolerant towards several functional groups and 
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were also easier to handle (air stable). Since then, several generations of catalysts have been 
developed and successfully used in this transformation; some of them are presented in Scheme 
1.22.  
 
Scheme 1.22: Some metathesis catalyst 
Despite Chauvin’s mechanism being widely accepted, later studies on the first- and second-
generation catalysts revealed useful information.38 As shown in Scheme 1.23, the oxidation state 
of ruthenium in all Grubbs type catalysts is (II). In the case of G1, the 16-electron ruthenium is 
coordinated with two chlorine ligands, two tricyclohexylphosphine ligands and a benzylidene 
ligand. The loss of one of these electron-rich phosphine ligands leads to the formation of the 
catalytically active 14-electron ruthenium complex 1.132. Coordination of this species with the 
olefin used as the starting material yields a 16-electron carbenoid intermediate 1.133. Once 1.134 
is formed, the reaction proceeds as previously explained in Scheme 1.21.  
 
Scheme 1.23: Activation of G1 
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1.3.2 Taxoid synthesis by RCM 
Synthesis of eight-membered rings represents a significant challenge for organic chemists due 
to transannular interactions resulting in unfavourable entropy and enthalpy changes. The 
presence of an eight-membered ring in the taxoid skeleton exemplifies the need for efficient 
and high yielding methodologies for its construction. Several attempts have been carried out in 
this field in order to synthesise Taxol’s B ring using RCM. In 1999 Blechert and co-workers 
reported the synthesis of a simplified Taxol AB ring system starting from 1.136 (Scheme 1.24).39 
A RCM reaction between C3 and C8 was performed, giving 1.137 in 59% yield when using G1  
as catalyst. Interestingly, the outcome of this RCM reaction depended on the stereochemistry 
of the starting material as only one diastereomer of 1.136 cyclised while the other one underwent 
dimerisation. Additionally, in 2004 Srikrishna et al. successfully synthesised Taxol´s BC skeleton 
1.139 in 95% yield after performing a RCM between C10 and C11.40   
 
Scheme 1.24: Taxol´s AB and BC bicycles by Blechert and Srikrishna using RCM 
Previous work by the Prunet group also proved RCM as an excellent tool for the synthesis of 
the BC bicyclic system of Taxol. Initially a RCM at C9-C10 was studied while modifying 
protecting groups at C1 and C2 (Scheme 1.25).41 Pleasingly, all substrates employed (1.140a-c) 
lead to the desired products 1.141a-c in excellent yields. The best result was obtained when the 
Grubbs-Nolan catalyst GN2 was used and cyclic silane 1.140c was employed as starting material. 
Further experiments were performed to study a RCM between C10 and C11.42 Once more, 
different protecting groups at C1 and C2 were tested (1.142a-c) as well as the use of G2 as 
catalyst. The results were promising as bicyclic cores 1.143a-c were isolated in excellent yields.  
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Scheme 1.25: Synthesis of Taxol´s BC bicycle by Prunet et al. using RCM 
1.3.3 Ring-closing dienyne metathesis (RCDEYM) 
In order to understand the ring-closing dienyne metathesis reaction (RCDEYM), it is necessary 
to comprehend the ring-closing enyne metathesis (RCEYM). The first example of enyne 
metathesis with a ruthenium catalyst was reported by Mori and coworkers in the synthesis of 
five-, six- and seven-membered heterocycles in the presence of 1 mol% of G0 (Scheme 1.26).43  
 
Scheme 1.26: Enyne metathesis reported by Mori et al. 
The enyne metathesis mechanistic studies were first achieved using NMR analysis in 1999.44 
Since then, several studies have been performed and two plausible mechanism are currently 
accepted.45 As shown in Scheme 1.27, the initial intermolecular reaction of the metal-carbene 
can occur with either the alkyne or the alkene moiety. Both pathways result in the formation of 
the same conjugated diene product 1.150 (exo-product). The preference between the “yne-then-
ene” and the “ene-then-yne” mechanism is determined by the ligands of the catalyst and the 
electronic and steric properties of the reactive alkene and alkyne in 1.146. For example, when 
an enyne containing a terminal alkene and a terminal alkyne under identical steric and electronic 
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environments; results show the reaction pathway initiates preferably at the alkene and the alkyne 
when using G1 and G2, respectively. The mechanism leading to the endo-product is not 
presented here since it is not relevant for this project.    
 
Scheme 1.27: Mechanisms of the enyne metathesis reaction 
When a RCEYM reaction results in a second ring-closing metathesis, the dienyne reaction is 
known as RCDEYM. In 1994, Grubbs and co-workers synthesised fused bicyclic ring 1.156 
from symmetrical 1.155 in 95% yield (Scheme 1.28a).46 Nevertheless, a selectivity problem can 
be observed when non-symmetrical dienyne precursors are employed. Two different products 
can be formed depending on where the first metallacarbene is formed. When differentiating the 
two olefins by adding an extra substituent to one of them, the reactivity can be modified towards 
the desired compound.46-47 For example, when 1.157a was submitted to a RCDEYM, no 
selectivity between the products 1.158 and 1.159 was observed (Scheme 1.28b). However, the 
introduction of a methyl group, resulting in compound 1.157b with two non-equivalently 
reactive olefins, led to 1.158 as the only product of the metathesis reaction. It is worth 
mentioning that the extra methyl introduced is not present in the final compound. 
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Scheme 1.28: RCDEYM by Grubbs 
In 1998, Grubbs applied this “domino” sequence to the construction of bicyclic systems from 
acyclic compounds (Scheme 1.29). For example, the tricycle 1.161 was successfully synthesised 
by submitting 1.160 to a RCDEYM in the presence of G1. Furthermore, extra alkynes can be 
added, and the tetracyclic steroid-like product 1.163 was produced in 70% yield.48 
 
Scheme 1.29: RCDEYM by Grubbs 
Different applications have been developed in this field, including the use of alkynyl boronates49 
and bicyclic phosphonates50 as starting materials, as well as the synthesis of unsatured cyclic 
lactones,51 highly polycyclic alkaloids52 and naturally occurring compounds.53  
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1.3.4 Synthesis of taxane analogues by RCDEYM 
In 2008 Granja and co-workers published the first attempts to synthesise taxane analogues using 
RCDEYM.54 The aim of this work was to study the effect of the relative configuration of the 
C1, C3, C4 and C8 stereocentres in the RCDEYM reaction (Scheme 1.30). It was found that a 
trans relationship between the substituents at C3 and C8(S) was essential for the cyclisation as 
the reaction was not successful when three isomers (1.164b-d) were tested and 1.164a was the 
only diastereomer that gave the desired metathesis product (1.165a). Disappointingly, 
compound 1.165a possesses the wrong relative configuration at C1 and C8 for the taxanes. 
 
Scheme 1.30: Granja and co-workers RCDEYM attempts towards taxane synthesis 
The effect of different substituents at the C4 position was also studied. Initially, only 
decomposition of ketone 1.166 was observed when G2 was used as catalyst (Scheme 1.31). Since 
later attempts to protect the ketone as a ketal failed, reduction to the corresponding alcohol was 
performed. Decomposition was also observed when submitting the free alcohols 1.167a-b to 
RCDEYM. However, after protection of the two hydroxyl groups in 1.168a-b, the desired 
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products 1.169a-b were successfully isolated. Interestingly, the stereochemistry at C4 does not 
affect the reaction yield. Once again, these compounds have the undesired configuration at C1 
for taxane derivatives. 
 
Scheme 1.31: Influence of stereochemistry at C4 on RCDEYM by Granja 
As a continuation of his work, Granja was interested in the introduction of the C1 hydroxyl 
group present in Taxol.55 Once the metathesis precursors 1.170a-b and 1.171a-b were 
synthesised, products 1.172a-b and 1.173a-b were successfully obtained after submitting the 
mixture of diastereomers to RCDEYM conditions. Remarkably, the ketone at C4 does not 
negatively affect the reaction. Additional experiments also showed that all alcohols must be 
protected for the reaction to occur. In this work, the gem-dimethyl of Taxol at C15 is not present, 
diminishing the steric hindrance around the alkyne.    
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Scheme 1.32: Granja´s studies towards taxane analogues synthesis by RCDEYM 
1.3.5 Relay ring-closing metathesis (RRCM) 
The relay ring-closing metathesis reaction (RRCM) involves the initiation of a RCM at a reactive 
alkene followed by a rapid intramolecular relay of the metal centre to an initially less reactive 
olefin in the starting material. To fully understand the relay ring-closing metathesis reaction 
(RRCM) and its importance, it is necessary to comprehend the reactivity difference observed in 
distinct olefins. Scheme 1.33 shows the possible products obtained in a metathesis reaction 
starting from two different olefins (1.174 and 1.175). In this case, 1.176 is the desired product, 
compounds 1.177 and 1.178 are homodimers of the CM and the driving force of the reaction is 
the release of volatile ethylene.   
 
Scheme 1.33: Possible products in CM  
Selectivity towards the formation of 1.176 is desirable and several efforts have been made to 
avoid dimerisation of the starting materials. In 2003, Grubbs and coworkers proposed a general 
model where the reactivity and ability to homodimerise of several olefins can be predicted 
depending on their electronic and steric properties.56 Four different types of olefins are 
proposed and their classification depends on the catalyst employed. As shown in Table 1.2, 
electron-rich unhindered alkenes are more reactive. Olefins will be less reactive if their steric 
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hindrance and/or electron deficiency is increased, to the point of being completely unreactive 
(type IV).  
Table 1.2 – Classification of olefins 
Olefin type G2 G1 
Type I (fast 
homodimerisation) 
Terminal olefins, 1° allylic 
alcohols, allyl halides 
Terminal olefins, 1° allylic 
alcohols 
Type II (slow 
homodimerisation) 
Acrylamide, acrolein, vinyl 
ketones, vinyl epoxides, 2° 
allylic alcohols 
Styrene, 2° allylic alcohols 
Type III (no 
homodimerisation) 
1,1-disbstituted olefins, 
non-bulky trisubstituted 
olefins 
Vinyl siloxanes 
Type IV (inert to CM but 
no catalyst deactivation) 
Protected trisubstituted allyl 
alcohols 
1,1-disubstituted olefins 
 
Even though the first observation of a RRCM was done in 1998 by Parrain and Santelli et al.,57 
it was not until 2004 that Hoye and coworkers studied its application in olefin activation.58 The 
RRCM strategy consists in the addition of a side chain, encompassing a more active terminal 
double bond, to an alkene that under conventional metathesis conditions is unreactive. For 
example, metallic carbene 1.180 was not formed when 1.179, containing two gem-disubstituted 
terminal olefins, was subjected to RCM in the presence of G1. However, when 1.182 was 
subjected to the same reaction conditions, carbene 1.183 was efficiently formed and volatile 
cyclic compound 1.184 was released. Once 1.180 was formed, the desired product 1.181 was 
isolated in 66% yield.  
 
Scheme 1.34: Possible products in CM  
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Nowadays, several applications of RRCM can be found in the synthesis of natural products. 
Oximidine III, a macrolactone with promising biological activity, was successfully synthesised 
by Porco and coworkers in 2004.59 Cyclisation of 1.185 in the presence of G2 formed the desired 
macrocycle 1.186 in 71% yield (Scheme 1.35). Interestingly, a RCM reaction without the addition 
of the tail let to a poor 15% yield of 1.186.  
 
Scheme 1.35: RRCM in the total synthesis of oximidine III 
Trauner and coworkers employed a RRCM strategy in the total synthesis of (-)-archazolide B in 
2007.60 Starting from 1.187, the desired macrocycle was formed in 27% yield using G2 as catalyst. 
Subsequent deprotection of the TBS group yielded (-)-archazolide B in 84% yield (Scheme 1.36). 
The conjugated alkene in 1.187 and the size of the new cycle formed must be considered to 
explain the low yield observed in the RCM step, 
 
Scheme 1.36: RRCM in the total synthesis of (-)-archazolide B 
The formation of eight-membered rings has been a challenge for organic chemists due to their 
unfavourable entropy and enthalpy caused by transannular interactions. The RCM reaction has 
been widely explored and applied as a versatile tool for the formation of cyclic compounds. In 
  
35 
 
addition to the examples described above, numerous applications of RCM can be found in the 
literature.61 RCDEYM and RRCM are powerful tools for the construction of complex polycyclic 
systems in a single step and have been widely employed in the synthesis of natural occurring 
compounds, including several taxanes. Taking this into account, the aim of this project 
(described in the next section) involves the use of RCDEYM and RRCM in a formal synthesis 
of Taxol.  
1.4 Project aim  
This project is focused on two different synthetic efforts towards a formal synthesis of Taxol, 
each one described in detail in the next two chapters. Previous work within the Prunet group is 
also detailed at the beginning of each chapter.   
In Chapter 2, a ring-closing dialkene alkyne metathesis (RCDEYM) is envisioned to form the 
tricyclic core. The primary target is the intermediate described by Holton during his synthesis 
of Taxol. The formation of the ABC skeleton by a cascade RCDEYM reaction constitutes the 
key step of this approach (Scheme 1.37) 
 
Scheme 1.37: RCDEYM as key step in the formal synthesis of Taxol 
The second strategy, discussed in Chapter 3, involves a relay ring-closing metathesis (RRCM) as 
the key step for the construction of the B ring once the A and C rings are already coupled 
(Scheme 1.38). In this case, the target molecule is a racemic C7 deoxygenated tricyclic core. A 
study on the effect of the lateral chain in the RRCM is also proposed. 
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Scheme 1.38: RRCM as key step in the formal synthesis of Taxol 
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Chapter 2: Towards a formal synthesis of  Taxol 
using a ring-closing dienyne metathesis strategy 
In this chapter, a ring-closing dialkene alkyne metathesis (RCDEYM) cascade toward a formal 
synthesis of Taxol is presented. This work is the extension of the previous work performed by 
Cong Ma,62 Rémi Aouzal63 and Aurélien Letort64 during their PhD theses under the supervision 
of Dr Joëlle Prunet.  
2.1 Previous work in the group 
Cong Ma´s retrosynthesis is outlined in Scheme 2.1.62 In this case, Taxol could be prepared from 
Holton’s intermediate as previously described in his landmark synthesis.20 In order to investigate 
the formation of the ABC tricyclic core, Ma chose a model system to work on and aimed for 
the construction of the C7-deoxy Holton intermediate since C7-deoxy taxanes do not exhibit a 
significant decrease of biological activity.65  
 
Scheme 2.1: Cong Ma´s retrosynthesis for C7-deoxy Holton´s intermediate 
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Installation of the A ring in the C7-deoxy ABC tricyclic core from diketone 2.1 could be 
achieved using a pinacol coupling. Diketone 2.1 would be prepared from alkyne 2.2, which in 
turn could be synthesised from diene 2.3 using a RCM reaction. 
Once intermediate 2.3 was synthesised, it was submitted to a RCM using 5 mol% of G2. Despite 
full conversion of the stating material achieved after 1 hour, no traces of the desired bicycle 2.2 
were observed and instead compound 2.4 was isolated in 91% yield (Scheme 2.2). Unexpectedly, 
a RCDEYM cascade reaction (involving the alkyne at C13) resulted in the formation of the 6-
8-6 tricyclic core of taxol 2.4 where the gem-dimethyl group was in the wrong position.   
 
Scheme 2.2: First RCDEYM reaction observed in the Prunet group 
The successive PhD student, Rémi Aouzal, proposed to take advantage of this unexpected but 
efficient metathesis cascade. Thus, he prepared a second generation of metathesis precursors 
(2.5a-b) in which the alkyne group was now positioned at C11 and the alkene group at C13. An 
extra methyl group was introduced at C13 in order to disfavour the RCM reaction to first take 
place at this position. Unfortunately, after subjecting 2.5a and 2.5b to RCM using 5 mol% of 
G2, the undesired bicyclic cores 2.7a and 2.7b were isolated in 68% and 83% yields respectively 
(Scheme 2.3).63 
 
Scheme 2.3: Aouzal’s attempts to form the ABC tricycle via RCDEYM  
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Isolation of 2.7a-b instead of desired 2.6a-b was attributed to the high steric hindrance around 
the alkyne caused by the gem-dimethyl group at C15. Since this steric hindrance cannot be 
decreased because this group is present in the Taxol skeleton, Aurélien Letort proposed to 
decrease the reactivity of the olefin at C13 by adding an extra methyl group. As shown in Scheme 
2.4, a third generation of metathesis precursors were successfully synthesised (2.8a-b and 2.9a-
b). Interestingly, the product of the reaction was determined by the protecting group of the diol 
at C1 and C2 and its relative configuration to C8. Only compound 2.9b resulted in the formation 
of desired tricyclic core 2.13b while bicycles 2.10a-b and 2.11a were isolated as the only products 
when using 2.8a-b and 2.9a as starting materials.64 
 
Scheme 2.4: Dienyne metathesis attempts by Letort 
After optimisation of the RCDEYM reaction, 2.13b was isolated in 70% yield after 12 h using 
Zhan-1B as catalyst. Applying the same reaction conditions to the C7-oxygeneted diene 2.14, 
led to the formation of the desired tricyclic core 2.15 in a range of 35 to 40% yield as the only 
isolable product.  
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Scheme 2.5: Optimised RCDEYM for the synthesis of 2.13b and 2.15 by Letort 
Letort´s final work focused on the synthesis of an advanced Taxol intermediate. Diol 2.16 was 
successfully prepared from 2.15. The alcohol at C10 in 2.16 has the opposite configuration to 
that of Holton´s intermediate but the correct configuration for Taxol. Several attempts made to 
obtain the opposite diastereomer were unsuccessful. The advanced intermediate 2.17 with five 
oxygenated functional groups was synthesised using substrate control. At this point, the oxetane 
D ring and the C9 ketone were the only two oxygenated groups missing. However, numerous 
efforts towards the functionalisation of the C4 olefin were unsuccessful, thus leading to the 
conclusion that an early derivatisation must be performed. 
 
Scheme 2.6: Letort´s studies towards Holton´s intermediate 
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2.2 Project presentation and retrosynthetic analysis 
The idea of functionalising the C4 position before the RCDEYM will be discussed in this 
chapter. Following the revised retrosynthetic route envisioned in the Prunet group, the primary 
target is the Holton intermediate and the key step is the formation of the ABC tricyclic core by 
a cascade RCDEYM reaction once C4 has been already oxidised (Scheme 2.7). The A and B 
rings would be obtained from the dienyne precursor 2.20 bearing a trisubstituted olefin at C13. 
This compound could be synthesised by a Shapiro coupling between the fragments A and C. 
 
Scheme 2.7: Taxol retrosynthesis using a RCDEYM as the key step 
 
2.3 Synthesis of  fragment A 
2.3.1 Plan of synthesis of fragment A 
The retrosynthetic analysis for the racemic fragment A (±)2.28 is presented in Scheme 2.8. 
Starting from commercially available ester 2.21, ketone 2.26 could be synthesised by direct 
addition of a prenyl moiety to Weinreb amide 2.25 using a Grignard reagent. Cyanation of 2.26 
followed by reduction to the aldehyde could lead to desired aldehyde (±)2.28.  
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Scheme 2.8: Plan of synthesis of fragment A 
2.3.2 Racemic synthesis 
Aldehyde (±)2.28 has been previously synthesised by Aurélien Letort in 66% overall yield. As 
shown in Scheme 2.9, this route was optimized. The first step of the synthesis was the alkylation 
of ethyl isobutyrate 2.21 with propargyl bromide. After in situ preparation of LDA using 
diisopropylamine and n-BuLi, ester 2.22 was successfully isolated in quantitative yield. 
Hydrolysis of the ester followed by isomerisation of the terminal alkyne afforded 2.24 in 84% 
yield over two steps. Treatment of 2.24 with carbonyldiimidazole and N,O-
dimethylhydroxylamine resulted in the desired Weinreb amide 2.25, which was then submitted 
to a Grignard addition affording stable β,γ-unsaturated ketone 2.26 in 95% yield. Further 
treatment of 2.26 with TMSCN in the presence of zinc iodide provided the silylated cyanohydrin 
(±)2.27 in almost quantitative yield. Reduction of this cyanohydrin (±)2.27 using DIBALH led 
to the corresponding imine that was then hydrolysed under mild acidic conditions by adding 
SiO2 to the reaction mixture. In summary, the racemic aldehyde (±)2.28 was obtained in 72% 
overall yield over 7 steps.  
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Scheme 2.9: Synthesis of racemic fragment A (±)-2.28 
2.3.3 Efforts towards the synthesis of an enantioenriched fragment A 
Attempting to further the efficiency of the synthetic route towards Taxol, the synthesis of an 
enantioenriched fragment A was investigated. Previously in the group, Letort tested the 
enantioselective cyanosilylation of ketone 2.26 using cinchona alkaloids as catalyst.66 When 
performing the reaction with cyanoformate and (DHQ)2AQN as the chiral ligand, alcohol 2.29 
was obtained in 83% yield with 33% ee (Scheme 2.10a). A cyanosilylation using Al-Salen 
complexes was also attempted, but unfortunately resulted in the formation of cyanohydrin 2.27 
in  95% yield but with only 7% ee (Scheme 2.10b). Finally, a cyanosilylation using a Schiff Base 
was tried,67 affording the desired cyanohydrin 2.27 in 81% yield, but, once again, with a low 
(10%) ee (Scheme 2.10c). 
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Scheme 2.10: Letort’s work towards the synthesis of enantioenriched fragment A 
In 2016 Zhou and co-workers reported the activation of a chiral (salen)AlCl complex by a 
phosphorane for the highly enantioselective cyanosilylation of ketones and enones (Scheme 
2.11).68 Several alkyl and aryl ketones, even in the presence of conjugated enones, afforded the 
desired cyanohydrins in moderate to good yields with excellent enantioselectivities. 
 
Scheme 2.11: Catalytic asymmetric ketone cyanosilylation by Zhou et al. 
These conditions were applied to ketone 2.26, furnishing the desired cyanohydrin 2.27 in 
quantitative yield. In order to determine the enantiomeric excess, coupling with an enantiopure 
compound was first envisioned. Reduction of 2.27 using DIBALH afforded 2.28 and its 
treatment with LiAlH4 yielded deprotected diol 2.30 in quantitative yield. Unfortunately, the 
esterification attempt with Boc-protected proline was unsuccessful, probably due to the steric 
hindrance of both substrates, so addition of a chromophore was attempted in order to 
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determine the enantiomeric excess by chiral HPLC.  Nitrobenzoate derivative 2.31 was isolated 
in 87% yield after coupling of 2.30 with p-nitro benzoyl chloride. Inconveniently, separation of 
the two enantiomers by HPLC with a chiral column was not possible and thus the enantiomeric 
excess (28% ee) was finally determined after Shapiro coupling of 2.28 with hydrazone 2.71 
(Scheme 2.28).  
 
Scheme 2.12: Synthetic efforts towards an enantioenriched fragment A 
2.4 Synthesis of  fragment C 
2.4.1 Retrosynthesis 
The retrosynthesis of Fragment C is outlined in Scheme 2.13 and uses the same key 
disconnections proposed by Letort in his thesis.64 Hydrazone 2.71 could be obtained by 
hydrazine condensation followed by acetalisation from 2.38, which in turn could be prepared 
from the (+)-Wieland-Miescher ketone 2.35 by performing a diastereoselective reduction and 
consecutively a decarbonylative ozonolysis. Finally, the (+)-Wieland-Miescher ketone 2.35 
would be synthesised starting from the commercially available diketone 2.32. 
  
46 
 
 
Scheme 2.13: Retrosynthesis of fragment C 
2.4.2 Synthesis of the ozonolysis precursor 
The ozonolysis precursor 2.37 has been previously synthesised by Letort in 74% yield over 4 
steps, and we used the same pathway, described in Scheme 2.14. Initially, the (+)-Wieland-
Miescher ketone 2.35 was synthesised by a Michael addition between 2.32 and methyl vinyl 
ketone followed by a Robinson annulation catalysed by (S)-binam-(L)-prolinamide 2.34.69 This 
catalyst is the only source of chirality used in the synthesis of enantiopure fragment C 2.71 and 
sets the absolute configuration of the quaternary stereocentre at C8. Reduction of 2.35 afforded 
alcohol 2.36 in 97% yield as a single enantiomer in a substrate-control diastereoselective 
reaction. Protection of the secondary alcohol using TESCl formed the desired substrate 2.37, 
in 86% overall yield over 4 steps from diketone 2.32. 
 
Scheme 2.14: Synthesis of ozonolysis precursor 2.37 
2.4.3 Ozonolysis 
With vinyl ketone 2.37 in hand, the previously reported conditions from Letort´s thesis for the 
preparation of acid 2.38 were followed, and the ozonolysis reaction was performed using 
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methanol as solvent. Unfortunately, it was not possible to reproduce the 88% yield obtained by 
Letort and a complex mixture of products was observed. Depending on the scale and reaction 
time, the ratio between the starting material 2.37, carboxylic acid 2.28 and lactone 2.39 varied 
significatively. Nevertheless, the maximum yield obtained for 2.38 was 53% (63% brsm) when 
using 3.37 mmol of 2.37. An increase in the reaction scale resulted in no formation of the desired 
acid but formation of lactone 2.39 in 66% yield as the only isolable product (Scheme 2.15). The 
low reproducibility and challenging purification of the product represented one of the major 
drawbacks in the synthesis.  
 
Scheme 2.15: First ozonolysis attempt 
The proposed mechanism for the decarbonylative ozonolysis is shown in Scheme 2.16. 
Molozonide 2.40 is formed after the [3+2] cycloaddition of 2.37 and ozone. Subsequent retro-
cycloaddition leads to carbonyl oxide 2.41. Once five-membered ring 2.42 is formed, addition 
of methanol is followed by a rearrangement furnishing the corresponding carboxylic acid 2.38 
along with methyl formate. Formation of lactone 2.39 can be explained by in situ removal of the 
TES protecting group and a lactonisation reaction.  
Scheme 2.16: Proposed mechanism of decarbonylative ozonolysis 
Three alternatives to avoid the formation of lactone 2.39 were explored. Firstly, an exchange of 
the alcohol protecting group was envisioned (Scheme 2.17a). Treatment of 2.36 with TBSCl 
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and imidazole afforded TBS protected alcohol 2.46 in excellent yield; however, the ozonolysis 
reaction produced the carboxylic acid 2.47 in a poor 36% yield.  
 
Scheme 2.17: Alternatives to avoid formation of lactone 2.39 
Secondly, an oxidative cleavage with sodium periodate and potassium permanganate was 
performed, providing 2.38 in 63% yield (Scheme 2.17b).70 Even though this cleavage emerged 
as a feasible alternative, when the reaction was scaled up to over 500 mg of 2.46, the yield 
dropped dramatically and thus it was no longer a viable option. Finally, an osmium tetroxide-
promoted oxidative cleavage was attempted but no reaction was observed and the starting 
material was fully recovered (Scheme 2.17c).71 
With these results in hand, an optimisation of the original ozonolysis reaction was attempted. 
As shown in Table 2.1, entries 1 and 2, the use of dry methanol did not increase the reaction 
yield. Changing the reaction solvent to dichloromethane led to decomposition products and 
only traces of 2.38 were observed by the crude 1H NMR (entry 3). When, five equivalents of 
pyridine were added to the reaction mixture, acid 2.38 was isolated in 42% and 59% yield using 
wet and dry methanol, respectively (entries 4 and 5). These conditions were easily reproducible, 
and the reaction could be performed on a six-gram scale (20.3 mmol).   
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Table 2.1: Ozonolysis optimisation  
 
Entry Conditions Yield 
1 Wet MeOH 52%* 
2 Dry MeOH 53%* 
3 Dry CH2Cl2, then MeOH Traces
* 
4 Wet MeOH, py (5 equiv) 42%* 
5 Dry MeOH, py (5 equiv) 59%** 
   
* When using 1.63 mmol of 2.37 
** When using either 1.63 or 20.0  mmol of 2.37  
 
2.4.4 Towards the synthesis of hemiacetal 2.49 
With carboxylic acid 2.38 in hand, the synthesis of hemiacetal 2.49 was explored. Initially, the 
synthesis of the aldehyde 2.48, followed by deprotection of the TES group was investigated 
(Scheme 2.18). Since 2.48 proved to be extremely unstable, the deprotection reaction was carried 
out on the crude aldehyde without further purification.   
 
Scheme 2.18: Proposed synthesis of lactol 2.49 
2.4.4.1 Fukuyama reduction  
The Fukuyama reaction is the reduction of a thioester to its corresponding aldehyde by a silyl 
hydride in the presence of a catalytic amount of palladium. Even though it is not a direct 
reduction of carboxylic acids to aldehydes, it is a mild alternative with a good functional group 
tolerance. The mechanism of the Fukuyama reduction is shown in scheme 2.19. Starting from 
thioester 2.50, the reaction begins with an oxidative addition of the C-SEt bond to the catalytic 
Pd(0). Transmetallation of 2.51 with triethylsilane affords acylpalladium hydride 2.53. Finally, 
  
50 
 
reductive elimination of 2.53 affords the desired aldehyde 2.54 and regenerates the catalytic 
Pd(0) species. 
 
Scheme 2.19: Mechanism of the Fukuyama reduction 
As shown in Scheme 2.20, keto acid 2.38 underwent a thioesterification affording thioester 2.55 
in quantitative yield. Although hemiacetal 2.49 was first obtained in 84% yield after the 
Fukuyama reduction and the acid-catalyzed deprotection, further attempts were not 
reproducible; furthermore, lactone 2.39 was being isolated instead. 
 
Scheme 2.20: Synthesis of lactol 2.49 via a Fukuyama reaction 
The lack of reproducibility in synthesizing 2.49 was attributed to the possible poisoning of the 
Pd(0) catalyst by the presence of small amounts of sulfur-containing compounds remaining in 
the purified thioester. Unfortunately, reduction of the equivalents of ethanethiol employed in 
the thio-esterification and degasification of the dichloromethane employed did not improved 
the results previously obtained. When palladium acetate was used as catalyst for the reduction 
instead, only starting material was recovered. In a final effort to avoid palladium poising, a 
catalytic amount of TESCl was added when conducting the Fukuyama reaction. Unfortunately, 
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after the deprotection of the TES group, thioether 2.56 instead of hemiacetal 2.49 was obtained 
as the only product (Scheme 2.21). A precedent in the literature was found that could explain 
this transformation.72 
 
Scheme 2.21: Synthesis of thioether 2.56 
2.4.4.2 Vilsmeier-Haack reduction 
A selective reduction of the acid over the ketone using the Vilsmeier-Haack conditions was 
attempted (Scheme 2.22).73 Firstly, the Vilsmeyer-Haack Reagent was formed by dissolving 
oxalyl chloride in DMF at -20°C and 2.38 was added dropwise, followed by the mild reducing 
agent LiAlH(t-BuO)3. Treatment of the crude product with HBr allowed isolation of the desired 
lactol 2.49 in 30% yield when 3.82 mmol (1.25 g) of 2.38 were used as starting material. Due to 
the unsuccessful attempts to improve the yield, these conditions were discarded.  
  
Scheme 2.22: Synthesis of lactol 2.49 via a Vilsmeier-Haack reduction 
2.4.4.3 Selective reduction via Weinreb amide 2.60 
Lastly, a selective reduction of a Weinreb amide in the presence of a ketone was attempted.74 
Using carboxylic acid 2.57 as a model substrate, Weinreb amide 2.58 was obtained in 
quantitative yield and then treated with tri-butyl phosphine and TMSOTf followed by slow 
addition of DIBALH, affording desired aldehyde 2.59 in 38% yield (Scheme 2.23). The same 
conditions were next applied to carboxylic acid 2.38, giving Weinreb amide 2.60 in 74% yield. 
Unfortunately, when the reduction was attempted, only decomposition of the starting material 
was observed.  
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Scheme 2.23: Selective reduction via Weinreb amide 2.60 
2.4.5 Using lactone 2.39 as starting material 
Due to the low reproducibility in the synthesis of hemiacetal 2.49, the use of lactone 2.39 was 
considered. Even though 2.39 was isolated as an undesired product in the ozonolysis and the 
Fukuyama reaction, a new pathway towards its synthesis was implemented. As shown in Scheme 
2.24, treatment of 2.38 with CSA afforded lactone 2.39 in 61% yield. Preparation from thioester 
2.55 was also achieved in 80% yield.  
 
Scheme 2.24: Synthesis of lactone 2.39 
With lactone 2.39 in hand, two different approaches were tested: (a) a reduction-oxidation 
sequence (Scheme 2.25a) and (b) a selective protection of the ketone (Scheme 2.25b). Initially, 
complete reduction of the hydroxyl groups was achieved with 2.1 equivalents of DIBALH, 
affording 2.61 in 90% yield as a mixture of 4 diastereoisomers. Selective oxidation of the alcohol 
over the hemiacetal was attempted by dissolving the mixture of diastereoisomers in acetone and 
adding 0.95 equivalents of Jones reagent. A complex mixture of polar compounds was obtained 
suggesting that protection of the ketone before the reduction was necessary. Selective protection 
of the ketone over the lactone in 2.39 as a hemiacetal using methyl orthoformate was also 
studied but afforded methyl ester (±)2.62 instead of desired 2.63.  
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Scheme 2.25: Selective reactions on lactone 2.39 
Disappointed by these results and considering that a hydrazone group is required for the Shapiro 
coupling, we decided to perform the lactone reduction at a later stage. Condensation of 
hydrazine with ketone 2.39 was achieved in the presence of catalytic amounts of concentrated 
hydrochloric acid thus affording the desired hydrazone 2.64 in 38% yield (Scheme 2.26). 
Reduction of 2.64 using DIBALH led to the isolation of lactol 2.65 in 42% yield. However, 
methylation of the hydroxyl group with silver(I)oxide and methyl iodide only gave 
decomposition products.  
 
Scheme 2.26: Installation of hydrazone before the lactone reduction  
2.4.6 Fragment C: Endgame 
As shown in Scheme 2.27, protection of ketone 2.39 as the phenylsulfonyl hydrazone 2.67, 
cheaper to prepare than the corresponding trisyl hydrazone 2.64, allowed the reduction to lactol 
2.68 using DIBALH in 86% yield. Copper (II) chloride was tested for the cleavage of the 
hydrazone, however, after stirring the reaction for three days, full conversion of the starting 
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material was not observed. When stirring 2.68 in THF with an aqueous solution of HBr (7%), 
the desired lactol 2.69 was isolated in 71% yield. Finally, methylation and subsequent hydrazine 
condensation afforded the desired fragment C 2.71 in 86% for the 2 steps. Overall, the fragment 
C 2.71 was obtained in 14% yield over 11 steps starting from diketone 2.32. The ozonolysis 
reaction and the lactone synthesis are the main drawbacks of this route to prepare this fragment.  
 
Scheme 2.27: Synthesis of fragment C 2.71  
2.5  Shapiro coupling 
With racemic fragment A (±)2.28 and enantiopure fragment C 2.71 in hand, the next step was 
to couple these two fragments. A Shapiro reaction using t-BuLi at -78°C was followed by 
cleavage of the TMS ether under acidic conditions, affording the two diastereomers 2.72a and 
2.72b in a 1:1 ratio and in 80% yield over the 2 steps. The diastereomeric ratio of the synthesised 
diols was then determined by comparison of the integrals of H-4 and H-13 from the crude 1H 
NMR spectrum. These two diastereomers, which can be separated by flash column 
chromatography, differ at the C1 and C2 configurations. They will be denominated as taxol-
like (2.72b) and taxol-unlike (2.72a). Formation of alkene 2.73 was also observed (11% yield). 
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Scheme 2.28: Shapiro coupling using racemic fragment A (±)2.28 and fragment C 2.71. 
As shown in Scheme 2.29, this reaction proceeds via the vinyl lithium intermediate 2.76 and 
requires two equivalents of t-BuLi. The first equivalent deprotonates the nitrogen of 2.71 
generating the first lithium salt 2.74a, while the second one removes a proton in the α-position 
of the hydrazone promoting the elimination of the sulfinate anion and resulting in the formation 
of 2.74b. Increasing the reaction temperature from -78°C to 0°C induces the release of nitrogen 
and thus generates the active vinyl lithium intermediate 2.76. Its reaction with aldehyde (±)2.28 
results in the formation of isomers 2.72a-b, whereas alkene 2.73 is obtained after quenching 
2.74c with water since a 1.2 : 1 ratio of 2.71 to (±)2.28 was employed. Furthermore, this reaction 
was performed using the enantio-enriched aldehyde previously synthesised (Scheme 2.12), 
affording a 28% ee of the desired isomer 2.72b. As shown in the experimental section and in 
the appendix section, it is possible to differentiate the protons at the C4 position between diols 
2.72a and b.   
 
Scheme 2.29: Formation of the active vinyl lithium intermediate 2.74c  
The steric Felkin-Anh model can explain the diastereoselectivity of the reaction for the Taxol 
like compound. As shown in Scheme 2.30, in the Newman projection of the aldehyde prior to 
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the attack of 2.74c; the largest group (bearing the gem-dimethyl moiety) is positioned 
perpendicular to the carbonyl group. After the addition of reactive vinyl species 2.74c, a trans 
relationship (i.e. would be trans if the B-ring were closed) between the two hydroxyl groups was 
observed. A similar model can be applied for the Taxol un-unlike alcohol. The absolute 
configuration for the taxol-like derivate 2.76b was confirmed by Letort using X-ray diffraction.  
All the 13C NMR and 1H NMR spectrum of the diols 2.72a-b and its derivatives were compared 
to those reported.64  
 
Scheme 2.30: Diastereoselectivity in the Shapiro reaction  
2.6  Functionalisation of  the C4 position 
2.6.1 Initial attempts 
Once diols 2.72a-b were isolated, several attempts to functionalise the C-4 position in both 
diastereomers were tested. Initially a directed hydroboration using Wilkinson catalyst and 9-
BBN in THF was attempted on 2.72a (Scheme 2.31).75 After stirring the reaction at room 
temperature for 24 hours, full conversion of the starting material was not observed but several 
compounds were distinguishable by TLC. Once the reaction was quenched, 1H NMR revealed 
several compounds, but no olefinic protons were observed. The lack of selectivity in this 
hydroboration procedure represented a drawback in the functionalisation of C4 over C13.  
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Scheme 2.31: Hydroboration using Wilkinson catalyst 
Thus, a selective oxidation of C4 over C13 must be accomplished. Firstly, directed epoxide 
formation was attempted using two different vanadium complexes (Table 2.2, entries 1 and 2).76 
Unfortunately, in both cases several compounds were observed by TLC and NMR, and ketone 
2.26 was isolated after purification, showing the oxidative cleavage of the diol. Sharpless 
epoxidation was also tried but similar results were obtained (entry 3). 
Table 2.2: Attempts to epoxidise the C3-C4 alkene in 2.72b 
 
Entry Conditions Outcome 
1 VO(acac)2, TBHP, CH2Cl2 Degradation, oxidative cleavage 
2 V(acac)3, TBHP, CH2Cl2 Degradation, oxidative cleavage 
3 Ti(Oi-Pr)4, (+)-Diisopropyl-L-tartrate Degradation, oxidative cleavage 
2.6.2 Wacker oxidation 
In 1995 Kang and co-workers reported a Pd(II)-catalysed oxidation of internal olefins in the 
presence of copper chloride.77 This Wacker oxidation employs milder conditions than the ones 
used in the epoxidation and thus opens the possibility to avoid the oxidative cleavage previously 
observed. As shown in Scheme 2.32, this methodology has been successfully applied to free diol 
2.79, as well as acetonide 2.80 and carbonate protected 2.81 diols with a vicinal Z-alkene. 
Ketones 2.82 and 2.83 in addition to α,β-unsaturated ketone 2.84 were isolated in high yields. 
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Scheme 2.32: Wacker oxidation precedent 
Initially, the reaction was tested on the taxol-unlike diol 2.72a using DMF as solvent. After 
stirring the reaction mixture overnight under an oxygen atmosphere, full conversion of the 
starting material was observed by TLC and a mixture of two isomers in 1:1 ratio was isolated in 
60% yield (Table 2.3, entry 1). Despite several analyses being performed on the products (one 
and two dimensional NMR, MS, HRMS, IR), the identification of the product was not possible. 
Though, since olefinic protons and carbons (C4 and C13) are observed while no alkyne peaks 
(C11 and C12) are seen on 13C NMR, it is proposed the reaction proceeds on the triple bond 
instead of the double bond. When using DCM and THF as solvent, the same product was 
isolated (entries 2 and 5). Meanwhile in t-BuOH and acetonitrile decomposition of the starting 
material was observed. Although in 2009 Jing and coworkers reported the synthesis of 1,2-
diketones by a Wacker-type oxidation of alkynes using molecular oxygen, in our case this 
transformation was not observed.78 
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Table 2.3: Wacker oxidation in taxol-unlike free diol 2.72a 
 
Entry Solvent Outcome 
1 DMF Unidentified product (60% yield). No alkyne observed 
2 CH2Cl2 Unidentified product (30% yield). No alkyne observed 
3 t-BuOH Decomposition  
4 CH3CN Decomposition  
5 THF Unidentified product (43% yield). No alkyne observed 
Protection of taxol-unlike diol 2.72a using 2,2-dimetoxypropane and CSA as catalyst furnished 
acetonide 2.85a in 61% yield (Scheme 2.33). Unfortunately, no reaction was observed when 
employing the Wacker oxidation conditions. Addition of more palladium chloride did not 
change the result previously obtained.  
 
Scheme 2.33: Wacker oxidation attempt in acetal 2.85a 
Finally, protection of the taxol-unlike diol 2.75a using carbonyl diimidazole and sodium hydride 
in DMF was performed affording the desired carbonate 2.86a in 90% yield. Once again, after 
Wacker oxidation conditions were tested, no reaction was observed. Additionally, an 
epoxidation using VO(acac)2 and TBHP was also tried but decomposition of the starting 
material was observed. 
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Scheme 2.34: Wacker oxidation and epoxidation attempts on carbonate 2.86a 
2.6.3 Oxidation attempts on protected alcohol 2.77 
Due to the oxidative cleavage of the diol 2.72b observed when epoxidation was attempted 
(Table 2.2), it was proposed to keep the alcohol at C1 protected after the Shapiro coupling. In 
this case, compound 2.77 was isolated in 92% yield as a mixture of diastereomers, which 
unfortunately could not be separated.  
 
Scheme 2.35: Shapiro reaction without TMS deprotection 
Vanadium-catalysed epoxidation was tested on the mixture of diastereomers (Table 2.4, entries 
1 and 2). Although in both cases degradation of the starting material was observed, ketone 2.26 
was not isolated and characteristic aldehydes peaks were distinguished in the crude 1H NMR 
spectrum. Further analysis let us confirm the reaction did not occur at the C3-C4 alkene as 
planned but cleavage of the acetal moiety was observed among several decomposition products. 
The same outcome was obtained when Sharpless epoxidation was tried (entry 3). Lastly, Wacker 
oxidation conditions were tested but once again degradation of the starting material was 
observed. 
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Table 2.4: Attempts to functionalise the C4 position in 2.77 
  
Entry Condition Outcome 
1 VO(acac)2, TBHP, CH2Cl2 Degradation 
2 V(acac)2, TBHP, CH2Cl2 Degradation 
3 Ti(OiPr)4, (+)-Diisopropyl L-tartrate Degradation 
4 PdCl2, CuCl, O2, DMF: Water (7:1) Degradation 
Next, an iodocarbonatation of the Boc protected alcohol 2.77 was envisioned.79 Treatment of 
2.77 with Boc2O in the presence of NaHDMS afforded 2.87 in 67% yield. After formation of 
the iodonium ion 2.88 and iodocarbonate intermediate 2.90, it was expected to obtain epoxide 
2.91. Unfortunately, after quenching the reaction, decomposition of the starting material was 
observed.  
 
Scheme 2.36: Iodocarbonatation attempt on 2.87 
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2.6.4 Functionalisation of C4 via an α-hydroxylation 
Since previous attempts to oxidise the C4 position after the Shapiro coupling were unsuccessful, 
a prior functionalisation was investigated (Scheme 2.37). Nevertheless, there are no reports of a 
Shapiro reaction with an α-alkoxy hydrazone to the best of our knowledge.  
 
Scheme 2.37: C4 functionalisation prior to the Shapiro coupling 
Compound 3.12 was used as a model substrate since it bears a quaternary carbon in the α-
position of the ketone and an acetal moiety in the β-position.*1Using Davis’ oxaziridine 2.91, 
alcohol 2.92 was prepared in 81% yield, and its subsequent protection successfully afforded 2.93 
(Scheme 2.38). EOMCl (ethoxymethyl chloride) instead of MOMCl (methoxymethyl chloride) 
was used for the protection of the alcohol due to its availability in the laboratory.  
 
Scheme 2.38: Functionalisation of C4 via an α-hydroxylation 
 
*The synthesis of 3.12 is discussed in detail in Chapter 3, Scheme 3.8 
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Disappointingly, hydrazone formation was not possible and 2.92 was recovered in 52% yield 
among several decomposition products. When the hydrazine condensation was attempted prior 
to the alcohol protection, the reaction was unsuccessful. These results suggested a different 
protecting group, such as methyl ether, must be employed.  
2.7  Conclusion  
Racemic fragment A was synthesised in 72% yield over 7 steps while enantiopure fragment C 
was obtained in 14% yield after 11 steps (Scheme 2.41). The synthesis of an enantioenriched 
fragment A was attempted using activation of chiral (salen)AlCl complex by a phosphorane but 
poor enantioselectivity was obtained (28% ee) and further alternatives should be explored. 
Coupling of both fragments was successfully achieved by a Shapiro reaction but 
functionalisation of the C4 position has not been possible. 
 
Scheme 2.39: Summary of results 
As shown in Scheme 2.42, the early functionalisation of C4 via an α-hydroxylation is envisioned. 
If the Shapiro reaction is not successful with a methyl protecting group, transformation of enol 
triflate 2.97 into vinyl brominated compound 2.99 by a tin halogen exchange is proposed based 
on the work conducted by Stéphanie Schiltz during her PhD studies under the supervision of 
Dr Joëlle Prunet.80 The advanced intermediate 2.100 is expected to be obtained after metallation 
of 2.99 and subsequent quenching with the fragment A.81 
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Scheme 2.40: Perspectives  
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Chapter 3: Relay ring-closing metathesis 
In this chapter, a route which involves a relay ring-closing metathesis (RRCM) as the key step 
towards a formal synthesis of Taxol is presented. This work is an extension of the previous 
work performed by Damien Bourgeois41b, 82 and Rémi Aouzal63 during their PhD theses under 
the supervision of Dr Joëlle Prunet. 
3.1 Previous work in the group 
As shown in Scheme 3.1, Damien Bourgeois envisioned the construction of Taxol´s A and C 
ring prior to the formation of the B ring. A RCM reaction between C9 and C10 of 3.2 was the 
key step of this approach and would allow the synthesis of the tricyclic core 3.1.  
 
Scheme 3.1: Bourgeois’s retrosynthesis 
Diene 3.3 was chosen as a model compound for the study of the RCM. It bears two terminal 
olefins, at C9 and C10, and is not functionalised at the C7 position. Unfortunately, all the RCM 
reactions performed on 3.3 led to the isolation of the starting material, even when a full 
equivalent of GN2 was employed (Scheme 3.2). Based on these results, it was concluded that 
the olefins at C9 and C10 were unreactive due to electronic or steric reasons and the formation 
of the carbene at either of them did not take place.  
 
Scheme 3.2: Bourgeois’s RCM attempt in 3.3 
A RRCM reaction was envisioned by Rémi Aouzal in an attempt to form the carbene at C10. 
Two different tethers were proposed and compounds 3.5 and 3.6 (all carbon and oxygenated 
version, respectively) were to be synthesised (Scheme 3.3). 
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Scheme 3.3: Aouzal´s retrosynthesis involving a RRCM 
Firstly, a RRCM reaction was performed using 3.7 as the starting material and dichloromethane 
as solvent but, unfortunately, the dimer 3.8 was isolated as the only product (Scheme 3.4). 
Dilution of the reaction mixture from 15 mM to 1.5 mM did not favour the intramolecular over 
the intermolecular reaction. Using toluene as the solvent and increasing the temperature resulted 
in isolation of 3.8 among other decomposition products.  
 
Scheme 3.4: Aouzal´s RRCM attempts on 3.7 
Aouzal also tried a RRCM reaction with 3.9, displaying an oxygen atom in the tether at C10, but 
disappointingly a complex mixture of unidentified products was obtained (Scheme 3.5). These 
results led to the conclusion that the carbene at C10 was not formed and thus the cyclisation 
could not take place. In this chapter, the installation of the tether at C9 instead of C10 will be 
investigated.  
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Scheme 3.5: Aouzal´s RRCM attempts on 3.9 
3.2 Project presentation and retrosynthetic analysis  
The retrosynthesis for the construction of the B ring of Taxol using a RRCM reaction as the 
key step is outlined in Scheme 3.6. The tricyclic core 3.4 was selected as the primary target of 
this project. Unlike the metathesis precursors proposed by Aouzal, in this case the tether would 
be placed at C9. The synthesis of two different metathesis precursors (with or without oxygen) 
is envisioned (compounds 3.10a-b), which could be obtained by a Shapiro coupling between 
fragments A (±)3.21a-b and fragment C 3.18.  
 
Scheme 3.6: Taxol retrosynthesis using a RRCM as the key step 
3.3 Synthesis of  fragment A 
3.3.1 Retrosynthesis 
The retrosynthesis of fragment A is outlined in Scheme 3.7 and uses the same key 
disconnections proposed by Muller et al.83 Aldehyde (±)3.18 could be obtained by cyanation 
followed by reduction from the ketone 3.16, which in turn could be prepared from the ketone 
3.13 by performing a Stille reaction on the corresponding vinyl triflate. Finally, ketone 3.13 can 
be synthesised starting from the commercially available diketone 2.32. 
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Scheme 3.7: Retrosynthesis of fragment A (±)3.18 
3.3.2 Racemic synthesis  
Aldehyde (±)3.18 has been previously synthesised in the Prunet group by Benoît Muller83 
achieving a 21% overall yield. As shown in Scheme 3.8, the first step of the synthesis is the 
methylation of 2.32 followed by mono-protection of 3.11, resulting in the isolation of ketone 
3.12 in 90% yield for two steps. After methylation of 3.12, ketone 3.13 was successfully 
transformed into triflate 3.14, which was then submitted to a Stille coupling affording stable 
diene 3.15 in 91% yield for three steps. The use of DMPU instead of HMPA in the synthesis of 
3.14 was also investigated, but unfortunately the low yield obtained forced the use of HMPA.  
 
Scheme 3.8: Synthesis of racemic fragment A (±)3.18 
Later acid-catalysed deprotection of the acetal afforded the desired ketone 3.16 in quantitative 
yield. Further treatment of 3.16 with TMSCN in the presence of zinc iodide provided the 
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silylated cyanohydrin (±)3.17 in 84% yield. Reduction of this cyanohydrin (±)3.17 using 
DIBALH led to the corresponding imine that was then hydrolysed under mild acidic conditions 
by adding SiO2 to the reaction mixture. In summary, the racemic aldehyde (±)3.18 was obtained 
in 69% overall yield over 8 steps. 
3.3.3 Efforts towards an enantio-enriched synthesis of fragment A 
Following the conditions reported by Zhou and coworkers,68 ketone 3.16 was submitted to an 
enantioselective cyanosilylation in the presence of an activated chiral (salen)AlCl complex, 
furnishing cyanohydrin 3.17 in quantitative yield (Scheme 3.9). In order to determine its 
enantiomeric excess, aldehyde 3.18 was treated with LiAlH4 and the deprotected diol 3.19 was 
successfully isolated in 78% yield. After coupling of 3.19 with p-nitro benzoyl chloride, a 74% 
enantiomeric excess of the ester 3.20 was determined by HPLC with a chiral column (see 
appendix for the chromatograms of the racemic and enantioenriched mixtures).    
 
Scheme 3.9: Synthetic efforts towards an enantioenriched fragment A 3.18 
3.4 Synthesis of  racemic fragment C 
3.4.1 Retrosynthesis 
As shown in scheme 3.10, the hydrazone (±)3.21 could be obtained by a hydrazine 
condensation to the diene intermediate (±)3.22, which in turn would be synthesised by a Julia-
Kocienski olefination between the keto-aldehyde (±)3.38 and the tetrazolylsulfone 3.23. The 
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tetrazolylsulfone 3.23 could be obtained from the thiol 3.25 and the alcohol 3.24. The synthesis 
of two different hydrazones, with or without an oxygen substituent, was envisaged.  
 
Scheme 3.10: Retrosynthesis of the racemic fragment C (±)3.21 
3.4.2 Synthesis of the sulfone 3.23 
3.4.2.1 Synthesis of the oxygenated sulfone 3.28 
Initially, a Mitsunobu-type reaction between the commercially available alcohol 3.26 and thiol 
3.25 furnished sulfide 3.27 in 85% yield (Scheme 3.11).84 Subsequent oxidation of 3.27 with 0.16 
equivalents of ammonium hepta-molybdate and 3 equivalents of hydrogen peroxide afforded 
sulfone 3.28 and sulfoxide 3.29 in 78% and 17% yield, respectively. When 5.7 equivalents of 
hydrogen peroxide were employed, 3.28 was successfully isolated in 89% yield as the only 
product.  
 
Scheme 3.11: Synthesis of the oxygenated sulfone 3.28 
3.4.2.2 Synthesis of the all carbon sulfone 3.34 
Two different pathways for the synthesis of sulfide 3.33 were attempted, using either alcohol 
3.30 or alkyl bromide 3.32 as starting material (Scheme 3.12). Firstly, installation of a tosyl group 
on 3.30 followed by its substitution afforded the desired sulfide 3.33 in quantitative yield. On 
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the other hand, direct substitution of bromide in 3.32 furnished 3.33 in a single step. Subsequent 
oxidation of 3.33 using hydrogen peroxide in the presence of a molybdenum complex yielded 
the sulfone 3.34 in 91% yield.   
 
Scheme 3.12: Synthesis of the all carbon sulfone 3.34 
3.4.3 Synthesis of the aldehyde (±)3.38 
Starting from 2-methylcyclohexanone 3.35 and p-formaldehyde, trifluoroacetate (±)3.36 was 
obtained in 46% yield in the presence of TFA (Scheme 3.13).85 Subsequent  hydrolysis of 
(±)3.36 under basic conditions afforded the desired alcohol (±)3.37 in quantitative yield. Its 
oxidation to aldehyde (±)3.38 was initially attempted by using the Dess-Martin periodinane; but 
low conversion of the starting material in short reaction times combined with decomposition 
of the product when increasing the reaction time forced us to change the oxidizing agent. 
Finally, aldehyde (±)3.38 was successfully isolated in quantitative yield when an excess of IBX 
was employed.  
 
Scheme 3.13: Synthesis of the aldehyde (±)3.38 
3.4.4 Julia-Kocienski olefination 
3.4.4.1 Generalities of the Julia-Kocienski olefination reaction  
In 1973, Marc Julia and Jean-Marc Paris reported the synthesis of di-, tri- or tetrasubstituted 
olefins from phenyl sulfones and aldehydes (or ketones).86 Scheme 3.14 illustrates the synthesis 
of the disubstituted olefin 3.42 starting from the phenyl sulfone 3.39 and the aldehyde 3.40. 
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The stereochemistry of the resulting alkene is independent of the stereochemistry at the sulfone 
intermediate 3.41 and this reaction exhibits a good E-selectivity. Unfortunately, a major 
disadvantage of this reaction is its low tolerance towards reducible functional groups in the 
starting materials. 
 
Scheme 3.14: Classical Julia olefination 
In 1991, Sylvestre Julia and coworkers explored the replacement of the phenyl sulfones 3.39 
used in the classical Julia olefination with the benzothiazol-2-ylsulfones 3.43 (Scheme 3.15).87 
Interestingly, this replacement significantly modifies the reaction pathway. Deprotonation of 
3.43 by LDA is followed by reaction of 3.44 with the aldehyde 3.40 to furnish the alkoxide 
intermediate 3.45. This alkoxide intermediate is highly reactive and thus results in the formation 
of the sulfinate 3.47 salt by a Smiles rearrangement. After spontaneous elimination of sulfur 
dioxide and lithium benzothiazolone 3.48, the desired alkene 3.42 is finally formed. The 
intermediate 3.44 can also undergo self-condensation affording the undesired sulfone 3.40.88   
 
Scheme 3.15: Mechanism of the modified Julia olefination 
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The E or Z selectivity in the modified Julia olefination is determined by the stereochemistry 
displayed at the sulfone intermediate 3.44 and it can be influenced to some extent by the reaction 
conditions. As shown in Scheme 3.16, after treatment of sulfone 3.43 with aldehyde 3.40 in the 
presence of a base, the syn and anti configuration of the alkoxide 3.45 are in equilibrium. When 
a small counterion such as lithium and a polar solvent is employed, a chelate will be formed and 
thus leading to the closed transition states 3.45 anti and 3.45 syn. Due to the gauche interaction 
between R1 and R2 in 3.45 anti, the Smiles rearrangement takes place faster on the other 
intermediate exhibiting the syn configuration, displacing the equilibrium towards the formation 
of the Z olefin.  
 
Scheme 3.16: Selectivity in the modified Julia olefination with benzothiazol-2-ylsulfones 
In 1998, Kocienski and coworkers reported the use of 1-phenyl-1H-tetrazol-5-yl sulfones 3.50 
as a useful alternative to benzothiazol-2-ylsulfones 3.43 in the modified Julia olefination 
(Scheme 3.17).89 This variation, called the Julia-Kocienski olefination (JKO), is distinguished by 
the ability to provide high levels of trans selectivity, and reduce the possibility to obtain the self-
condensation product. When using polar solvents and a larger counterion in the base, such as 
  
74 
 
potassium, the open transition state 3.51 will be favoured. In this case, the anti configuration is 
observed in alkoxide 3.52 which leads to the E configuration obtained in the alkene 3.42.  
 
Scheme 3.17: Selectivity in the JKO with 1-phenyl-1H-tetrazol-5-yl sulfones 3.50 
Even though the reaction conditions play a key role in the diastereoselectivity of the product 
obtained, the size of R1 and R2 and their steric hindrance cannot be underestimated.  
3.4.4.2 Julia-Kocienski olefination using sulfone 3.28 as starting material 
Unfortunately, when sulfone 3.28 was treated with LiHMDS followed by slow addition of 
aldehyde (±)3.38,84 no traces of the desired diene (±)3.55 were observed but compound 3.56 
was obtained in 27% yield as the only isolable product (Scheme 3.18). A plausible mechanism 
for this transformation is proposed. After formation of carbanion 3.57 and due to the presence 
of oxygen in the molecule, the allylic alkoxide 3.59 and the sulfone 3.58 could be formed by -
elimination. Subsequent nucleophilic attack of alkoxide 3.59 onto 3.58 would furnish the allylic 
ether 3.56 via the intermediate 3.60.  
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Scheme 3.18: Julia-Kocienski olefination using sulfone 3.28 
3.4.4.3 Julia-Kocienski olefination using sulfone 3.34 as the starting material 
When the sulfone 3.34 was submitted to the previously described JKO reaction conditions, the 
desired diene (±)3.61 was successfully isolated in quantitative yield (Scheme 3.19). 
Unfortunately, after the hydrazine condensation, reduction of the terminal double bond was 
observed and alkene (±)3.62 was obtained in 82% yield. A precedent in the literature was found 
for the reduction of non-hindered olefins by o-nitrobenzenesulfonylhydrazide.90  
 
Scheme 3.19: Julia Kocienski olefination using sulfone 3.34 
3.4.5 Revised synthesis plan 
Since none of the hydrazones 3.21a-b were successfully synthesised, a revised synthesis plan 
was proposed. As shown in Scheme 3.20, a later installation of the tether in 3.10 was envisioned 
by a JKO reaction on protected alcohol 3.63, which in turn can be obtained from the 
successfully synthesised fragment A (±)3.18 and the new fragment C (±)3.64. This approach is 
lees convergent but allows for diversification at a later stage in the synthesis. 
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Scheme 3.20: Revised synthesis plan 
3.4.6 Fragment C: Endgame 
Treatment of the previously synthesised alcohol (±)3.37 with MOMCl afforded the desired 
protected alcohol (±)3.65 in 64% yield (Scheme 3.21). Later attempts to form the hydrazone 
(±)3.66 were unsuccessful and cleavage of the MOM ether was observed in the 1H NMR 
spectrum of the crude reaction mixture. Finally, the new fragment C (±)3.68 was obtained in 
38% yield over 4 steps when the alcohol was protected as the corresponding ethoxymethyl 
(EOM) ether.  
 
Scheme 3.21: Synthesis of fragment C (±)3.68 
3.5 Shapiro coupling 
With racemic fragments A (±)3.18 and C (±)3.68 in hand, the next step was to couple these 
two fragments. A Shapiro reaction using t-BuLi at -78°C afforded a 1:1 mixture of the two 
diastereomers (±)3.69a and (±)3.69b in 56% yield (Scheme 3.22). These two diastereomers, 
which can be separated by flash column chromatography, differ at the relative configuration at 
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C1 and C2 with respect to C8. They will be denominated as Taxol-like ((±)3.69b) and Taxol-
unlike ((±)3.69a). Their relative stereochemistry have been determined by X-ray diffraction 
analysis of a later intermediate. Formation of alkene (±)3.70 was also observed (42% yield) and 
is responsible for the low yield obtained for the desired products. Unfortunately, performing 
the reaction with an excess of t-BuLi did not increase the yield of (±)3.69. 
 
Scheme 3.22: Shapiro coupling using racemic fragments A (±)3.18 and C (±)3.68 
3.6 From Shapiro coupling to metathesis precursor  
3.6.1 Synthesis of the Julia-Kocienski olefination precursors 
After careful separation of both diastereomers (±)3.69a-b, the synthesis of the metathesis 
precursors 3.10 was explored (Scheme 3.20). As shown in scheme 3.23, diols (±)3.71a-b were 
successfully isolated in excellent yield after deprotection of the TMS group in the presence of 
aqueous HCl. Subsequent treatment with NaH and COIm2 afforded the desired carbonates 
(±)3.72a-b in quantitative yield. 
 
Scheme 3.23: Synthesis of advanced carbonates (±)3.72a-b 
With (±)3.72a-b in hand, the deprotection of the EOM ether was first studied using (±)3.70 
as a model substrate (Table 3.1). Initially, deprotection using ZnBr2 in dichloromethane was 
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attempted but unfortunately, decomposition of the starting material was observed (entry 1).91 
After treatment of (±)3.70 with 6N aqueous HCl, 79% of the starting material was recovered 
but no signals of the deprotected alcohol (±)3.73 were observed in the crude 1H NMR spectrum 
(entry 2). Finally, when concentrated sulfuric acid was added dropwise to a solution of (±)3.70 
in a mixture of water and acetone, full conversion was observed and the desired alcohol (±)3.73 
was isolated in 40% yield (entry 3). The low yield obtained was attributed to the high product 
volatility.  
Table 3.1: EOM deprotection on (±)3.70 
 
Entry Conditions Yield 
1 ZnBr2, CH2Cl2 Decomposition 
2 6 M HCl (aq), H2O, THF 79% recovered SM 
3 H2SO4 (conc), H2O, Acetone 40%* 
*Low yield due to high product volatility   
The optimised conditions for the EOM deprotection were applied to both diastereomers 
(±)3.72a and (±)3.72b. As shown in Scheme 3.24, the alcohol (±)3.74a was isolated in 93% 
yield and further derivatisation furnished the ester (±)3.75a in quantitative yield. Unfortunately, 
despite several crystallisation methods were tried on (±)3.74a and (±)3.75a, the formation of 
crystals of good enough quality to perform an X-ray diffraction analysis was not possible.  
 
Scheme 3.24: EOM cleavage in (±)3.72a and its further derivatisation 
To our delight, when (±)3.72b was treated with sulfuric acid, it afforded the free alcohol 
(±)3.74b in quantitative yield as a crystalline solid (Scheme 3.25). Its X-ray diffraction analysis 
established the bicyclic structure of the product and confirmed that it possessed the required 
relative configuration at C1, C2 and C8 for Taxol.   
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Scheme 3.25: EOM cleavage in (±)3.72b and X-ray diffraction analysis of (±)3.74b   
3.6.2 Metathesis precursors synthesis by a Julia-Kocienski olefination 
Typically, it is advised to carry out the JKO reaction under “Barbier-like conditions”, where the 
base is added to a mixture of the aldehyde and the sulfone. Due to the presence of an enolisable 
ketone in (±)3.38, this option was not possible when the JKO was first attempted using the 
sulfone 3.28 (Scheme 3.17). By installing the tether at a later stage, the presence of the enolisable 
ketone is avoided and thus the “Barbier-like conditions” can be employed. Initially, the aldehyde 
3.76 was employed as a model substrate and the diene 3.77 was successfully isolated in 56% 
yield as single isomer without traces of the undesired ether 3.56 (Scheme 3.26). The oxidation-
olefination sequence was then attempted on alcohols 3.78 and (±)3.80 furnishing diene 3.79 as 
a 1:1 mixture of E and Z isomers and triene (±)3.81 as the E isomer exclusively, respectively. 
 
Scheme 3.26: Julia-Kocienski olefination reaction in model substrates 
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Finally, alcohols (±)3.74a-b were oxidised to the corresponding aldehydes and these were 
treated with KHMDS in the presence of either sulfone 3.28 or 3.34, resulting in the formation 
of the RRCM precursors with ((±)3.82a-b) or without ((±)3.83a-b) oxygen (Scheme 3.27).  
 
Scheme 3.27: Metathesis precursors synthesis by a Julia-Kocienski olefination 
3.7 Relay ring-closing metathesis 
The metathesis precursors (±)3.82a-b and (±)3.83a-b were then submitted to the diverse 
RRCM conditions outlined in Table 3.2. Initially, the oxygenated versions (±)3.82a-b were 
added dropwise to a refluxed solution of HG2 in toluene, but traces of the migration-
deprotection product (±)3.88a-b were observed in the crude 1H NMR spectrum and only a 
small amount of the starting material was recovered (entries 1 and 2). The “infinite dilution” 
condition was employed to avoid the dimerization of the starting material by attempting an 
excess of the catalyst compared to the reagent at any time of the reaction. The use of DCE as 
solvent avoided the formation of the undesired (±)3.88b product but traces of the dimer 
(±)3.86b were observed when (±)3.82b was used as the starting material; suggesting that higher 
temperatures are required for the migration-deprotection process(entry 3).92 Interestingly, the 
combination of the Stewart-Grubbs catalyst (SG)93 and DCE afforded the truncated product 
(±)3.85a in 30% yield when 30 mol% of the catalyst were employed with the Taxol un-like 
metathesis precursor (±)3.82a (entry 4). On the basis of this result, we established that RRCM 
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had taken place but unfortunately the newly formed carbene at C9 was not reactive enough 
under the reaction conditions to form the desired B ring.  
Table 3.2: RRCM attempts 
 
Entry 
Starting 
Material 
Cat Solvent Conditions Outcome 
1 (±)3.82a 
HG2 
(30 mol%) 
Toluene 
110°C, 
16 h 
(±)3.88a (traces) 
(±)3.82a (10%) 
2 (±)3.82b 
HG2 
(30 mol%) 
Toluene 
110°C, 
16 h 
(±)3.88b (traces) 
(±)3.82b (21%) 
3 (±)3.82b 
HG2 
(30 mol%) 
DCE 
84°C, 
2 days 
Mixture of (±)3.82b 
and (±)3.86b* 
4 (±)3.82a 
SG  
(30 mol%) 
DCE 
84°C,  
2 days 
(±)3.85a (30%)  
5 (±)3.82b 
SG  
(100 mol%) 
DCE 
84°C 
3 days 
(±)3.82b (50%) 
(±)3.85b (Traces) 
6 (±)3.83a 
SG  
(30 mol%) 
Toluene 
110°C,  
2 days 
(±)3.85a (traces) and 
(±)3.83a* 
7 (±)3.83b 
SG  
(30 mol%) 
Toluene 
110°C,  
2 days 
(±)3.85b (traces) and 
(±)3.83b* 
8 (±)3.83b 
SG  
(100 mol%) 
Toluene 
110°C, 
3 days 
(±)3.83b (60%) 
* Due to similar RF, separation of the products was not possible 
Since increasing the reaction temperature was not a viable option due to the possible formation 
of (±)3.88a-b, we decided to test the non-oxygenated metathesis precursors (±)3.83a-b; 
unfortunately only traces of the truncated products (±)3.85a-b were confirmed by 1H NMR 
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and HRMS (Table 3.2 entries 6 and 7). Finally, it was decided to explore whether an increase of 
the catalyst loading could form the desired tricyclic core with the desired Taxol-like 
configuration. Disappointingly, a 50-60% of the starting material was recovered when a full 
equivalent of SG was employed (entries 5 and 8). A comparison between entries 4 and 5 
suggested that the Taxol-like configuration is less reactive towards the relay reaction than the 
Taxol-unlike one. 
As shown in Scheme 3.28, the first carbene is formed in (±)3.82a at the most reactive terminal 
olefin position and thus (±)3.89a is obtained. According to the results outlined in Table 3.2, if 
toluene is used as solvent, the carbene (±)3.89a will react with another molecule of (±)3.82a 
and thus the dimerisation product (±)3.86a will be obtained. In the case of using DCE, when 
no dimerisation is observed, the desired relay reaction will occur and the new carbene (±)3.90a 
will be formed. At this stage, either an intra or an inter molecular reaction can occur. The desired 
tricyclic core (±)3.84a is the result of the intramolecular reaction, but unfortunately the reaction 
rate of the intermolecular reaction is higher and thus the truncation product (±)3.85a is 
obtained.  When the reaction was performed using a full equivalent of catalyst (entries 5 and 8), 
it was expected to convert the starting material in to (±)3.90 with a faster reaction rate than the 
reaction to form the truncated product (±)3.85 or the dimer (±)3.86. The possible product 
((±)3.103) of the intermolecular reaction between (±)3.95a and (±)3.82a does not occur due 
to the transition state leading to a highly hindered metallacyclobutane.  
 
Scheme 3.28: RRCM on (±)3.82a 
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Further optimisation of the RRCM reaction, involving the use of more active catalysts or/and 
the substitution of the terminal olefin with an alkyl group to decrease its reactivity, is envisioned.  
3.8 Towards the synthesis of  an enantioenriched fragment C 
In 2005, Nakada and coworkers reported an enantioselective reduction of prochiral 1,3-
cycloalkanediones bearing a methyl group and a protected hydroxymethyl group at their C2 
position using baker’s yeast.94 Following this precedent, addition of 3-bromopropene to 
diketone 2.32 furnished (±)3.91, which was then protected as bis-ketal (±)3.92 (Scheme 3.29). 
Isomerisation of the double bond in the presence of a palladium catalyst afforded the 
thermodynamically more stable (±)3.93 as a single isomer. After alkene (±)3.93 was submitted 
to an ozonolysis reaction followed by a reductive workup, alcohol (±)3.94 was successfully 
isolated in 58% yield. A subsequent protection-deprotection sequence furnished the desired 
diketone (±)3.96 in 26% yield over two steps. Unfortunately, alcohol 3.97 was not obtained 
when the baker’s yeast reduction was applied to (±)3.96 and 41% of the staring material was 
recovered instead.    
 
Scheme 3.29: Towards the synthesis of an enantioenriched fragment C 
3.9 Conclusion  
Racemic fragment A (±)3.18 was synthesised in 69% yield over 8 steps while fragment C 
(±)3.69 was obtained in 38% yield after 4 steps (Scheme 3.30). Additionally, an enantioenriched 
fragment A was synthesised in quantitative yield and 74% ee from ketone 3.16. Coupling of 
both fragments was achieved by a Shapiro reaction and advanced intermediates (±)3.82a-b and 
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(±)3.83a-b were successfully synthesised, but unfortunately the construction of the ABC 
tricyclic core (±)3.84a-b has not yet been possible. 
.   
Scheme 3.30: Summary of results 
As shown in Scheme 3.31, substitution of the terminal olefin in the metathesis precursors 
(±)3.82a-b and (±)3.83a-b is envisioned. In order to decrease the reactivity of the terminal 
olefin, an extra methyl group would be installed; in addition, the carbonate could be removed 
to decrease the ring strain in the desired ABC tricycles (±)3.84a-b . Furthermore, optimisation 
of the synthesis of (±)3.96 must be performed94 and its reduction towards the enantiopure 
(±)3.99 and further cyclisation to 3.102a-b should be studied.     
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Scheme 3.31: Perspectives  
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Chapter 4: Experimental  
5.1 General  
Apparatus 
1H NMR spectra were recorded on either a Bruker AVI DPX-400 or a Bruker DPX-400 (400 
MHz) instrument. The chemical shifts are expressed in parts per million (ppm) referenced to 
TMS. Data are reported as follows: δ, chemical shift; multiplicity (recorded as br, broad; s, 
singlet; d, doublet; t, triplet; q, quartet and m, multiplet), coupling constants (J in Hertz, Hz), 
integration and assignment (aromatic, Ar). Assignments were obtained using J-mod 
experiments, and when necessary, COSY, NOESY, HMBC and HSQC experiments. 
13C NMR spectra were recorded on the same instruments at 100 MHz. The chemical shifts are 
expressed in parts per million (ppm), referenced to TMS.  
Infrared (IR) spectra were obtained on a FTIR-8400 instrument with a Golden Gate™ 
attachment that uses a type II-a diamond as a single reflection element so that the IR spectrum 
of the compound (solid or liquid) could be detected directly (thin layer) and are reported in 
terms of frequency of absorption. 
High resolution mass spectrometry (HRMS) was recorded under ESI and EI conditions by 
the analytical services at the University of Glasgow. Mass spectrum data are reported as m/z 
Optical rotations were recorded on an Autopol V polarimeter.  
Ozonolysis  was carried out using a Degremont Technologies Triogen ozone generator. 
HPLC analyses were obtained on a Shimadzu HPLC consisting of a Shimadzu DGU-20A5 
degasser, Shimadzu LC-20AT liquid chromatography, Shimadzu CMB-20A communication bus 
module, Shimadzu SPD-M20A diode array detector and Shimadzu CTO-20A column. Analysis 
was performed using Shimadzu LabSolutions v5.42 software and separation was achieved using 
the column described. All HPLC traces of enantio-enriched compounds were compared to the 
traces of the corresponding racemic compounds prepared in an analogous fashion.   
 Chromatography  
Flash chromatography was performed under forced flow conditions using HPLC graded 
solvents and EMD Geduran Silica Gel 60 as solid support. 
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Thin Layer Chromatography (TLC) was performed on Merck silica gel 60 covered aluminum 
sheets. TLC plates were developed under UV-light and/or with an acidic ethanolic anisaldehyde 
solution, a KMnO4 solution or a cerium ammonium molybdate solution followed by heating.  
Solvents and reagents  
Dry solvents such as THF, CH2Cl2, Et2O, CH3CN, and toluene were collected from an in house 
solvent purification system (Pure-SolvTM 500 Solvent Purification System). Dry ethanol, 
methanol, DMF, DMSO, EtOAc, 1,2-dichoromethane were used from commercial 
bottles. All reagents were used directly from supplier, unless stated otherwise. 
General conditions 
Reactions involving air-sensitive agents and dry solvents were performed in glassware that had 
been dried in an oven (150°C) or flame-dried prior to use. These reactions were carried out with 
the exclusion of air using an argon atmosphere. Solvents were degassed using the freeze and 
thaw method when stated. 
Nomenclature 
Chem Draw Ultra 14.0 momenclature was used for all compounds. For the description of NMR 
spectra, the numbering used follows the chain extension as described on the formula, not the 
IUPAC numbering. 
5.2 Preparation of  reagents 
(tert-Butoxycarbonyl)-L-proline95 
 
Chemical formula: C10H17NO4 
MW: 215.25 
To a stirred solution of L-proline (346 mg, 3.00 mmol) in a saturated aqueous solution of 
NaHCO3 (4.4 mL) at 0°C was slowly added a solution of Boc2O (721 mg, 3.30 mmol, 1.10 equiv) 
in THF (1.6 mL). The reaction mixture was allowed to warm to room temperature and was 
stirred for 19 h. The THF was then removed under reduced pressure and the resulting solution 
was acidified to pH 2 by adding an aqueous solution of 1N HCl. The aqueous layer was extracted 
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with EtOAc, and the combined organic extracts were washed with brine, dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure to afford the  protected carbamate as 
a pale white solid (615 mg, 2.85 mmol, 95%). 
1H NMR (400 MHz, CDCl3) δ ppm: The presence of two rotamers was observed in the 
1H 
NMR spectra in a 1:1 ratio. However, it was not possible to differentiate all signals 
corresponding to each rotamer.4.39–4.18 (m, 1H, CH-1), 3.66–3.25 (m, 2H, CH2-4), 2.24 (d, J 
= 7.3 Hz, 1H, CH2-2), 2.15–1.79 (m, 3H, CH2-2,3), 1.43–1.39 (m, 9H, CH3-8). 
13C NMR (100 MHz, CDCl3) δ ppm: 179.0 (COOH-5), 175.6 (COOH-5), 156.1 (CO-6), 
153.9 (CO-6), 81.2 (C-7), 80.30 (C-7), 59.0 (CH-1), 58.9 (CH-1), 46.9 (CH2-4), 46.3 (CH2-4), 
30.8 (CH2-2), 28.7 (CH2-2), 28.3 (CH3-8), 28.2 (CH3-8), 24.3 (CH2-3), 23.6 (CH2-3). 
HRMS (ESI): Calcd for C10H17NNaO4
+ [M+Na]+, 238.1050; found, 238.1044. 
 
(R)-N-((S)-2'-((4-methylphenyl)sulfonamido)-[1,1'-binaphthalen]-2-yl)pyrrolidine-2-
carboxamide (2.34)69 
 
Chemical formula: C32H29N3O3S 
MW: 535.66 
To a stirred solution of (S)-[1,1'-binaphthalene]-2,2'-diamine (1.00 g, 3.52 mmol) in CH2Cl2 (42 
mL) was added pyridine (3.12 mL, 3.87 mmol, 1.10 equiv) and p-toluenesulfonylchloride (650 
mg, 3.4 mmol, 0.97 equiv). The reaction mixture was stirred at room temperature for 16 h. 
EtOAc was added to quench the reaction and the organic layer was washed with an aqueous 
solution of 1N HCl, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure to afford a pink foam which was used in the next step without further purification.  
To a stirred solution of (tert-butoxycarbonyl)-L-proline (972 mg, 4.51 mmol, 1.60 equiv) in THF 
(32 mL) at 0°C was slowly added triethylamine (630 µL, 4.51 mmol, 1.60 equiv) and ethyl 
orthoformate (32 µL, 5.4 mmol, 1.6 equiv). The reaction mixture was stirred at this temperature 
for 30 min before a solution of the previously obtained pink foam in THF (8 mL) was added 
dropwise, and the resulting solution was refluxed for 24 h. The reaction mixture was allowed to 
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cool to room temperature and filtered through a medium porosity sintered glass funnel. The 
filter cake was washed with THF and the solvent was then removed under reduced pressure to 
afford a pale-yellow foam which was used in the next step without further purification. 
To a stirred solution of the previously obtained yellow foam in CH2Cl2 (30 mL) was added 
trifluoroacetic acid (4.6 mL, 60 mmol, 26 equiv). The reaction mixture was stirred at room 
temperature for 2 h. The resulting solution was cooled down to 0°C and a saturated aqueous 
solution of 2.5M NaOH (26 mL) was carefully added to quench the reaction. The aqueous layer 
was extracted with CH2Cl2, and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture 
was then purified by flash chromatography using petroleum ether:EtOAc (1:2) to (1:3) to afford 
the catalyst 2.34 as a white solid (1.05 g, 1.96 mmol, 56% for three steps). 
1H NMR (400 MHz, CDCl3) δ ppm: 9.30 (bs, 1H, NH), 8.81 (d, J = 9.0 Hz, 1H, CH-Ar), 
8.18 (d, J = 9.1 Hz, 1H, CH-Ar), 8.06 (d, J = 9.0 Hz, 1H, CH-Ar), 7.99 (d, J = 9.1 Hz, 1H, CH-
Ar), 7.94 (d, J = 8.2 Hz, 1H, CH-Ar), 7.87 (d, J = 8.2 Hz, 1H, CH-Ar), 7.50–7.33 (m, 4H, CH-
Ar), 7.18 (dd, J = 16.1, 7.9 Hz, 2H, CH-Ar), 7.11 (d, J = 8.2 Hz, 2H, CH-Ar), 6.93 (d, J = 8.4 
Hz, 1H, CH-Ar), 6.86 (d, J = 8.4 Hz, 1H, CH-Ar), 6.32 (bs, 1H, NH), 3.30 (dd, J = 9.5, 3.9 
Hz, 1H, CH), 2.36 (s, 3H, CH3), 2.22 (dd, J = 15.0, 8.3 Hz, 1H, CH2), 1.85–1.70 (m, 1H, CH2), 
1.62–1.56 (m, 1H, CH2), 1.28–1.12 (m, 2H, CH2), 1.02 (bs, 1H, NH), 0.73–0.60 (m, 1H, CH2). 
13C NMR (100 MHz, CDCl3) δ ppm: 173.3 (CO), 143.9, 136.4, 135.6, 133.7, 132.5, 132.1, 
131.2, 130.7, 130.5, 130.1, 129.5, 128.6, 128.1, 127.4, 127.4, 125.6, 125.2, 125.1, 124.1, 120.6, 
119.3, 119.2, 116.8, 60.4 (CH), 46.1 (CH2), 30.52 (CH2), 25.2 (CH2), 21.5 (CH3). 
IR (thin film): 2960, 1598, 1462, 1190, 1157, 908, 738 cm-1. 
HRMS (ESI): Calcd for C32H29N3NaO3S
+ [M+Na]+, 558.1822; found, 558.1798. 
 
2,4,6-Triisopropylbenzenesulfonohydrazide96 
 
Chemical formula: C15H26N2O2S 
MW: 298.45 
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To a stirred solution of 2,4,6-triisopropylbenzenesulfonyl chloride (12.0 g, 39.6 mmol) in THF 
(60 mL) at -10°C was added hydrazone hydrate (4.36 mL, 87.1 mmol, 2.20 equiv) over 30 min. 
The reaction mixture was stirred at this temperature for 5 h. Water was added to quench the 
reaction and the aqueous layer was extracted with Et2O. The combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure at 20°C to afford the hydrazide as a white solid (11.6 g, 38.8 mmol, 99%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.20 (s, 2H, CH-Ar), 5.45 (bs, 1H, NH), 4.20–4.11 (m, 
2H, CH), 3.65 (bs, 2H, NH2), 2.97–2.89 (m, 1H, CH), 1.31–1.26 (m, 18H, CH3). 
13C NMR (100 MHz, CDCl3) δ ppm: 153.8 (C-Ar), 151.8 (C-Ar), 128.6 (CH-Ar), 124.0 (CH-
Ar), 34.2 (CH), 29.8 (CH), 24.9 (CH3), 23.5 (CH3). 
IR (thin film): 3315, 2957, 2866, 1598, 1460, 1425, 1361, 1321, 1161 cm-1. 
HRMS (ESI): Calcd for C15H26N2NaO2S
+ [M+Na]+, 321.1607; found, 321.1595. 
MP: 113°C (lit.97 113-114°C). 
 
(E)-N-benzylidene-4-methylbenzenesulfonamide98 
 
Chemical formula: C14H13NO2S 
MW: 259.32 
A mortar was charged with anhydrous AlCl3 (130 mg, 1.0 mmol, 0.50 equiv), p-
methylbenzenesulfonamide (340 mg, 2.0 mmol, 1.0 equiv) and freshly distilled benzaldehyde 
(200 µL, 2.0 mmol, 1.0 equiv). The resulting mixture was grounded with a pestle at room 
temperature for 25 min. The solid mixture was then diluted with EtOAc and filtered through a 
pad of Celite. The filter cake was washed with EtOAc and the solvent was removed under 
reduced pressure to afford the benzenesulfonamide as a white solid (520 mg, 2.0 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 9.02 (s, 1H, CH-CN), 7.92–7.83 (m, 4H, CH-Ar), 7.60 
(d, J = 7.4 Hz, 1H, CH-Ar), 7.48 (d, J = 7.7 Hz, 2H, CH-Ar), 7.34 (d, J = 8.0 Hz, 2H, CH-Ar), 
2.43 (s, 3H, CH3). 
13C NMR (100 MHz, CDCl3) δ ppm: 170.1 (CH-CN), 144.6(C-Ar), 135.1 (C-Ar), 134.9 (CH-
Ar), 132.4 (C-Ar), 131.3 (CH-Ar), 129.8 (CH-Ar), 129.1 (CH-Ar), 128.1 (CH-Ar), 21.6 (CH3). 
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IR (thin film): 3356, 3259, 1699, 1597, 1155, 1089 cm-1. 
HRMS (ESI): Calcd for C14H13NNaO2S
+ [M+Na]+, 282.0559; found, 282.0551. 
MP: 80°C (lit.99 79-82°C). 
 
3-Phenyl-2-tosyl-1,2-oxaziridine100 
 
Chemical formula: C14H13NO3S  
MW: 275.32 
To a stirred suspension of powdered KOH (163 mg, 4.07mol, 3.50 equiv) and m-CPBA (219 
mg, 1.28 mol, 1.10 equiv) in CH2Cl2 (0.58 mL) was added a solution of (E)-N-benzylidene-4-
methyl benzenesulfonamide in CH2Cl2 (300 mg, 1.16 mmol) in CH2Cl2 (1.74 mL). The resulting 
solution was stirred at room temperature for 15 min and the solvent was the removed under 
reduced pressure to afford the oxaziridine as a white solid (318 mg, 1.16 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.93 (d, J = 8.3 Hz, 2H, CH-Ar), 7.53–7.29 (m, 7H, CH-
Ar), 5.45 (s, 1H, CH-CHNO), 2.46 (s, 3H, CH3). 
13C NMR (100 MHz, CDCl3) δ ppm: 146.3 (C-Ar), 131.3 (C-Ar), 131.3 (CH-Ar), 130.4 (C-
Ar), 130.0 (CH-Ar), 129.3 (CH-Ar), 128.6 (CH-Ar), 128.1 (CH-Ar), 76.2 (CH-CHNO), 21.7 
(CH3). 
IR (thin film): 2972, 1417, 1379, 1089, 1049 cm-1. 
HRMS (ESI): Calcd for C14H13NNaO3S 
+ [M+Na]+, 298.0508; found, 282.0503. 
MP: 70°C. 
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5.3 Experimental procedures and products characterisation 
Ethyl 2,2-dimethylpent-4-ynoate (2.22)64 
 
Chemical formula: C9H14O2 
MW: 154.21 
To a stirred solution of diisopropylamine (11.5 mL, 81.9 mmol, 1.10 equiv) in THF (200 mL) 
at -78°C was added dropwise nBuLi (33.0 mL, 2.38M in hexane, 78.5 mmol, 1.05 equiv). The 
resulting solution was stirred at this temperature for 30 min and ethyl isobutyrate 2.21 (10.0 mL, 
74.5 mmol) in THF (150 mL) was added dropwise over 4 h. The reaction mixture was allowed 
to warm to 0°C for 45 min and then cooled down to -78°C. A solution of propargyl bromide 
(8.7 mL, 80% in toluene, 78.3 mmol, 1.05 equiv) in THF (50 mL) was added and the mixture 
was stirred at room temperature for 16 h. A saturated aqueous solution of NH4Cl. was added 
to quench the reaction. The aqueous layer was extracted with CH2Cl2, and the combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (95:5) to afford the ester 2.22 as a pale yellow oil (11.5 g, 74.5 mmol, 
quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.19–4.07 (m, 2H, CH2-7), 2.43 (d, J = 2.6 Hz, 2H, CH2-
3), 1.99 (t, J = 2.6 Hz, 1H, CH-1), 1.26 (s, 6H, CH3-5 ), 1.28–1.22 (t, J = 7.1 Hz, 3H CH3-8). 
13C NMR (100 MHz, CDCl3) δ ppm: 176.6 (CO-6), 81.1 (C-2), 70.4 (CH-1), 60.7 (CH2-7), 
41.9 (C-4), 29.5 (CH2-3), 24.5 (2CH3-5), 14.2 (CH3-8). 
IR (thin film): 3293, 2120, 1717, 1217 cm-1. 
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2,2-Dimethylpent-4-ynoic acid (2.23)64 
 
Chemical formula: C7H10O2 
MW: 126.16 
To a stirred solution of propargylated ethyl ester 2.22 (22.7 g, 147 mmol) in MeOH (290 mL) 
and water (118 mL) was added KOH (13.2 g, 235 mmol, 1.60 equiv). The resulting solution was 
stirred for 16 h at room temperature. A 2N aqueous HCl solution was added to quench the 
reaction and adjust the pH to 1. The aqueous layer was extracted with CH2Cl2 and the combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure to afford the acid 2.23 (17.3 g, 137 mmol, 93%) as a pale 
yellow oil which was used in the next step without further purification.  
1H NMR (400 MHz, CDCl3) δ ppm: 2.46 (d, J = 2.6 Hz, 2H, CH2-3), 2.03 (t, J = 2.6 Hz, 1H, 
CH-1), 1.32 (s, 6H, 2CH3-5). 
13C NMR (100 MHz, CDCl3) δ ppm: 183.2 (COOH-6), 80.6 (C-2), 70.7 (CH-1), 41.9 (C-4), 
29.2 (CH2-3), 24.3 (2CH3-5). 
IR (thin film): 3304, 2976, 1707, 1473 cm-1. 
 
2,2-Dimethylpent-3-ynoic acid (2.24)64 
 
Chemical formula: C7H10O2 
MW: 126.16 
To a stirred solution of acid 2.23 (8.18 g, 64.8 mmol) in DMSO (94 mL) was added potassium 
tert-butoxide (18.2 g, 162 mmol, 2.50 equiv) and the resulting solution was stirred at 75°C for 25 
min. A 1N aqueous HCl solution was added to quench the reaction and adjust the pH to 1. The 
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aqueous layer was extracted with Et2O, and the combined organic extracts were washed with 
1N aqueous HCl and brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (1:1) to afford the acid 2.24 as a pale yellow oil (7.38 g, 58.5 mmol, 90%). 
1H NMR (400 MHz, CDCl3) δ ppm: 1.81 (s, 3H, CH3-1), 1.47 (s, 6H, 2CH3-5). 
13C NMR (100 MHz, CDCl3) δ ppm: 180.8 (COOH-6), 80.7 (C-3), 78.0 (C-2), 38.2 (C-4), 
27.2 (2CH3-5), 3.5 (CH3-1). 
IR (thin film): 3298, 1716, 1288, 1174, 1056 cm-1. 
 
N-Methoxy-N,2,2-trimethylpent-3-ynamide (2.25)64 
 
Chemical formula: C9H15NO2 
MW: 169.22 
To a stirred solution of acid 2.24 (14.7 g, 116 mmol) in dichloromethane (250 mL) was added 
1,1’-carbonyl diimidazole (20.9 g, 129 mmol, 1.10 equiv). The resulting mixture was stirred for 
30 min, before N,O-dimethylhydroxylamine hydrochloride (12.5 g, 128 mmol, 1.10 equiv) was 
added. The reaction mixture was then stirred at room temperature for 24 h. A 1N aqueous HCl 
solution was added to quench the reaction and the resulting mixture was stirred vigorously for 
10 min. The aqueous layer was extracted with CH2Cl2, and the combined organic extracts were 
washed with 1N aqueous HCl and brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (95:5) to afford the Weinreb amide 2.25 as a 
colourless oil (19.1 g, 113 mmol, 97%). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.74 (s, 3H, CH3-8), 3.21 (s, 3H, CH3-7), 1.82 (s, 3H, 
CH3-1), 1.43 (s, 6H, 2CH3-5). 
13C NMR (100 MHz, CDCl3) δ ppm: 174.0 (C-6), 82.9 (C-3), 76.5 (C-2), 60.5 (CH3-8), 37.1 
(C-4), 33.8 (CH3-7), 27.3 (2CH3-5), 3.7 (CH3-1). 
IR (thin film): 2983, 2933, 1658, 1454, 1382, 1355, 1253, 1170, 999 cm-1. 
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HRMS (ESI): Calcd for C9H15NNaO2
+ [M+Na]+, 192.0995; found, 192.0996. 
 
2,6,6-Trimethylnon-2-en-7-yn-5-one (2.26)64 
 
Chemical formula: C12H18O 
MW: 178.28 
To a stirred suspension of magnesium turnings (27.1 g, 1.10 mol, 10.0 equiv) in THF (150 mL) 
was added 1,2-dibromoethane (0.1 mL), followed by a dropwise addition of prenyl chloride 
(14.2 mL, 125 mmol, 1.10 equiv) over 45 min. The resulting suspension was stirred for an 
additional 15 min. Then the freshly made Grignard reagent was added via cannula to a solution 
of Weinreb amide 2.25 (19.1 g, 113 mmol) in THF (350 mL). The resulting mixture was stirred 
at room temperature for 2 h. A saturated aqueous solution of NH4Cl was added to quench the 
reaction. The aqueous layer was extracted with Et2O, and the combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum 
ether:Et2O (97:3) to afford the ketone 2.26 as a colourless oil (19.2 g, 107 mmol, 95%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.29–5.34 (m, 1H, CH-8), 3.48 (d, J = 6.9 Hz, 2H, CH2-
7), 1.83 (s, 3H, CH3-1), 1.75 (s, 3H, CH3-10), 1.63 (s, 3H, CH3-10), 1.32 (s, 6H, 2CH3-5). 
13C NMR (100 MHz, CDCl3) δ ppm: 209.3 (CO-6), 134.9 (C-9), 116.7 (CH-8), 82.3 (C-3), 
78.9 (C-2), 43.5 (C-4), 37.3 (CH2-7), 26.3 (2CH3-5), 25.7 (CH3-10), 18.0 (CH3-10), 3.6 (CH3-1) 
IR (thin film): 2976, 2920, 1720, 1424, 1452 cm-1. 
HRMS (ESI): Calcd for C12H18NaO, 201.1250; found, 201.1243.  
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5-Methyl-2-(2-methylpent-3-yn-2-yl)-2-((trimethylsilyl)oxy)hex-4-enenitrile ((±)2.27)64 
Method A 
 
 Chemical formula: C16H27NOSi 
MW: 277.48 
To a stirred solution of ketone 2.26 (300 mg, 1.68 mmol) in CH2Cl2 (5 mL) was added ZnI2 (108 
mg, 0.338 mmol, 0.20 equiv) and TMSCN (444 µL, 3.38 mmol, 2.0 equiv). The reaction mixture 
was refluxed for 16 h and then allowed to cool down to room temperature. The volatiles were 
removed under reduced pressure with a trap of aqueous NaOCl/NaOH set up to quench the 
excess of TMSCN. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (99:1) to afford the cyanohydrin (±)2.27 as a colourless oil (461 mg, 1.63 
mmol, 99%).  
Method B 
 
To a stirred solution of ketone 2.26 (270 mg, 1.51 mmol) in CH2Cl2 (1.50 mL) at -40°C was 
added (salen)AlCl (R,R) (91 mg, 0.15 mmol, 0.10 equiv), (tert-butoxycarbonylmethylene) 
triphenylphosphorane (58 mg, 0.15 mmol, 0.10 equiv) and Ph3PO (210 mg, 0.75 mmol, 0.50 
equiv). The resulting solution was stirred at -40°C for 30 min before TMSCN (400 µL, 3.0 
mmol, 2.0 equiv) was added dropwise. The reaction mixture was stirred for 4 days at -40°C and 
then allowed to warm to room temperature. The volatiles were removed under reduced pressure 
with a trap of aqueous NaOCl/NaOH set up to quench the excess of TMSCN. The crude 
mixture was then purified by flash chromatography using petroleum ether:Et2O (99:1) to afford 
the cyanohydrin 2.27 as a colourless oil (421 mg, 1.51 mmol, quant). The separation of the two 
isomers was not possible by chiral HPLC when using either an AD-H or an OD-H column with 
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an injection volume of 20 µL and using 5-10% iPrOH in hexanes. After transformation to the 
aldehyde (±)2.28, it was coupled with the hydrazone 2.71 and the enatiomeric excess was 
calculated based on the diastereomer ratio of 2.72a and 2.72b (1H NMR and 13C NMR in the 
appendix section). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.41–5.29 (m, 1H, CH-8), 2.72 (dd, J = 14.5, 7.0 Hz, 1H, 
CH2-7), 2.51 (dd, J = 14.5, 8.0 Hz, 1H, CH2-7), 1.81 (s, 3H, CH3-1), 1.78 (s, 3H, CH3-10), 1.66 
(s, 3H, CH3-10), 1.34 (s, 3H, CH3-5), 1.24 (s, 3H, CH3-5), 0.21 (s, 9H, Si(CH3)3). 
13C NMR (100 MHz, CDCl3) δ ppm: 136.2 (C-9), 120.2 (CH-8), 118.7(CN), 82.5 (C-3), 79.5 
(C-2), 79.2 (C-6), 40.7 (C-4), 36.0 (CH2-7), 26.0 (CH3-5), 25.9 (CH3-5), 23.5 (CH3-10), 18.1 
(CH3-10), 3.6 (CH3-1), 1.5 (Si(CH3)3). 
HRMS (ESI): Calcd for C16H27NNaO2Si
+ [M+Na]+, 300.1754; found, 300.1750. 
 
5-Methyl-2-(2-methylpent-3-yn-2-yl)-2-((trimethylsilyl)oxy)hex-4-enal ((±)2.28)64 
 
Chemical formula: C16H28O2Si 
MW: 280.48 
To a stirred solution of cyanohydrin (±)2.27 (417 mg, 1.50 mmol) in freshly distilled hexane 
(24.5 mL) at -78°C was added DIBALH (2.25 mL, 1 M in hexane, 2.25 mmol, 1.50 equiv). The 
reaction mixture was allowed to warm to 0°C and was stirred at this temperature for 30 min. 
The mixture was then cooled down to -78°C, and EtOAc was added dropwise. The resulting 
mixture was stirred at this temperature for 20 min and then SiO2 (5.3 g) was added. The reaction 
mixture was then allowed to warm to room temperature and stirred for 2 h. The resulting 
suspension was filtered, and the silica was washed thoroughly with EtOAc. The solvent was 
removed under reduced pressure and the crude mixture was then purified by flash 
chromatography using pentane: CH2Cl2 (95:5) to (9:1) to afford the aldehyde (±)2.28 as a 
colourless oil (171 mg, 0.61 mmol, 92%). 
1H NMR (400 MHz, CDCl3) δ ppm: 9.82 (s, 1H, CHO), 5.05–4.92 (m, 1H, CH-8), 2.92 (dd, 
J = 14.8, 7.4 Hz, 1H, CH2-7), 2.45 (dd, J = 14.8, 7.8 Hz, 1H, CH2-7), 1.81 (s, 3H, CH3-1), 1.67 
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(s, 3H, CH3-10), 1.61 (s, 3H, CH3-10), 1.22 (s, 3H, CH3-5), 1.07 (s, 3H, CH3-5), 0.12 (s, 9H, 
Si(CH3)3). 
13C NMR (100 MHz, CDCl3) δ ppm: 204.4 (CHO), 134.7 (C-9), 118.8 (CH-8), 87.3 (C-6), 
84.0 (C-3), 78.8 (C-2), 37.4 (C-4), 32.1 (CH2-7), 25.9 (CH3-10), 25.6 (CH3-5), 24.4 (CH3-5), 
17.8 (CH3-10), 3.6 (CH3-1), 2.7 (Si(CH3)3). 
IR (thin film): 2976, 1738, 1377, 1249, 1153 cm-1. 
HRMS (ESI): Calcd for C16H28NaO2Si
+ [M+Na]+, 303.1751; found, 303.1738. 
 
5-Methyl-2-(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol (2.30) 
 
Chemical formula: C13H22O2 
MW: 210.32 
To a stirred suspension of LiAlH4 (23 mg, 0.60 mmol, 1.5 equiv) in THF (1.0 mL) was added a 
solution of the aldehyde 2.28 (177 mg, 0.40 mmol) in THF (1.0 mL). The reaction mixture was 
stirred at room temperature for 2 h. An aqueous solution of Rochelle salt was added to quench 
the reaction and the resulting mixture was stirred at room temperature for 16h. The aqueous 
layer was extracted with Et2O, and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure to afford the diol 
(±)2.30 as a colourless oil (127 mg, 0.60 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.25–5.17 (m, 1H, CH-8), 3.59 (dd, J = 11.4, 4.7 Hz, 1H, 
CH2-11), 3.50 (dd, J = 11.3, 6.0 Hz, 1H, CH2-11), 2.34–2.19 (m, 3H, CH2-7, OH), 2.13–2.02 
(m, 1H, OH), 1.67 (s, 3H, CH3-1), 1.62 (s, 3H, CH3-10), 1.53 (s, 3H, CH3-10), 1.12 (s, 6H, 
2CH3-5). 
13C NMR (100 MHz, CDCl3) δ ppm: 135.5 (C-9), 119.6 (CH-8), 84.9 (C-3), 78.3 (C-6), 76.1 
(C-2), 65.3 (CH2-11), 39.3 (C-4), 31.9 (CH2-7), 26.1 (CH3-5), 25.0 (CH3-10), 24.9 (CH3-10), 
17.9 (CH3-5), 3.5 (CH3-1). 
IR (thin film): 2970, 2918, 1452, 1382, 1265, 1030 cm-1. 
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HRMS (ESI): Calcd for C13H22NaO2
+ [M+Na]+, 233.1512; found, 233.1506. 
 
2-Hydroxy-5-methyl-2-(2-methylpent-3-yn-2-yl)hex-4-en-1-yl 4-nitrobenzoate (2.31) 
 
Chemical formula: C20H25NO5 
MW: 359.42 
To a stirred solution of diol 2.30 (115 mg, 0.550 mmol) in CH2Cl2 (12 mL) was added 
triethylamine (200 µL, 1.43 mmol, 2.60 equiv), DMAP (68 mg, 0.55 mmol, 1.0 equiv) and 4-
nitrobenzoyl chloride (204 mg, 1.10 mmol, 2.0 equiv). The reaction mixture was stirred at room 
temperature for 16 h. A saturated aqueous solution of NaHCO3 was added to quench the 
reaction. The aqueous layer was extracted with Et2O, and the combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum 
ether:Et2O (9:1) to (6:4) to afford the alcohol 2.31 as a pale yellow oil (172 mg, 0.48 mmol, 
87%). 
1H NMR (400 MHz, CDCl3) δ ppm: 8.20–8.30 (m, 4H, CH-Ar), 5.33 (t, J = 7.6 Hz, 1H, CH-
8), 4.52–4.46 (m, 2H, CH2-11), 2.45–2.57 (m, 2H, CH2-7), 2.24 (s, 1H, OH), 1.77 (s, 3H, CH3-
1), 1.71 (s, 3H, CH3-10), 1.61 (s, 3H, CH3-10), 1.33 (bs, 6H, CH3-5). 
13C NMR (100 MHz, CDCl3) δ ppm: 164.6 (CO-12), 150.6 (C-NO2), 135.7 (C-Ar), 135.5 (C-
9), 130.8 (CH-Ar), 123.6 (CH-Ar), 118.8 (CH-8), 84.1 (C-3), 78.5 (C-6), 75.5 (C-2), 68.0 (CH2-
11), 39.9 (C-4), 32.0 (CH2-7), 26.1 (CH3-5), 25.2 (CH3-10), 25.0 (CH3-10), 17.9 (CH3-5), 3.6 
(CH3-1). 
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2-Methyl-2-(3-oxobutyl)cyclohexane-1,3-dione (2.33)64 
 
Chemical formula: C11H16O3 
MW: 196.25 
To a stirred solution of 2-methylcyclohexadione 2.32 (10.0 g, 79.0 mmol) in H2O (40 mL) was 
added acetic acid (0.23 mL, 3.96 mmol, 0.05 equiv), hydroquinone (44.0 mg, 0.40 mmol, 0.005 
equiv) and freshly distilled methyl vinyl ketone (12.9 mL, 158 mmol, 2.0 equiv). The reaction 
mixture was stirred at 80°C for 24 h. After cooling down, a saturated aqueous solution of NaCl 
was added to quench the reaction. The aqueous layer was extracted with EtOAc, and the organic 
phase was washed with brine, dried over anhydrous MgSO4, filtered and concentrate under 
reduced pressure. The crude mixture was purified by flash chromatography using petroleum 
ether:Et2O: (8:2) to (7:3) to afford the diketone 2.33 as a pale yellow oil (15.2 g, 77.4 mmol, 
98%).  
1H NMR (400 MHz, CDCl3) δ ppm: 2.78–2.53 (m, 4H, CH2), 2.32 (t, J = 7.5 Hz, 2H, CH2), 
2.08 (s, 3H, CH3-8), 2.05–2.00 (m, 3H, CH2), 1.95–1.82 (m, 1H, CH2), 1.22 (s, 3H, CH3-9). 
13C NMR (100 MHz, CDCl3) δ ppm: 201.0 (CO-3), 207.5 (CO-7), 64.3 (C-4), 38.3 (CH3-8), 
37.7 (CH2-2), 29.9 (CH2), 29.5 (CH2), 20.0 (CH3-9), 17.5 (CH2-1). 
IR (thin film): 1713, 1690 cm-1. 
HRMS (ESI): Calcd for C11H16NaO3
+ [M+Na]+, 219.0992; found 219.0993. 
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(S)-8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (2.35)64 
 
Chemical formula: C11H14O2 
MW: 178.23 
To a flask containing meso ketone 2.33 (17.7 g, 90.2 mmol) were added N-tosyl-(S)-binam-(L)-
prolinamide catalyst 2.34 (485 mg, 0.900 mmol, 0.01 equiv) and benzoic acid (276 mg, 2.26 
mmol, 0.025 equiv). The reaction mixture was stirred at 22°C for 5 days. After complete 
reaction, EtOAc (95 mL) was added followed by activated charcoal (3.15 g), and the resulting 
mixture was stirred for 15 h at 22°C. The mixture was diluted with hexane (95 mL) and filtered 
through slurry-packed silica (180 g). The silica cake was eluted with EtOAc:hexanes (1:1). The 
filtrate was concentrated under reduced pressure and dried under vacuum for 6 h affording a 
brown oil that crystallized on standing. t-Butyl methyl ether (5.0 mL) was added, and the mixture 
was warmed to 45 °C with a water bath to dissolve the solids. The solution was cooled to room 
temperature over 1 h, then placed in a freezer at -15 °C for 12 h, resulting in the formation of 
large reddish-brown crystals. The supernatant was removed, and the final traces of solvent were 
removed under vacuum for 16 h to afford (+)-Wieland-Miescher ketone 2.35 (14.5 g, 81.3 
mmol, 90%, 98% ee). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.85 (s, 1H, CH-6), 2.60–2.76 (m, 2H, CH2-2,4), 2.51–
2.34 (m, 4H, CH2-2,4,8), 2.16–2.02 (m, 3H, CH2-3,9), 1.67 (ddt, J = 17.6, 13.3, 6.6 Hz, 1H, 
CH2-3), 1.41 (s, 3H, CH3-11). 
13C NMR (100 MHz, CDCl3) δ ppm: 211.1 (CO-1), 198.3 (CO-7), 165.9 (C-5), 125.8 (CH-6), 
50.6 (C-10), 37.7 (CH2-2), 33.6 (CH2-8), 31.8 (CH2-4), 29.6 (CH2-9), 23.3 (CH3-11), 22.9 (CH2-
3). 
IR (thin film): 1713, 16970 cm-1. 
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HRMS (ESI): Calcd for C11H14O2
+ [M]+, 178.0994; found, 178.0991. 
[α]D: +94 (c 1.0, toluene), 97% ee.  (lit.
64 [α]D: +94 (c 1.0, toluene), 97% ee). 
(4aS,5S)-5-Hydroxy-4a-methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.36)64 
 
Chemical formula: C11H16O2 
MW: 180.25 
To a stirred solution of ketone 2.35 (17.7 g, 99.3 mmol) in MeOH:CH2Cl2 (1:1) (286 mL) 
at -78°C was added NaBH4 (3.77 g, 99.3 mmol, 1.0 equiv). The reaction mixture was stirred at 
this temperature for 30 min. Acetone was carefully added to quench the reaction followed by 
slow addition of H2O. The aqueous layer was extracted with CH2Cl2 and the combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:EtOAc (6:4) to (3:7) to afford the alcohol 2.36 as a colourless oil (17.6 g, 96.6 
mmol, 97%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.77 (d, J = 0.8 Hz, 1H, CH-6), 3.41 (d, J = 11.4 Hz, 1H, 
CH-1), 2.46–2.26 (m, 3H, CH2-4,8), 2.23–2.10 (m, 2H, CH2-4,9), 1.96–1.76 (m, 4H, CH2-
2,3,9,OH), 1.72–1.61 (m, 1H, CH2-2), 1.41 (tdd, J = 12.5, 8.3, 4.2 Hz, 1H, CH2-3), 1.18 (s, 3H, 
CH3-11). 
13C NMR (100 MHz, CDCl3) δ ppm: 199.7 (CO-7), 168.6 (C-5), 125.4 (CH-6), 78.2 (CH-1), 
41.6 (C-10), 34.2 (CH2-9), 33.7 (CH2-8), 32.0 (CH2-4), 30.2 (CH2-2), 23.1 (CH2-3), 15.2 (CH3-
11). 
IR (thin film): 3420, 1659 cm-1.  
HRMS (ESI): Calcd for C11H16O2
+ [M]+, 180.1150; found, 180.1144. 
[α]D: +182 (c 1.5, benzene).(lit.
64 [α]D: +185 (c 1.0, benzene)) 
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(4aS,5S)-4a-Methyl-5-((triethylsilyl)oxy)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one 
(2.37)64 
 
Chemical formula: C17H30O2Si 
MW: 294.51 
To a stirred solution of alcohol 2.36 (17.1 g, 95.0 mmol) in CH2Cl2 (60 mL) were added 
imidazole (16.2 g, 238 mmol, 2.50 equiv) and TESCl (24.0 mL, 142 mmol, 1.50 equiv). The 
reaction mixture was stirred at room temperature for 24 h. A saturated aqueous solution of 
NaHCO3 was added to quench the reaction. The aqueous layer was extracted with CH2Cl2, and 
the combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered 
and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (9:1) to (7:3) to afford the protected alcohol 2.37 
as a colourless oil (27.9 g, 219 mmol, quant).  
1H NMR (400 MHz, CDCl3) δ ppm: 5.75 (s, 1H, CH-6), 3.45–3.32 (m, 1H, CH-1), 2.44–2.24 
(m, 3H, CH2), 2.13 (dddd, J = 10.5, 10.0, 7.0, 2.1 Hz, 2H, CH2), 1.83 (ddd, J = 7.6, 5.5, 2.8 Hz, 
1H, CH2), 1.78–1.64 (m, 3H, CH2), 1.35 (d, J = 13.1 Hz, 1H, CH2), 1.15 (s, 3H, CH3-11), 0.95 
(td, J = 7.9, 2.1 Hz, 9H, CH3-TES), 0.63–0.54 (m, 6H, CH2-TES). 
13C NMR (100 MHz, CDCl3) δ ppm: 199.8 (CO-7), 168.9 (C-5), 125.3 (CH-6), 78.9 (CH-1), 
42.2 (C-10), 34.6 (CH2), 33.9 (CH2), 32.1 (CH2), 30.8 (CH2), 23.0 (CH2), 15.5 (CH3-11), 6.9 
(CH3-TES), 5.2 (CH2-TES). 
IR (thin film): 2912, 2873, 1681, 1672, 1107, 1078 cm-1. 
HRMS (ESI): Calcd for C17H30NaO2Si
+ [M+Na]+, 317.1907; found, 317.1893. 
[α]D: +108 (c 1.0, CHCl3).(lit.
64 [α]D: +105 (c 1.0, toluene)) 
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3-((1R,6S)-1-Methyl-2-oxo-6-((triethylsilyl)oxy)cyclohexyl)propanoic acid (2.38)64 
Method A 
 
Chemical formula: C16H30O4Si 
MW: 314.50 
To a stirred solution of 2.37 (6.0 g, 20 mmol) in MeOH (213 mL) at -78°C was added pyridine 
(8.14 mL, 100 mmol, 5.0 equiv). A stream of O3 was passed for 50 min and the reaction mixture 
was then allowed to stir at room temperature for 2 h. The solvent was removed under reduced 
pressure and the crude mixture was purified by flash chromatography using petroleum 
ether:Et2O:AcOH (80:20:0.1) to afford the acid 2.38 as a colourless oil (3.8 g, 12 mmol, 60%). 
Method B 
 
To a stirred solution of enone 3.37 (550 mg, 1.83 mmol) in MeOH (16 mL) was added a solution 
of Na2CO3 (208 mg, 1.96 mmol, 1.05 equiv) in H2O (0.73 mL). The reaction mixture was 
refluxed for 5 min before a solution of NaIO4 (2.09 g, 9.40 mmol, 5.13 equiv) and KMnO4 (15 
mg, 0.1 mmol, 0.05 equiv ) in H2O (11 mL) was added dropwise. The resulting solution was 
refluxed for 3 h and the reaction mixture was filtered through a sintered funnel to remove the 
inorganic material. The filter cake as washed with water and CH2Cl2. The filtrate was acidified 
to pH 1 by addition of a 1M HCl. The aqueous layer was extracted with CH2Cl2, and the 
combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O:AcOH (80:20:0.1) to afford the acid 2.38 as a 
colourless oil (361 mg, 1.15 mmol, 63%). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.81 (dd, J = 6.5, 1.9 Hz, 1H, CH-1), 2.46-2.26 (m, 3H, 
CH2-4,8), 2.22 (ddd, J = 16.4, 11.6, 4.9 Hz, 1H, CH2-8), 2.08–1.95 (m, 3H, CH2), 1.81 (m, 2H, 
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CH2), 1.65 (dd, J = 9.1, 6.6 Hz, 1H, CH2), 1.07 (s, 3H, CH3-10), 0.94 (t, J = 7.9 Hz, 9H, CH3-
TES), 0.58 (q, J = 8.0 Hz, 6H, CH2-TES). 
13C NMR (100 MHz, CDCl3) δ ppm: 214.0 (CO-5), 178.9 (COOH-9), 76.5 (CH-1), 54.3 (C-
6), 37.7 (CH2-4), 30.1 (CH2), 29.0 (CH2), 29.0 (CH2), 20.4 (CH2), 17.5 (CH3-10), 6.9 (CH2-
TES), 5.0 (CH3-TES). 
IR (thin film): 3259, 2975, 1742, 1718, 1249, 1050 cm-1. 
HRMS (ESI): Calcd for C16H30NaO4Si
+ [M+Na]+, 337.1806; found, 337.1797. 
[α]D: -10.8 (c 1.0, CHCl3). 
 
(4aS,5S)-5-((tert-Butyldimethylsilyl)oxy)-4a-methyl-4,4a,5,6,7,8-hexahydronaphthalen-
2(3H)-one (2.46)80 
 
Chemical formula: C17H30O2Si 
MW: 294.51 
To a stirred solution of alcohol 2.36 (300 mg, 1.66 mmol) in DMF (0.40 mL) were added 
imidazole (226 mg, 3.32 mmol, 2.0 equiv) and TBSCl (500 mg, 3.32 mmol, 2.0 equiv). The 
reaction mixture was stirred at room temperature for 16 h. Water was added to quench the 
reaction and the aqueous layer was extracted with EtOAc. The combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum 
ether:Et2O (30:1) to (25:5) to afford the protected alcohol 2.46 as a white solid (433 mg, 1.47 
mmol, 89%).  
1H NMR (400 MHz, CDCl3) δ ppm: 5.71 (d, J = 1.6 Hz, 1H, CH-6), 3.31 (dd, J = 10.8, 5.0 
Hz, 1H, CH-1), 2.44–2.22 (m, 3H, CH2), 2.17–1.99 (m, 2H, CH2), 1.85–1.73 (m, 1H, CH2), 
1.64 (tdd, J = 13.1, 12.3, 7.4 Hz, 3H, CH2), 1.32 (ddd, J = 13.2, 11.1, 4.5 Hz, 1H, CH2), 1.11 (s, 
3H, CH3-11), 0.84 (s, 9H, CH3-SiC(CH3)3), -0.01 (d, J = 6.9 Hz, 6H, CH3-Si(CH3)2). 
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13C NMR (100 MHz, CDCl3) δ ppm: 199.7 (C-1), 168.8 (C-3), 125.4 (C-2), 78.9 (C-7), 42.2 
(C-8), 34.8 (CH2), 33.9 (CH2), 32.1 (CH2), 30.8 (CH2), 25.8 (SiC(CH3)3), 23.0 (CH2), 18.0 
(SiC(CH3)3), 15.6 (CH3-8), -5.0 (Si(CH3)2). 
 
3-((1R,2S)-2-((tert-Butyldimethylsilyl)oxy)-1-methyl-6-oxocyclohexyl)propanoic acid 
(2.47)80 
 
Chemical formula: C16H30O4Si 
MW: 314.50 
To a stirred solution of protected alcohol 2.46 (412 mg, 1.40 mmol) in MeOH (15 mL) at -78°C 
was passed a stream of O3 for 50 min. The reaction mixture was then allowed to stir at room 
temperature for 2 h. The solvent was removed under reduced pressure and the crude mixture 
was purified by flash chromatography using petroleum ether:Et2O:AcOH (80:20:0.1) to afford 
the acid 2.47 as a colourless oil (158 mg, 0.500 mmol, 36%). 
1H NMR (400 MHz, CDCl3) δ ppm: 10.78 (bs, 1H, COOH), 3.85–3.69 (m, 1H, CH-1), 2.30 
(dt, J = 13.2, 6.4 Hz, 3H, CH2), 2.16 (d, J = 4.9 Hz, 1H, CH2), 2.06–1.90 (m, 3H, CH2), 1.83–
1.58 (m, 3H, CH2), 1.02 (s, 3H, CH3-10), 0.83 (s, 9H, CH3-SiC(CH3)3), 0.00 (d, J = 4.0 Hz, 6H, 
CH3-Si(CH3)2). 
13C NMR (100 MHz, CDCl3) δ ppm: 214.1 (CO-5), 179.3 (COOH), 76.4 (CH-1), 54.1 (C-6), 
37.6 (CH2-4), 30.1 (CH2), 29.0 (CH2), 28.7 (CH2), 25.7 (C-SiC(CH3)3), 20.3 (CH2), 17.9 (CH3-
SiC(CH3)3), 17.7 (CH3-10), -4.3 (CH3-Si(CH3)2), -5.1 (CH3-Si(CH3)2). 
HRMS (ESI): Calcd for C16H30NaO4Si
+ [M+Na]+, 337.1806; found, 337.1795. 
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S-Ethyl 3-((1R,6S)-1-methyl-2-oxo-6-((triethylsilyl)oxy)cyclohexyl)propanethioate 
(2.55)64 
 
Chemical formula: C18H34O3SSi 
MW: 358.61 
To a stirred solution of acid 2.38 (811 mg, 2.58 mmol) in CH2Cl2 (6.30 mL) was added carbonyl 
diimidazole (543 mg, 3.35 mmol, 1.30 equiv). The reaction mixture was stirred for 30 min before 
EtSH (318 µL, 5.16 mmol, 2.0 equiv) was added. The reaction mixture was stirred for 16 h at 
room temperature and the volatiles were removed under reduced pressure. Water was added 
and the aqueous layer was extracted with CH2Cl2. The combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:Et2O (95:5) to 
afford the thioester 2.55 as a colourless oil (924 mg, 68.6 mmol, quant) 
1H NMR (400 MHz, CDCl3) δ ppm: 3.81 (d, J = 6.1 Hz, 1H, CH-1), 2.86 (q, J = 7.4 Hz, 2H, 
CH2-11), 2.54 (ddd, J = 15.6, 11.4, 5.4 Hz, 1H, CH2), 2.43–2.28 (m, 3H, CH2), 2.13–1.92 (m, 
3H, CH2), 1.88–1.63 (m, 3H, CH2), 1.23 (t, J = 7.4 Hz, 3H, CH3-12), 1.06 (s, 3H, CH3-10), 0.94 
(t, J = 7.9 Hz, 9H, CH3-TES), 0.58 (q, J = 8.0 Hz, 6H, CH2-TES). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.8 (CO-5), 199.2 (CO-9), 76.8 (CH-1), 54.3 (C-6), 
39.1 (CH2), 37.7 (CH2), 31.0 (CH2), 28.9 (CH2), 23.3 (CH2-11), 20.4 (CH2), 17.6 (CH3-10), 14.7 
(CH3-12), 6.9 (CH3-TES), 5.0 (CH2-TES). 
IR (thin film): 2949, 2873, 1708, 1460, 1114, 1078, 1018 cm-1.  
HRMS (ESI): Calcd for C18H34NaO3SSi
+ [M+Na]+, 381.1890; found, 381.1876. 
[α]D: -20.4 (c 1.0, CHCl3) 
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(4aR,8aS)-2-Hydroxy-4a-methyloctahydro-5H-chromen-5-one (2.49)64 
Method A 
 
Chemical formula: C10H16O3  
MW: 184.24 
To a stirred solution of thioester 2.55 (117 mg, 0.32 mmol) in CH2Cl2 (4.60 mL) were added 
triethylsilane (102 µL, 0.64 mmol, 2.0 equiv) and 10% Pd/C (34 mg) portionwise. The reaction 
mixture was stirred for 30 min. Then the reaction mixture was filtered through a short pad of 
Celite and the solvent was concentrated under reduced pressure. The crude mixture was 
dissolved in THF (150 mL), cooled down to 0°C and an aqueous solution of 7% HBr (3.5 mL) 
was slowly added. The resulting mixture was stirred at this temperature for 2h. A saturated 
aqueous solution of NaHCO3 was slowly added to quench the reaction. The aqueous layer was 
extracted with EtOAc, and the combined organic extracts were dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:EtOAc (7:3) to afford the hemiacetal 2.49 as a 1:1 
mixture of diastereomers (49 mg, 0.27 mmol, 84%). 
Method B 
 
To a stirred solution of DMF (2.94 mL, 38.2 mmol, 10.0 equiv) in CH2Cl2 (10.0 mL) at -20°C 
was added oxalyl chloride (1.0 mL, 11.5 mmol, 3.0 equiv). The resulting mixture was stirred at 
this temperature for 90 min and then was concentrated under reduced pressure. The resulting 
mixture was then cooled down to -30°C and diluted with acetonitrile (5.0 mL) and THF (12.5 
mL). A solution of the acid 2.38 (1.25 g, 3.82 mmol) in THF (5.0 mL) and pyridine (1.0 mL) 
was added dropwise and the resulting solution was allowed to stir at -30°C for 90 min. The 
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solution was then cooled down to -78°C and a solution of CuI (72 mg, 0.38 mmol, 0.1 equiv) 
and LiAlH(t-BuO)3 (1.96 g, 7.64 mmol, 2.0 equiv) in THF (15 mL) was slowly added. The 
resulting mixture was stirred at -78°C for 15 min and an aqueous solution of 7% HBr was added 
to quench the reaction. The aqueous layer was extracted with Et2O, and the combined organic 
extracts were washed with brine and an aqueous saturated solution of NaHCO3, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography using petroleum ether:Et2O (8:2) to (6:4) to afford the 
hemiacetal 2.49 as a 1:1 mixture of diastereomers (216 mg, 1.17 mmol, 30%). 
Method C 
 
To a stirred solution of hydrazine 2.68 (320 mg, 0.94 mmol) in THF (17 mL) was added 
dropwise an aqueous solution of 7% HBr (10 mL). The reaction mixture was stirred at room 
temperature for 16 h. A saturated aqueous solution of NaHCO3 was added to quench the 
reaction. The aqueous layer was extracted with Et2O, and the combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum 
ether:EtOAc (7:3) to afford the 2.49 as a with solid (126mg, 0.67 mmol, 71%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.23 (d, J = 3.6 Hz, 0.5H, CH-9), 4.71 (dd, J = 9.6, 2.2 
Hz, 0.5H, CH-9), 4.00 (dd, J = 12.0, 4.1 Hz, 0.5H, CH-1), 3.91 (bs, 0.5H, OH), 3.36 (dd, J = 
11.6, 4.2 Hz, 0.5H, CH-1), 3.16 (bs, 0.5H, OH), 2.75–2.54 (m, 1H, CH2-4), 2.26–2.12 (m, 1H, 
CH2-4), 2.04–1.46 (m, 8H, CH2), 1.23 (s, 1.5H, CH3-10), 1.19 (s, 1.5H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.6 (CO-5), 96.9 (CH-9), 91.4 (CH-9), 79.4 (CH-1), 
71.6 (CH-1), 48.6 (C-6), 48.4 (C-6), 36.4 (CH2), 29.3 (CH2), 28.9 (CH2), 26.0 (CH2), 25.8 (CH2), 
24.7 (CH2), 20.8 (CH2), 16.2 (CH3-10), 15.2 (CH3-10). 
IR (thin film): 3471, 2931, 2872, 1705, 1452, 1053 cm-1. 
HRMS (ESI): Calcd for C10H16NaO3
+ [M+Na]+, 207.0992; found, 207.0987. 
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N-Methoxy-N-methyl-4-oxo-4-phenylbutanamide (2.58) 
 
Chemical formula: C12H15NO3 
MW: 221.26 
To a stirred solution of acid 2.57 (392 mg, 2.20 mmol) in CH2Cl2 (4.8 mL) was added carbonyl 
diimidazole (393 mg, 2.42 mmol, 1.10 equiv). The reaction mixture was stirred 30 min at room 
temperature before N,O-dimethylhydroxylamine hydrochloride (236 mg, 2.42 mmol, 1.10 
equiv) was added. The resulting mixture was stirred at room temperature for 24 h. An aqueous 
solution of 1N HCl was added to quench the reaction. The aqueous layer was extracted with 
CH2Cl2, and the combined organic extracts were washed with brine, dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure to afford the Weinreb amide 2.58 as 
a colourless oil (492 mg, 2.2 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 8.04–7.95 (m, 2H, CH-Ar), 7.54 (ddd, J = 6.7, 4.0, 1.3 
Hz, 1H, CH-Ar), 7.49–7.40 (m, 2H, CH-Ar), 3.77 (s, 3H, CH3-6), 3.33 (td, J = 6.7, 2.1 Hz, 2H, 
CH2-2), 3.20 (s, 3H, CH3-5), 2.89 (t, J = 6.2 Hz, 2H, CH2-3). 
13C NMR (100 MHz, CDCl3) δ ppm: 199.0 (CO-1), 173.3 (CO-4), 136.8 (C-Ar), 133.1 (CH-
Ar), 128.6 (CH-Ar), 128.1 (CH-Ar), 61.3 (CH3-6), 33.0 (CH2-2), 32.3 (CH3-5), 26.1 (CH2-3). 
IR (thin film): 2920, 1685, 1660, 1448, 1361 cm-1. 
 
N-Methoxy-N-methyl-3-((1R,6S)-1-methyl-2-oxo-6-((triethylsilyl)oxy)cyclohexyl) 
propanamide (2.60) 
 
Chemical formula: C18H35NO4Si 
MW: 357.57 
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To a stirred solution of acid 2.38 (208 mg, 0.660 mmol) in CH2Cl2 (1.5 mL) was added carbonyl 
diimidazole (118 mg, 0.730 mmol, 1.10 equiv). The reaction mixture was stirred 30 min at room 
temperature before N,O-dimethylhydroxylamine hydrochloride (71 mg, 0.73 mmol, 1.1 equiv) 
was added. The resulting mixture was stirred at room temperature for 24 h. An aqueous solution 
of 1N HCl was added to quench the reaction. The aqueous layer was extracted with CH2Cl2, 
and the combined organic extracts were washed with brine, dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (1:1) to afford the Weinreb amide 2.58 as a pale 
yellow oil (174 mg, 0.470 mmol, 74%). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.93–3.83 (m, 1H, CH-1), 3.65 (s, 3H, CH3-12), 3.15 (s, 
3H, CH3-11), 2.23 (m, 7H, CH2), 1.79–1.65 (m, 3H, CH2), 1.06 (s, 3H, CH3-10), 0.98–0.87 (m, 
9H, CH3-TES), 0.57 (q, J = 7.9 Hz, 6H, CH2-TES). 
 
(4aR,8aS)-4a-Methylhexahydro-2H-chromene-2,5(3H)-dione (2.39) 
Method A 
 
Chemical formula: C10H14O3 
MW: 182.22 
To a stirred solution of acid 2.38 (5.15 g, 16.3 mmol) in toluene (123 mL) was added CSA (4.96 
g, 21.3 mmol, 1.30 equiv). The reaction mixture was refluxed for 20 h and then the solvent was 
removed under reduced pressure. The crude mixture was then purified by flash chromatography 
using petroleum ether: Et2O (1:1) to afford the lactol 2.39 as a pale yellow oil (1.81 g, 9.93 
mmol).  
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Method B 
 
To a stirred solution of thioester 2.55 (717 mg, 1.99 mmol) in THF (4.3 mL) at 0°C was added 
an aqueous solution of 7% HBr (4.3 mL). The reaction mixture stirred at this temperature for 
2 h. A saturated aqueous solution of NaHCO3 was added to quench the reaction. The aqueous 
layer was extracted with Et2O, and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture 
was then purified by flash chromatography using petroleum ether (7:3) to afford the lactone 
2.39 as a pale yellow oil (290 mg, 1.59 mmol, 80%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.19 (dd, J = 11.6, 4.4 Hz, 1H, CH-1), 2.75–2.57 (m, 3H, 
CH2-4,8), 2.35–2.19 (m, 2H, CH2-2,8), 2.15–1.98 (m, 3H, CH2-2,3), 1.84–1.75 (m, 1H, CH2-
7), 1.63–1.54 (m, 1H, CH2-7), 1.23 (s, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 210.4 (CO-5), 170.7 (CO-9), 81.5 (CH-1), 48.3 (C-6), 
36.4 (CH2-7), 27.0 (CH2-3), 26.6 (CH2-2), 25.9 (CH2-8), 20.1 (CH2-4), 16.6 (CH3-10). 
IR (thin film): 2953, 1745, 1712, 1462, 1217, 1055 cm-1. 
HRMS (ESI): Calcd for C10H14NaO3
+ [M+Na]+, 205.0835; found, 205.0839. 
[α]25 : -41.6 (c 1.50, CH2Cl2) 
 
Methyl 3-((1R)-2-methoxy-1-methyl-6-oxocyclohexyl)propanoate ((±)2.62) 
 
Chemical formula: C12H20O4 
MW: 228.29 
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To a stirred solution of hemiacetal 2.39 (138 mg, 0.74 mmol) in MeOH (7.4 mL) was added 
trimethylorthoformate (99 µL, 0.90 mmol, 1.2 equiv) and PTSA (258 mg, 1.36 mmol, 1.80 equiv) 
The reaction mixture was refluxed for 2 days. The reaction mixture was allowed to cool to room 
temperature and an aqueous solution of 1M of MeONa was added to quench the reaction. The 
aqueous layer was extracted with Et2O, and the combined organic extracts were washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether2:EtOAc (6:4) 
to afford ester (±)2.62 as a pale yellow oil (62 mg, 0.27 mmol, 36%). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.69–3.53 (m, 3H, CH3-12), 3.38–3.19 (m, 3H, CH3-11), 
3.21–3.17 (m, 1H, CH-1), 2.41–1.79 (m, 9H, CH2), 1.65–1.56 (m, 1H, CH2-9), 1.12–1.07 (m, 
3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.2 (CO-5), 174.2 (CO-9), 173.9 (CO-9), 85.9 (CH-
1), 84.7 (CH-1), 57.2 (CH3-11), 57.1 (CH3-11), 53.6 (C-6), 53.4 (C-6), 51.6 (CH3-12), 51.6 (CH3-
12), 37.7 (CH2), 37.6 (CH2), 30.5 (CH2), 29.1(CH2), 28.9 (CH2), 27.6 (CH2), 23.4 (CH2), 23.3 
(CH2), 20.2 (CH2), 19.5 (CH3-10), 17.4 (CH3-10) 
HRMS (ESI): Calcd for C12H20NaO4
+ [M+Na]+, 251.1254; found, 251.1255. 
 
2,4,6-Triisopropyl-N'-((4aS,8aS,E)-4a-methyl-2-oxooctahydro-5H-chromen-5-
ylidene)benzenesulfonohydrazide (2.64) 
 
Chemical formula: C25H38N2O4S 
MW: 462.65 
To a stirred solution of ketone 2.39 (120 mg, 0.660 mmol) in THF (10 mL) at 0°C was added 
TrisNHNH2 (200 mg, 0.67 mmol, 1.0 equiv) and 2 drops of concentrated HCl. The reaction 
mixture was stirred at room temperature for 1 h. A saturated aqueous solution of NaHCO3 was 
added to quench the reaction. The aqueous layer was extracted with Et2O, and the combined 
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organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether: Et2O (8:2) to afford the hydrazone 2.64 as a white solid 
(252 mg, 0.250 mmol, 38%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.85 (bs, 1H, NH), 7.10 (s, 2H, CH-Ar), 4.16–4.04 (m, 
2H, CH-iPr), 3.94 (dd, J = 12.0, 4.2 Hz, 1H, CH-1), 2.89–2.81 (m, 1H, CH-iPr ), 2.65–2.29 
(m, 3H, CH2), 2.01–1.82 (m, 4H, CH2), 1.63 (m, 3H, CH2), 1.22–1.13 (m, 18H, CH3-iPr), 0.96 
(s, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 170.9 (CO-9), 158.8 (CN-5), 153.5 (C-Ar), 151.2 (C-Ar), 
130.9 (C-Ar), 123.6 (C-Ar), 82.3 (CO-1), 41.6 (C-6), 34.1 (CH-iPr), 29.8 (CH-iPr), 28.7 (CH2-
2), 27.0 (CH2-8), 26.1 (CH2-3), 24.8 (CH3-iPr), 24.7 (CH3-iPr), 23.5 (CH3-iPr), 23.5 (CH3-
iPr), 21.6 (CH2-4), 20.9 (CH2-7), 17.0 (CH3-10) 
IR (thin film): 2960, 1460, 1363, 1330, 1190, 1124 cm-1. 
HRMS (ESI): Calcd for C25H38N2NaO4S
+ [M+Na]+, 485.2444; found, 485.2422. 
 
N'-((4aS,8aS,E)-2-Hydroxy-4a-methyloctahydro-5H-chromen-5-ylidene)-2,4,6-
triisopropylbenzenesulfonohydrazide (2.65) 
 
Chemical formula: C25H40N2O4S 
MW: 464.67 
To a stirred solution of hydrazone 2.64 (102 mg, 0.220 mmol) in CH2Cl2 (3.3 mL) at -78°C was 
added DIBALH (0.22 mL, 1 M in hexane, 0.22 mmol, 1.0 equiv) dropwise. The reaction mixture 
was stirred at this temperature for 30 min. MeOH was added to quench the reaction and the 
resulting solution was allowed to warm up to room temperature. An aqueous solution of 
Rochelle salt was added and the reaction mixture was stirred for 24 h. The aqueous layer was 
extracted with CH2Cl2, and the combined organic extracts were washed with brine, dried over 
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anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography using petroleum ether:Et2O (8:2) to afford the hemiacetal 
2.65 as a white solid (43 mg, 0.092 mmol, 42%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.14 (s, 2H, CH-Ar), 4.19 (dq, J = 13.5, 6.7 Hz, 2H, CH- 
iPr), 4.08 (d, J = 10.2 Hz, 1H, CH-1), 3.21 (dd, J = 10.6, 5.3 Hz, 1H, CH-9), 2.89 (dt, J = 13.8, 
6.9 Hz, 1H, CH-iPr), 2.60 (td, J = 14.4, 7.1 Hz, 1H, CH2-4), 2.17 (dd, J = 14.9, 3.8 Hz, 1H, 
CH2-4), 2.00–1.93 (m, 1H, CH2-8), 1.80–1.44 (m, 7H, CH2), 1.26–1.22 (m, 18H, CH3- iPr), 
1.14–1.10 (m, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 163.8 (CN-5), 153.1 (C-Ar), 151.5 (C-Ar), 131.0 (C-Ar), 
123.7 (CH-Ar), 89.1 (CO-9), 80.0 (CO-1), 48.5 (C-6), 36.4 (CH2-4), 34.1 (CH-iPr), 29.7 (CH-
iPr), 29.6 (CH2), 25.9 (CH2), 25.1 (CH2), 24.9 (CH3-iPr), 24.8 (CH3-iPr), 20.7 (CH2), 16.1 
(CH3-1). 
 
N'-((4aS,8aS,E)-4a-Methyl-2-oxooctahydro-5H-chromen-5-
ylidene)benzenesulfonohydrazide (2.67) 
 
Chemical formula: C16H20N2O4S 
MW: 336.41 
To a stirred solution of ketone 2.39 (400 mg, 2.19 mmol) in THF (13 mL) at 0°C was added 
phenyl hydrazine (417 mg, 2.42 mmol, 1.10 equiv) and 2 drops of concentrated HCl. The 
reaction mixture was stirred at room temperature for 2 h and 30 min. A saturated aqueous 
solution of NaHCO3 was added to quench the reaction. The aqueous layer was extracted with 
Et2O, and the combined organic extracts were washed with brine, dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using pretroleum ether:EtOAc (1:1) to afford the hydrazone 2.67 as a white 
solid  (605 mg, 1.79 mmol, 82%). 
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1H NMR (400 MHz, CDCl3) δ ppm: 7.96–7.90 (m, 2H, CH-Ar), 7.56 (m, 3H, CH-Ar), 7.40 
(bs, 1H, NH), 4.01 (dd, J = 12.0, 4.2 Hz, 1H, CH-1), 2.72–2.48 (m, 3H, CH2), 2.15 (d, J = 4.5 
Hz, 1H, CH2), 1.99–1.74 (m, 5H, CH2), 1.38–1.31 (m, 1H, CH2), 1.02 (s, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 170.9 (CO-9), 161.5 (CN-5), 137.9 (C-Ar), 133.4 (CH-
Ar), 128.9 (CH-Ar), 128.1 (CH-Ar), 82.2 (CH-1), 41.7 (C-6), 28.8 (CH2), 27.1 (CH2), 26.1 
(CH2), 21.9 (CH2), 20.8 (CH2), 17.0 (CH3-10). 
IR (thin film): 2158, 2019, 1977, 1264, 1172, 1126, 910, 747 cm-1. 
HRMS (ESI): Calcd for C16H20N2O4S
+ [M]+, 336.1146; found, 336.1144 
MP: 164°C. 
 
(2S,4aR,8aS)-2-Methoxy-4a-methyloctahydro-5H-chromen-5-one (2.70)64 
 
Chemical formula: C11H18O3 
MW: 198.26 
To a stirred solution of hemiacetal 2.69 (1.74 g, 9.44 mmol) in CH2Cl2 (14 mL) was added Ag2O 
(2.40 g, 10.4 mmol, 1.10 equiv) and MeI (1.80 mL, 28.8 mmol, 3.0 equiv). The resulting solution 
was stirred at room temperature for 2 days. The reaction mixture was filtered through a pad of 
Celite, the filter cake was washed with CH2Cl2 and the filtrate was then concentrated under 
reduced pressure to afford to afford the acetal 2.70 as a white foam (1.72 g, 8.67 mmol, 92%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.28 (dd, J = 9.5, 2.3 Hz, 1H, CH-9), 3.49 (s, 3H, OCH3), 
3.30 (dd, J = 11.4, 4.3 Hz, 1H, CH-1), 2.72–2.57 (m, 1H, CH2-4), 2.18 (dd, J = 15.0, 4.9 Hz, 
1H, CH2-4), 2.01–1.50 (m, 8H, CH2), 1.23 (s, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.7 (CO-5), 104.0 (CH-9), 79.3 (CH-1), 56.5 (OCH3), 
48.7 (C-6), 36.5 (CH2-4), 29.3 (CH2-7), 27.3 (CH2-8), 26.0 (CH2-2), 20.9 (CH2-3), 16.3 (CH3-
10). 
IR (thin film): 2947, 1710, 1066 cm-1. 
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HRMS (EI): Calcd for C11H18O3
+ [M]+, 198.1256; found, 198.1270. 
[α]D: +102 (c 1.5, CHCl3). 
 
2,4,6-Triisopropyl-N'-((2S,4aS,8aS,E)-2-methoxy-4a-methyloctahydro-5H-chromen-5-
ylidene)benzenesulfonohydrazide (2.71)64 
 
Chemical formula: C26H42N2O4S 
MW: 478.69 
To a stirred solution of ketone 2.70 (1.72 g, 8.67 mmol) in THF (12 mL) at 0°C was added 
TrisNHNH2 (2.82 g, 9.52 mmol, 1.1 equiv) and 3 drops of concentrated HCl. The reaction 
mixture was stirred at room temperature for 2 h. A saturated aqueous solution of NaHCO3 was 
added to quench the reaction. The aqueous layer was extracted with Et2O, and the combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether: Et2O (8:2) to (6:4) to afford the hydrazone 2.71 as a 
white solid (3.92 mg, 8.20 mmol, 94%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.30 (bs, 1H, NH), 7.16 (s, 2H, CH-Ar), 4.21 (dd, J = 
8.1, 3.3 Hz, 1H, CH-9), 4.16 (dt, J = 13.5, 6.8 Hz, 2H, CH- iPr), 3.46 (s, 3H, CH3-OMe), 3.16–
3.09 (m, 1H, CH-1), 2.97–2.85 (m, 1H, CH- iPr), 2.51–2.43 (m, 1H, CH2-4), 2.00 (dd, J = 13.7, 
6.2 Hz, 1H, CH2-4), 1.95–1.89 (m, 1H, CH2), 1.75–1.68 (m, 2H, CH2), 1.64–1.54 (m, 4H, CH2), 
1.44–1.33 (m, 1H, CH2), 1.28–1.22 (m, 18H, CH3- iPr), 1.02 (s, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 161.8 (CN-5), 153.2 (C-Ar), 151.1 (2C-Ar), 131.2 (C-
Ar), 123.5 (2CH-Ar), 104.0 (CH-9), 79.4 (CH-1), 56.4 (CH3-OMe), 42.1 (C-6), 34.2 (CH- iPr), 
31.3 (CH2), 29.9 (2CH-iPr), 27.5 (CH2), 26.1 (CH2), 24.8 (2CH3-iPr), 24.7 (2CH3-iPr), 23.6 
(CH3-iPr), 23.5 (CH3-iPr), 21.5 (2CH2), 17.3 (CH3-10). 
IR (thin film): 2955, 2858, 1707, 1598, 1460, 1332, 1067 cm-1. 
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HRMS (ESI): Calcd for C26H42N2NaO4S
+ [M+Na]+, 501.2757; found, 501.2743. 
[α]D: +35.8 (c 1.0, CHCl3) 
 
1-((2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromen-5-yl)-5-
methyl-2-(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol (2.72a-b)64 
 
Chemical formula: C24H38O4 
MW: 390.56 
To a stirred solution of hydrazone 2.71 (644 mg, 1.34 mmol, 1.20 equiv) in THF (1.6 mL) 
at -78°C was added dropwise t-BuLi (234 µL, 1.14 M in hexane, 2.67 mmol, 2.40 equiv). The 
solution turned dark red. The resulting solution was stirred at this temperature for 30 min and 
warmed for a few min to room temperature and intense nitrogen bubbling occurred. The 
reaction mixture was then cooled down to -78°C and a solution of aldehyde (±)2.28 (314 mg, 
1.12 mmol) in THF (0.8 mL) was added. The resulting mixture was stirred at -78°C for 5 h and 
became yellow. A saturated aqueous solution of NaHCO3 was added to quench the reaction. 
The aqueous layer was extracted with Et2O, and the combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was dissolved in THF (2.2 mL) and a 1N aqueous solution of HCl (1.1 mL) was 
then added. The resulting mixture was stirred at room temperature overnight. A saturated 
aqueous solution of NaHCO3 was added to quench the reaction. The aqueous layer was 
extracted with EtOAc, and the combined organic extracts were washed with brine, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography CH2Cl2:EtOAc (97:3) to (9:1) to afford the title diols 
2.72a (217 mg, 5.50 mmol, 40%) and 2.72b (215 mg, 5.50 mmol, 40%) as highly viscous 
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colourless oils, as well as 2.73 (27.3 mg, 0.15 mmol, 11%) as a colourless oil (resulting from the 
excess of hydrazone 2.71 employed).  
 
(1R,2R)-1-((2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromen-5-
yl)-5-methyl-2-(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol (2.72a) 
 
1H NMR (400 MHz, CDCl3) δ ppm: 6.07 (t, J = 3.7 Hz, 1H, CH-4), 5.32 (ddd, J = 7.0, 5.7, 
1.3 Hz, 1H, CH-13), 4.44–4.30 (m, 2H, CH-2,10´), 3.51 (s, 3H, CH3-OMe), 3.32 (dd, J = 10.8, 
5.2 Hz, 1H, CH-7), 3.11-3.04 (m, 2H, 2OH), 2.39–2.21 (m, 2H, CH2-14), 2.25–2.17 (m, 2H, 
CH2-5), 2.01–1.90 (m, 1H, CH2-10), 1.79 (s, 3H, CH3-18), 1.78–1.69 (m, 5H, CH2), 1.70 (m, 
3H, CH3-H13´´)1.56 (s, 3H, CH3-H13´´), 1.27 (s, 3H, CH3-16), 1.22 (s, 3H, CH3-17),  1.11 (s, 
3H, CH3-19). 
13C NMR (100 MHz, CDCl3) δ ppm: 143.6 (C-3), 131.7 (C-13´), 126.4 (CH-4), 120.7 (CH-
13), 104.0 (CH-10´), 86.4 (C-11), 79.3 (C-12), 79.0 (CH-7), 78.1 (C-1), 70.7 (C-2), 56.3 (CH3-
OMe), 41.7 (C-15), 37.0 (C-8), 33.0 (CH2-14), 32.7 (CH2-10), 27.9 (CH2-9), 26.2 (CH3-16), 26.2 
(CH3-17), 26.0 (CH3-13´´), 24.8 (CH2-5), 23.4 (CH2-6), 18.9 (CH3-19), 17.9 (CH3-13´´), 3.6 
(CH3-18). 
IR (thin film): 2493, 2918, 2362, 1454, 1228, 1112, 1095 cm-1. 
HRMS (ESI): Calcd for C24H38NaO4
+ [M+Na]+, 413.2662; found, 413.2651. 
[α]D: -27.6 (c 1.0, CHCl3). 
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(1S,2S)-1-((2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromen-5-
yl)-5-methyl-2-(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol (2.72b) 
 
1H NMR (400 MHz, CDCl3) δ ppm: 5.98 (t, J = 3.8 Hz, 1H, CH-4), 5.35 (t, J = 6.9 Hz, 1H, 
CH-13), 4.41 (d, J = 4.6 Hz, 1H, CH-2), 4.34 (dd, J = 8.5, 4.0 Hz, 1H, CH-10'), 3.51 (s, 3H, 
CH3-OMe), 3.36–3.30 (m, 1H, CH-7), 3.17 (s, 1H, OH-1), 2.85 (d, J = 4.6 Hz, 1H, OH-2), 
2.49–2.39 (m, 1H, CH2-14), 2.32 (m, 1H, CH2-14), 2.25–2.17 (m, 2H, CH2-5), 1.91–1.85 (m, 
1H, CH2-9), 1.81–1.75 (m, 4H, CH2-4,10), 1.74–1.67 (m, 6H,CH3-18,13''), 1.58 (s, 3H, CH3-
13''), 1.46 (td, J = 12.5, 5.9 Hz, 1H, CH2-9), 1.28 (s, 3H, CH3-16), 1.26 (s, 3H, CH3-17), 1.20 
(s, 3H, CH3-19). 
13C NMR (100 MHz, CDCl3) δ ppm: 146.2 (C-3), 131.5 (C-13'), 126.2 (CH-4), 121.3 (CH-
13), 103.8 (CH-10'), 86.6 (C-11), 78.7 (C-12), 78.3 (CH-7), 78.2 (CH-1), 69.5 (CH-2), 56.3 
(CH3-OMe), 41.8 (C-15), 37.5 (C-8), 33.4 (CH2-14), 32.5 (CH2-9), 28.1 (CH2), 26.3 (CH3-16), 
26.2 (CH3-17), 26.1 (CH3-13''), 24.6 (CH2-5), 23.5 (CH2), 19.9 (CH3-19), 18.1 (CH3-13'''), 3.6 
(CH3-18). 
IR (thin film): 3495, 2947, 2914, 2835, 1868, 1454, 1382, 1265, 1065 cm-1. 
HRMS (ESI): Calcd for C24H38NaO4
+ [M+Na]+, 413.2662; found, 413.2648. 
 
(2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromene (2.73)101 
 
Chemical formula: C11H18O2 
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MW: 182.26 
1H NMR (400 MHz, CDCl3) δ ppm: 5.47–5.36 (m, 2H, CH-4, 5), 4.37 (dd, J = 8.4, 4.2 Hz, 
1H, CH-9), 3.51 (s, 3H, CH3-OMe), 3.27 (dd, J = 11.6, 4.5 Hz, 1H, CH-1), 2.21–2.12 (m, 2H, 
CH2-3), 1.79–1.65 (m, 4H, CH2-2, 8), 1.57 (dd, J = 12.7, 3.3 Hz, 1H, CH2-7), 1.41 (td, J = 12.8, 
6.2 Hz, 1H, CH2-7), 1.04 (s, 3H, CH3-10). 
13C NMR (100 MHz, CDCl3) δ ppm: 135.5 (CH-5), 124.4  (CH-4), 104.4 (CH-9), 78.5 (CH-
1), 56.4 (CH3-OMe), 35.0 (CH2-7), 34.2 (C-6), 27.9 (CH2-8), 25.4 (CH2-3), 23.7 (CH2-2), 19.6 
(CH3-10). 
HRMS (ESI): Calcd for C11H18NaO2
+ [M+Na]+, 205.1204; found, 205.1202 
 
(4aS,8aS)-5-((4R,5R)-2,2-Dimethyl-5-(3-methylbut-2-en-1-yl)-5-(2-methylpent-3-yn-2-
yl)-1,3-dioxolan-4-yl)-2-methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromene 
(2.85a) 
 
Chemical formula: C27H42O4  
MW: 430.63 
To a stirred solution of 2.72a (211 mg, 0.540 mmol) in 2,2-dimetoxypropane (5.0 mL) was 
added CSA (15 mg, 0.64 µmol, 0.01 equiv). The reaction mixture was stirred at room 
temperature for 16 h. A saturated aqueous solution of NaHCO3 was added to quench the 
reaction. The aqueous layer was extracted with Et2O, and the combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum ether: 
Et2O (9:1) to afford the acetal 2.85a as a pale yellow oil (141 mg, 0.330 mmol, 61%) and as a 
7:3 mixture of diastereomers. 
1H NMR (400 MHz, CDCl3) δ ppm: The presence of two diastereomers was observed in the 
NMR spectra in a 0.7 (M):0.3 (m) ratio. 6.01 (d, J = 3.6 Hz, 1H, CH-13), 5.51 (dd, J = 3.5, 2.1 
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Hz, 1H, CH-4), 4.84 (s, 1H, CH-2), 4.68 (m) (d, J = 2.8 Hz, 0.3H, CH-10´), 4.34 (M) (dd, J = 
8.6, 3.4 Hz, 0.7H, CH-10´), 3.85 (m) (dd, J = 12.4, 4.1 Hz, 0.3H, CH-7), 3.50 (M) (d, J = 6.6 
Hz, 2.1H, CH3-OMe), 3.41 (M) (dd, J = 11.8, 4.3 Hz, 0.7 H, CH-7), 3.30 (m) (s, 0.9H, CH3-
OMe), 2.69–2.46 (m, 2H, CH2-14), 2.36–2.16 (m, 2H, CH2-9), 1.91 (M) (t, J = 8.4 Hz, 1.3H, 
CH2-10), 1.78 (s, 3H, CH3-18), 1.75–1.64 (m, 3H, CH2-5,6,10), 1.68 (s, 3H, CH3-2´´), 1.60 (s, 
3H, CH3-2´´), 1.58–1.52 (m, 0.7H, CH2-10), 1.45–1.36 (m, 6H, CH3-13´´), 1.29 (s, 3H, CH3-16 
or 17), 1.23 (s, 3H, CH3-16 or 17), 1.21 (s, 1H, CH3-16 or 17), 1.17 (s, 3H, CH3-19). 
13C NMR (100 MHz, CDCl3) δ ppm: The presence of two diastereomers was observed in the 
NMR spectra. 139.4 (m) (C-3), 139.0 (M) (C-3), 130.0 (M) (C-13´), 129.9 (m) (C-13´), 127.8 (M) 
(CH-13), 127.6 (m) (CH-13), 122.4 (m) (CH-4), 122.3 (M) (CH-4), 104.9 (M) (C-1), 104.8 (m) 
(C-1), 103.8 (M) (CH3-10'), 97.8 (m) (CH3-10'), 87.1 (M) (C-11) , 86.0 (m) (C-11), 78.4 (C-2'), 
77.6 (M) (CH-2), 77.5 (m) (CH-2), 76.7 (M) (CH-7), 76.3 (m) (CH-7), 70.6 (C-12), 56.2 (M) 
(CH3-OMe), 54.0 (m) (CH3-OMe), 38.7 (M) (C-8), 38.6 (m) (C-8), 38.0 (M) (C-15), 37.8 (m) 
(C-15), 32.5 (CH2-14), 31.3 (CH2-9), 28.6 (m) (CH2-10), 27.9 (M) (CH2-10), 27.7 (m) (CH3-2''), 
27.2 (M) (CH3-2'') , 26.9 (CH3-13''), 26.4 (CH3-16 or 17), 26.3 (CH3-16 or 17), 25.0 (M) (CH2-
5), 24.8 (m) (CH2-5), 23.1 (M) (CH2-6), 22.84 (m) (CH2-6), 19.23 (CH3-13''), 18.35 (m) (CH3-
19), 18.16 (M) (CH3-19), 3.48 (CH3-18). 
IR (thin film): 3495, 2947, 2914, 2835, 1868, 1454, 1382, 1265, 1065 cm-1. 
HRMS (ESI): Calcd for C27H42NaO4
+ [M+Na]+, 453.2975; found, 453.2955. 
 
(4R,5R)-5-((2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-chromen-5-
yl)-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one (2.86a) 
 
Chemical formula: C25H36O5 
MW: 416.56 
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To a stirred solution of diol 2.72a (540 mg, 1.44 mmol) in DMF (20 mL) was added NaH (60 
%) (166 mg, 4.17 mmol, 3.0 equiv) and N,N-carbonyl diimidazole (1.16 g, 7.15 mmol, 5.0 equiv). 
The reaction mixture was stirred at room temperature for 30 min. A saturated aqueous solution 
of NH4Cl was added to quench the reaction. The aqueous layer was extracted with Et2O, and 
the combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered 
and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (8:2) to afford the carbonate 2.86a as a pale yellow 
oil (541 mg, 1.30 mmol, 90%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.65 (t, J = 3.7 Hz, 1H, CH-4), 5.33 (s, 1H, CH-2), 5.27 
(t, J = 6.6 Hz, 1H, CH-13), 4.36 (dd, J = 9.4, 2.8 Hz, 1H, CH-10'), 3.51 (s, 3H, CH3-OMe ), 
3.30 (dd, J = 11.0, 5.0 Hz, 1H, CH-7), 2.68–2.55 (m, 2H, CH2-14), 2.36–2.25 (m, 2H, CH2-5), 
2.09–2.02 (m, 1H, CH2-9), 1.77 (s, 3H, CH3-18), 1.85–1.71 (m, 4H, CH2-6,10), 1.68 (s, 3H, 
CH3-13''), 1.57 (s, 3H, CH3-13''), 1.54 (d, J = 3.9 Hz, 1H, CH2-9), 1.28 (s, 6H, CH3-16,17), 
1.17 (s, 3H, CH3-19). 
13C NMR (100 MHz, CDCl3) δ ppm: 154.9 (CO-1'), 138.9 (C-3), 132.6 (C-13'), 130.3 (CH-4), 
119.0 (CH-13), 103.8 (CH-10'), 89.7 (C-1), 83.1 (C-11), 80.2 (C-12), 79.6 (CH-2), 78.5 (CH-7), 
56.4 (CH3-OMe), 41.9 (C-15), 36.2 (C-8), 32.2 (CH2-9), 31.2 (CH2-14), 27.7 (CH2-10), 25.8 
(CH3-13''), 24.9 (CH2-5), 24.8 (CH3-16 or 17), 24.3 (CH3-16 or 17), 23.1 (CH2-6), 18.6 (CH3-
19), 18.1 (CH3-13''), 3.6 (CH3-18). 
IR (thin film): 2918, 2361, 1799, 1444, 1323, 1165, 1024 cm-1. 
HRMS (ESI): Calcd for C25H36NaO5
+ [M+Na]+, 439.2455; found, 439.2440. 
 
9-Hydroxy-3,3,7,7-tetramethyl-1,5-dioxaspiro[5.5]undecan-8-one (2.92) 
 
Chemical formula: C13H22O4 
MW: 242.32 
To a stirred solution of ketone 3.12 (904 mg, 3.99 mmol) in THF (47 mL) at -78°C was added 
KHMDS (880 mg, 4.41 mmol, 1.10 equiv). The reaction mixture was stirred at this temperature 
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for 1h before 2.91 (2.20 g, 7.99 mmol, 2.0 equiv) was added portionwise. The resulting solution 
was stirred at room temperature for 24 h. A saturated aqueous solution of NaHCl4 was added 
to quench the reaction. The aqueous layer was extracted with EtOAc, and the combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (6:4) to afford the alcohol 2.92 as a white solid (782 mg, 3.23 mmol, 81%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.40 (dd, J = 11.9, 7.7 Hz, 1H, CH-6), 3.70 (d, J = 11.4 
Hz, 1H, CH2-9 or 11), 3.51 (d, J = 11.4 Hz, 1H, CH2-9 or 11), 3.38 (dd, J = 11.4, 2.7 Hz, 1H, 
CH2-9 or 11), 3.28 (dd, J = 11.4, 2.6 Hz, 1H, CH2-9 or 11), 2.81–2.71 (m, 1H, CH2-4 or 5), 
2.27–2.16 (m, 1H, CH2-4 or 5), 1.75 (td, J = 14.5, 4.0 Hz, 1H, CH2-4 o 5), 1.43–1.30 (m, 1H, 
CH2-4 or 5), 1.27 (s, 3H, CH3-7), 1.21 (s, 3H, CH3-8), 1.15 (s, 3H, CH3-12), 0.72 (s, 3H, CH3-
13). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.0 (C-1), 101.9 (C-3), 71.0 (CH-6), 70.7 (CH2-9 or 
11), 69.7 (CH2-9 or 11), 54.4 (C-2), 29.8 (C-10), 28.2 (CH2-4 or 5), 23.2 (CH3-12), 22.8 (CH3-
7), 22.2 (CH3-13), 19.4 (CH2-4 or 5), 16.1 (CH3-8). 
IR (thin film): 3307, 1712, 173, 1166, 1120, 1078, 918 cm-1. 
HRMS (ESI): Calcd for C13H22NaO4
+ [M+Na]+, 265.1410; found, 265.1406. 
MP: 79°C. 
 
9-(Ethoxymethoxy)-3,3,7,7-tetramethyl-1,5-dioxaspiro[5.5]undecan-8-one (2.93) 
 
Chemical formula: C16H28O5 
MW: 300.40 
To a stirred solution of 2.92 (769 mg, 3.17 mmol) in CH2Cl2 (95 mL) was added TBAI (234 mg, 
0.63 mmol, 0.20 equiv), DIPEA (3.86 mL, 22.2 mmol, 7.0 equiv) and EOMCl (1.17 mL, 12.6 
mmol, 4.0 equiv).  The reaction mixture was stirred at room temperature for 24 h. A saturated 
aqueous solution of NaHCO3 was added to quench the reaction. The aqueous layer was 
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extracted with CH2Cl2, and the combined organic extracts were washed with brine, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography using petroleum ether:Et2O (7:3) to afford the protected 
alcohol 2.93 as a pale yellow oil (775 mg, 2.58 mmol, 81%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.72 (dd, J = 24.8, 7.1 Hz, 2H, CH2-14), 4.44 (dd, J = 
11.8, 7.1 Hz, 1H, CH-6), 3.68–3.63 (m, 2H, CH2-15, 9 or 11), 3.55–3.52 (m, 2H, CH2-15, 9 or 
11), 3.36–3.22 (m, 2H, CH2-9, 11), 2.73-2.69 (m, 1H, CH2-4 or 5), 2.02–1.99 (m, 1H, CH2-4 or 
5 ), 1.84–1.72 (m, 1H, CH2-4 or 5), 1.52–1.50 (m, 1H, CH2-4 or 5), 1.19-1.15 (m, 9H, CH3-7, 
8, 16), 1.10 (s, 3H, CH3-12 or 13), 0.68 (s, 3H, CH3-12 or 13). 
13C NMR (100 MHz, CDCl3) δ ppm: 209.2 (C-1), 101.4 (C-3), 94.2 (CH2-14), 75.0 (CH-6), 
70.6 (CH2-9 or 11), 69.5 (CH2- 9 or 11), 63.6 (CH2-15), 55.2 (C-2), 29.7 (C-10), 26.1 (CH2-4 or 
5), 23.1 (CH3-7 or 8), 22.4 (CH3-12 or 13), 22.1 (CH3-12 or 13), 19.7 (CH2-4 or 5), 16.4 (CH3-
7 or 8), 15.1 (CH3-16). 
IR (thin film): 2951, 1726, 1473, 1446, 1382, 1116, 1055 cm-1. 
HRMS (ESI): Calcd for C16H28NaO5
+ [M+Na]+, 323.1829; found, 323.1819. 
 
2,2-Dimethylcyclohexane-1,3-dione (3.11)83 
 
Chemical formula: C8H12O2 
MW: 140.18 
To a stirred solution of diketone 2.32 (25.0 g, 198 mmol) in acetone (30 mL) was added K2CO3 
(54.8 g, 396 mmol, 2.0 equiv) and MeI (31 mL, 490 mmol, 2.5 equiv). The reaction mixture was 
refluxed for 20h. The resulting mixture was filtered and the filter cake was washed with Et2O. 
Brine was added to the filtrate and the aqueous layer was extracted with Et2O. The combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:EtOAc (8:2) to afford the diketone (±)3.22 as a white 
solid (27.8 g, 198 mmol, quant). 
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1H NMR (400 MHz, CDCl3) δ ppm: 2.72–2.62 (m, 4H, CH2-4,6), 1.99–1.87 (m, 2H, CH2-5), 
1.29 (s, 6H, CH3-7,8). 
13C NMR (100 MHz, CDCl3) δ ppm: 210.3 (CO-1,3), 61.6 (C-2), 37.2 (CH2-4,6), 22.1 (CH3-
7,8), 17.9 (CH2-5). 
IR (thin film): 1695, 910, 373 cm-1. 
HRMS (EI): Calcd for C8H12O2
+ [M]+, 140.0837; found, 140.0843.  
 
3,3,7,7-Tetramethyl-1,5-dioxaspiro[5.5]undecan-8-one (3.12)83 
 
Chemical formula: C13H22O3 
MW: 226.32 
To a stirred solution of diketone 3.11 (8.80 g, 62.8 mmol) in CH2Cl2 (130 mL) was added 2,2-
dimethylpropane-1,3-diol (19.9 g, 191 mmol, 3.04 equiv) and p-toluenesulfonic acid (200 mg, 
1.05 mmol, 0.016 equiv). The reaction mixture refluxed for 4h. The solvent was removed under 
reduced pressure and the resulting mixture was diluted with hexane and washed with brine. The 
organic layer was dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure to afford the acetal 3.12 as a white crystalline solid (12.7 g, 56.4 mmol, 90%). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.62 (d, J = 11.1 Hz, 2H, CH2-9, 11), 3.32 (dd, J = 10.3, 
1.3 Hz, 2H, CH2-9, 11), 2.40 (t, J = 7.0 Hz, 2H, CH2-6), 2.24–2.15 (m, 2H, CH2-4), 1.72–1.61 
(m, 2H, CH2-5), 1.19 (s, 6H, CH3-7,8), 1.15 (s, 3H, CH3-12 or 13), 0.71 (s, 3H, CH3-12 or 13). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.3 (CO-1), 101.9 (C-3), 70.2 (CH2-9,11), 55.4 (C-2), 
36.4 (CH2-6), 29.8 (C-10), 23.2 (CH3-12 or 13), 22.3 (CH3-12 or 13), 20.7 (CH2-5), 19.4 (CH3-
7,8), 18.7 (CH2-4). 
IR (thin film): 1674, 1112, 910, 739 cm-1. 
HRMS (ESI): Calcd for C13H22NaO3
+ [M+Na]+, 249.1461; found, 249.1464. 
MP: 67°C (lit.29b 68°C). 
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3,3,7,7,9-Pentamethyl-1,5-dioxaspiro[5.5]undecan-8-one (3.13)83 
 
Chemical formula: C14H24O3 
MW: 240.34 
To a stirred solution of freshly distilled DIPA (2.45 mL, 17.5 mmol, 1.23 equiv) in THF (33 
mL) at -78°C was slowly added n-BuLi (12.5 mL, 1.41 M in hexane, 17.6 mmol, 1.23 equiv). The 
resulting solution was stirred at -78°C for 30 min and then treated with a solution of ketone 
3.12 (3.23 g, 14.2 mmol) in THF (10 mL). The reaction mixture was allowed to warm up to 
room temperature and stirred for 40 min. The resulting yellow solution was cooled down to -
78°C and MeI (1.40 mL, 22.5 mmol, 1.60 equiv) was added to the reaction mixture. The reaction 
mixture was allowed to warm to room temperature and was then stirred for 1h. A saturated 
aqueous solution of NaHCl4 was added and the aqueous layer was extracted with Et2O. The 
combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (9:1) to afford the ketone 3.13 as a white crystalline 
solid (3.83 g, 16.0 mmol, 91%). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.71 (d, J = 11.3 Hz, 1H, CH2-9 or 11), 3.50 (d, J = 11.3 
Hz, 1H, CH2-9 or 11), 3.37–3.25 (m, 2H, CH2-9 or 11), 2.74–2.66 (m, 1H, CH2-4), 2.64–2.53 
(m, 1H, CH-6), 1.87 –1.80 (m, 1H, CH2-5), 1.77 –1.73 (m, 1H, CH2-4), 1.29–1.22 (m, 1H, CH2-
5), 1.20 (s, 3H, CH3-7 or 8), 1.18 (s, 3H, CH3-12 or 13), 1.14 (s, 3H, CH3-12 or 13), 1.01 (d, J = 
6.5 Hz, 3H, CH3-14), 0.70 (s, 3H, CH3-7 or 8). 
13C NMR (100 MHz, CDCl3) δ ppm: 214.0 (CO-1), 102.2 (C-3), 70.5 (CH2-9 or 11), 69.7 
(CH2-9 or 11), 55.0 (C-2), 39.2 (CH-6), 29.8 (C-10), 27.8 (CH2-5), 23.2 (CH3-12, 13 or 14), 22.3 
(CH3-7 or 8), 21.1 (CH2-4), 16.3 (CH3-7 or 8), 14.9 (CH3-12, 13 or 14). 
IR (thin film): 2954, 1708, 1128, 1112, 1087, 1029 cm-1. 
HRMS (ESI): Calcd for C14H24NaO3
+ [M+Na]+, 263.1618; found, 263.1616. 
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MP: 78°C-80°C° (lit.102 79.5°C-81.5°C). 
 
3,3,7,7,9-Pentamethyl-1,5-dioxaspiro[5.5]undec-8-en-8-yl trifluoromethanesulfonate 
(3.14)83 
 
Chemical formula: C15H23F3O5S 
MW: 372.40 
To a stirred solution of freshly distilled DIPA (6.4 mL, 45 mmol, 2.2 equiv) in THF (116 mL) 
at -78°C was slowly added n-BuLi (18.7 mL, 2.40 M in hexane, 44.8 mmol, 2.2 equiv). The 
resulting solution was stirred at -78°C for 30 min and then treated with a solution of ketone 
3.13 (4.91 g, 20.4 mmol) in THF (45 mL) and HMPA (9.3 mL, 53 mmol, 2.6 equiv). The yellow 
reaction mixture was stirred at 0°C for 30 min. A solution of PhNTf2 (11.6 g, 32.6 mmol, 1.6 
equiv) in THF (23 mL) was added and the resulting solution was stirred at room temperature 
for 16h. Water was added, and the aqueous layer was extracted with Et2O. The combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (100:2.5) to afford the triflate 3.14 as a white 
crystalline solid (7.60 g, 20.4 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.64 (d, J = 11.3 Hz, 2H, CH2-9,11), 3.38 (dd, J = 10.3, 
1.3 Hz, 2H, CH2-9,11), 2.07 (bs, 4H, CH2-4,5), 1.75 (s, 3H, CH3-14 ), 1.21 (s, 6H, CH3-7,8), 
1.18 (s, 3H, CH3-12), 0.73 (s, 3H, CH3-13). 
13C NMR (100 MHz, CDCl3) δ ppm: 147.0 (C-1), 124.4 (C-6), 118.7 (q, J = 250 Hz, CF3), 99.9 
(C-3), 70.5 (CH2-9,11), 45.3 (C-2), 29.8 (C-10), 27.7 (CH2-5), 23.0 (CH3), 22.1 (CH3), 20.5 
(CH3), 18.1 (CH2-4), 17.3 (CH3-14). 
IR (thin film): 2967, 2880, 1689, 1400, 1242, 1209, 1141, 1020 cm-1. 
HRMS (ESI): Calcd for C15H23F3NaO5S
+ [M+Na]+, 35.1111; found, 395.1105. 
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MP: 78°C. 
 
 
3,3,7,7,9-Pentamethyl-8-vinyl-1,5-dioxaspiro[5.5]undec-8-ene (3.15)83 
 
Chemical formula: C16H26O2 
MW: 250.38 
To a stirred slurry of LiCl (5.99 g, 141 mmol, 3.0 equiv) and Pd(PPh3)4 (5.44 g, 4.71 mmol, 0.10 
equiv) in THF (300 mL) was added vinyl triflate 3.14 (17.5 g, 47.0 mmol) and 
triethyl(vinyl)stannane (21 mL, 72 mmol, 1.5 equiv). The reaction mixture was refluxed for 3 
days and the resulting solution was allowed to cool down to room temperature. Et2O was added 
to dilute the reaction mixture and the organic layer was washed with water, a 5% aqueous 
solution of NH4OH and brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (97:3) to afford the diene 3.15 as a pale yellow oil (10.7 g, 42.7 mmol, 
91%). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.16 (ddd, J = 17.6, 11.2, 1.0 Hz, 1H, CH-15), 5.25 (dd, 
J = 11.2, 2.7 Hz, 1H, CH2-16), 4.97 (dd, J = 17.6, 2.7 Hz, 1H, CH2-16), 3.70 (d, J = 11.1 Hz, 
2H, CH2-9, 11), 3.37 (dd, J = 10.3, 1.3 Hz, 2H, CH2-9, 11), 2.12–1.93 (m, 4H, CH2-4,5), 1.68 
(s, 3H, CH3-14), 1.18 (s, 3H, CH3-12 or 13), 1.09 (s, 6H, CH3-7,8), 0.72 (s, 3H, CH3-12 or 13). 
13C NMR (100 MHz, CDCl3) δ ppm: 137.1 (C-1), 135.3 (CH-15), 126.5 (C-6), 118.9 (CH2-
16), 100.2 (C-3), 70.2 (CH2-9,11), 43.2 (C-2), 29.9 (CH2-5), 29.8 (C-10), 23.2 (CH3), 22.5 (CH3), 
22.3 (CH3), 21.0 (CH3-14), 18.4 (CH2-4). 
IR (thin film): 2102, 2050, 1500, 1066, 1103, 1066 cm-1. 
HRMS (ESI): Calcd for C16H26NaO2
+ [M+Na]+, 273.1825; found, 273.1819. 
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2,2,4-Trimethyl-3-vinylcyclohex-3-en-1-one (3.16)83 
 
Chemical formula: C11H16O  
MW: 164.25 
To a stirred solution of  acetal 3.15 (10.7 g, 42.8 mmol) in acetone (360 mL) was added a catalytic 
amount of p-toluenesulfonic acid. The reaction mixture was stirred at room temperature for 2h 
and the solvent was then removed under reduced pressure. A saturated aqueous solution of 
NaHCO3 was added to the resulting mixture and the aqueous layer was extracted with Et2O. 
The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered 
and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (95:5) to afford the ketone 3.16 as a pale yellow 
oil (7.03 g, 42.8 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.21–6.05 (m, 1H, CH-10), 5.34 (dd, J = 11.2, 2.4 Hz, 
1H, CH2-11), 5.07 (dd, J = 17.6, 2.3 Hz, 1H, CH2-11), 2.54 (t, J = 7.0 Hz, 2H, CH2-4), 2.39 (t, 
J = 6.9 Hz, 2H, CH2-5), 1.78 (s, 3H, CH3-9), 1.16 (s, 6H, CH3-7,8). 
13C NMR (100 MHz, CDCl3) δ ppm: 215.1 (C-3), 137.4 (C-1), 133.9 (CH-10), 128.7 (C-6), 
119.8 (CH2-11), 46.7 (C-2), 35.9 (CH2-4), 31.8 (CH2-5), 24.8 (CH3-7,8), 21.1 (CH3-9). 
IR (thin film): 2943, 1708, 910, 739 cm-1. 
HRMS (ESI): Calcd for C11H16NaO, 187.1093
+ [M+Na]+; found, 187.1089. 
 
2,2,4-Trimethyl-1-((trimethylsilyl)oxy)-3-vinylcyclohex-3-ene-1-carbonitrile (((±))3.17)83 
Method A 
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Chemical formula: C15H25NOSi 
MW: 263.46 
To a stirred solution of ketone 3.16 (1.82 g, 11.1 mmol) in CH2Cl2 (55 mL) was added ZnI2 (709 
mg, 2.22 mmol, 0.20 equiv) and TMSCN (2.90 mL, 22.2 mmol, 2.0 equiv). The reaction mixture 
was refluxed for 16 h and then allowed to cool down to room temperature. The volatiles were 
removed under reduced pressure with a trap of aqueous NaOCl/NaOH set up to quench the 
excess of TMSCN. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (100:5) to afford the cyanohydrin (±)3.17 as a colourless oil (2.47 g, 9.37 
mmol, 84%).  
Method B68 
 
To a stirred solution of ketone 3.16 (246 mg, 1.50 mmol) in CH2Cl2 (1.50 mL) at -40°C was 
added (salen)AlCl (R,R) (91 mg, 0.15 mmol, 0.10 equiv), (tert-butoxycarbonylmethylene) 
triphenylphosphorane (58 mg, 0.15 mmol, 0.10 equiv) and Ph3PO (210 mg, 0.75 mmol, 0.50 
equiv). The resulting solution was stirred at -40°C for 30 min before TMSCN (400 µL, 3.0 
mmol, 2.0 equiv) was added dropwise. The reaction mixture was stirred for 4 days at -40°C and 
then allowed to warm to room temperature. The volatiles were removed under reduced pressure 
with a trap of aqueous NaOCl/NaOH set up to quench the excess of TMSCN. The crude 
mixture was then purified by flash chromatography using petroleum ether:Et2O (100:5) to 
afford the cyanohydrin 3.17 as a colourless oil (396 mg, 1.51 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.19–6.02 (m, 1H, CH-10), 5.29 (dd, J = 11.2, 2.5 Hz, 
1H, CH2-11), 4.98 (dd, J = 17.6, 2.5 Hz, 1H, CH2-11), 2.44–2.26 (m, 1H, CH2-4 or 5), 2.38–
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2.29 (m, 1H, CH2-4 or 5), 2.06–1.97 (m, 2H, CH2-4 or 5), 1.68 (s, 3H, CH3-9), 1.19 (s, 3H, 
CH3-7 or 8), 1.01 (s, 3H, CH3-7 or 8), 0.24 (s, 9H, CH3-OTMS). 
13C NMR (100 MHz, CDCl3) δ ppm: 135.6 (C-1), 134.6 (CH-10), 126.9 (C-6), 121.3 (CN), 
119.6 (CH2-11), 76.2 (C-3), 42.3 (C-2), 30.9 (CH2-4 or 5), 29.5 (CH2-4 or 5), 23.5 (CH3-7 or 8), 
22.3 (CH3-7 or 8), 20.9 (CH3-9), 1.3 (CH3-OTMS). 
IR (thin film): 1253, 1147, 1126, 910, 846, 737 cm-1. 
HRMS (ESI): Calcd for C15H25NNaOSi 
+ [M+Na]+, 286.1598; found, 286.1588. 
[α]D: -72.8 (c 1.0, CHCl3). 
 
2,2,4-Trimethyl-1-((trimethylsilyl)oxy)-3-vinylcyclohex-3-ene-1-carbaldehyde 
((±)3.18)83 
 
Chemical formula: C15H26O2Si  
MW: 266.46 
To a stirred solution of cyanohydrin (±)3.17 (2.47 g, 9.38 mmol) in freshly distilled hexane (90 
mL) at -78°C was added DIBALH (14 mL, 1 M in hexane, 14 mmol, 1.5 equiv). The reaction 
mixture was allowed to warm to 0°C and was stirred at this temperature for 30 min. The mixture 
was then cooled down to -78°C, and EtOAc was added dropwise. The resulting mixture was 
stirred at this temperature for 20 min and then SiO2 (30 g) was added. The reaction mixture was 
then allowed to warm to room temperature and stirred for 2 h. The resulting suspension was 
filtered and the silica was washed thoroughly with EtOAc. The solvent was removed under 
reduced pressure to afford the aldehyde (±)3.18 as a pale yellow oil (2.50 g, 9.38 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 9.78 (s, 1H, CHO), 6.13 (dd, J = 17.6, 11.1 Hz, 1H, CH-
10), 5.29 (dd, J = 11.2, 2.5 Hz, 1H, CH2-11), 4.98 (dd, J = 17.6, 2.5 Hz, 1H, CH2-11), 2.17 (t, J 
= 6.8 Hz, 2H, CH2-4), 1.90 (t, J = 6.8 Hz, 2H, CH2-5), 1.69 (s, 3H, CH3-9), 1.04 (s, 3H, CH3-
7 or 8), 0.96 (s, 3H, CH3-7 or 8), 0.13 (s, 9H, CH3-OTMS). 
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13C NMR (100 MHz, CDCl3) δ ppm: 205.0 (C-CHO), 136.9 (C-1), 134.8 (CH-10), 127.1 (C-
6), 119.3 (CH2-11), 83.0 (C-3), 40.7 (C-2), 29.7 (CH2-4), 27.8 (CH2-5), 24.0 (CH3-7 or 8), 22.4 
(CH3-7 or 8), 20.9 (CH3-9), 2.4 (CH3-OTMS). 
IR (thin film): 1728, 1251, 910, 842 cm-1. 
HRMS (ESI): Calcd for C15H26NaO2Si 
+ [M+Na]+, 289.1594; found, 289.1580. 
 
(S)-1-(Hydroxymethyl)-2,2,4-trimethyl-3-vinylcyclohex-3-en-1-ol (3.19) 
 
Chemical formula: C12H20O2 
MW: 196.29 
To a stirred suspension of LiAlH4 (57 mg, 1.5 mmol, 1.5 equiv) in THF (3.5 mL) was added a 
solution of the aldehyde 3.18 (270 mg, 1.00 mmol) in THF (3.5 mL). The reaction mixture was 
stirred at room temperature for 2 h. An aqueous solution of Rochelle salt (10% wt)was added 
to quench the reaction and the resulting mixture was stirred at room temperature for 16h. The 
aqueous layer was extracted with Et2O, and the combined organic extracts were washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure to afford 
the diol 3.19 as a white solid (153 mg, 0.78 mmol, 78%). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.11 (dd, J = 17.1, 11.6 Hz, 1H, CH-10), 5.28 (d, J = 
11.1 Hz, 1H, CH2-11), 4.94 (d, J = 17.6 Hz, 1H, CH2-11), 3.72 (d, J = 11.0 Hz, 1H, CH2-12), 
3.47 (d, J = 10.9 Hz, 1H, CH2-12), 2.11–2.02 (m, 4H, CH2-5, 2OH), 1.87–1.68 (m, 2H, CH2-
4), 1.68 (s, 3H, CH3-9), 1.06 (s, 3H, CH3-7 or 8), 0.93 (s, 3H, CH3-7 or 8). 
13C NMR (100 MHz, CDCl3) δ ppm: 137.0 (C-1), 135.0 (CH-10), 127.5 (C-6), 119.3 (CH2-11), 
74.9 (C-3), 65.0 (CH2-12), 40.4 (C-2), 29.1 (CH2-5), 26.3 (CH2-4), 22.8 (CH3-9), 22.7 (CH3-7 
or 8), 21.2 (CH3-7 or 8). 
IR (thin film): 3379, 2974, 1618, 1458, 915 cm-1. 
HRMS (ESI): Calcd for C12H20NaO2
+ [M+Na]+, 219.1356; found, 219.1358. 
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(S)-(1-Hydroxy-2,2,4-trimethyl-3-vinylcyclohex-3-en-1-yl)methyl 4-nitrobenzoate (3.20) 
 
Chemical formula: C19H23NO5 
MW: 345.40 
To a stirred solution of diol 3.19 (37 mg, 0.19 mmol) in CH2Cl2 (4.1 mL) was added triethylamine 
(66 µL, 0.47 mmol, 2.5 equiv), DMAP (23 mg, 0.19 mmol, 1.0 equiv) and p-nitrobenzoyl chloride 
(71 mg, 0.38 mmol, 2.0 equiv). The reaction mixture was stirred at room temperature for 16 h. 
A saturated aqueous solution of NaHCO3 was added to quench the reaction. The aqueous layer 
was extracted with Et2O, and the combined organic extracts were washed with brine, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography using petroleum ether:Et2O (1:1) to afford the alcohol 
3.20 as a white solid (57 mg, 0.16 mmol, 87%) and with 74% ee determined by chiral HPLC 
when using an AD-H column with an injection volume of 20 µL and using 5% iPrOH in 
hexanes as eluent.  
1H NMR (400 MHz, CDCl3) δ ppm: 8.29–8.17 (m, 4H, CH-Ar), 6.13 (dd, J = 17.6, 11.0 Hz, 
1H, CH-10), 5.32 (dd, J = 11.1, 2.4 Hz, 1H, CH2-11), 4.99 (dd, J = 17.6, 2.4 Hz, 1H, CH2-11), 
4.54 (d, J = 11.6 Hz, 1H, CH2-12), 4.44–4.39 (m, 1H, CH2-12), 2.23–2.02 (m, 2H, CH2-4 or 5), 
1.94–1.87 (m, 2H, CH2-4 or 5), 1.70 (s, 3H, CH3-9), 1.14 (s, 3H, CH3-7 or 8), 1.07 (s, 3H, CH3-
7 or 8). 
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13C NMR (100 MHz, CDCl3) δ ppm: 165.1 (C-13), 136.9 (C-1), 135.5 (C-Ar), 134.7 (CH-10), 
130.7 (CH-Ar), 130.6 (C-Ar), 127.4 (C-6), 123.5 (CH-Ar), 119.6 (CH2-11), 74.3 (C-3), 68.9 
(CH2-12), 40.9 (C-2), 29.4 (CH2-4 or 5), 27.2 (CH2-4 or 5), 23.1 (CH3-7 or 8), 22.3 (CH3-7 or 
8), 21.0 (CH3-9). 
HRMS (ESI): Calcd for C19H23NaO5
+ [M+Na]+, 368.1468; found, 368.1456. 
MP: 121°C. 
[α]D: -29.8 (c 1.0, CHCl3), 74% ee. 
5-((2-(Allyloxy)ethyl)thio)-1-phenyl-1H-tetrazole (3.27) 
 
Chemical formula: C12H14N4OS 
MW: 262.33 
To a stirred solution of alcohol 3.26 (210 µL, 2.00 mmol) and thiol 3.25 (463 mg, 2.59 mmol, 
1.30 equiv) in THF (7.32 mL) at 0°C was added DIAD (512 µL, 2.60 mmol, 1.30 equiv) and 
PPh3 (577 mg, 2.20 mmol, 1.10 equiv). The reaction mixture was stirred at this temperature for 
1h and then a saturated aqueous solution of NaHCO3 was added to quench the reaction. The 
aqueous layer was extracted with Et2O, and the combined organic extracts were washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:Et2O (8:2) to 
(6:4) to afford the sulfide 3.27 as colourless oil (447 mg, 1.70 mmol, 85%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.72–7.38 (m, 5H, CH-Ar), 5.87 (m, 1H, CH-5), 5.22 
(m, 2H, CH2-6), 4.02 (m, 2H, CH2-4), 3.83 (t, J = 5.9 Hz, 2H, CH2-3), 3.61 (t, J = 5.9 Hz, 2H, 
CH2-2). 
13C NMR (100 MHz, CDCl3) δ ppm: 154.2 (C-1), 134.1 (CH-5), 133.6 (C-Ar), 130.1 (CH-Ar), 
129.8 (CH-Ar), 123.8 (CH-Ar), 117.6 (CH2-6), 72.0 (CH2-4), 67.8 (CH2-3), 33.3 (CH2-2). 
IR (thin film): 2175, 2162, 1596, 1499, 1384, 1089, 1012, 762 cm-1. 
HRMS (ESI): Calcd for C12H14N4NaOS
+ [M+Na]+, 285.0781; found, 285.0771. 
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5-((2-(Allyloxy)ethyl)sulfonyl)-1-phenyl-1H-tetrazole (3.28) 
 
Chemical formula: C12H14N4O3S 
MW: 294.33 
To a stirred solution of sulfide 3.27 (3.90 g, 14.9 mmol) in ethanol (200 mL) at 0°C was added 
(NH4)6Mo7O24·H2O (2.94 g, 2.38 mmol, 0.160 equiv) and 30% H2O2 (9.60 mL, 84.9 mmol, 5.70 
equiv). The resulting mixture was stirred at room temperature for 3 days. Brine was added to 
quench the reaction and the aqueous layer was extracted with Et2O. The combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (7:3) to (1:1) to afford the sulfone 3.28 as a white solid (3.89 g, 13.2 mmol, 
89%). When 3 equivalents of H2O2 were used instead, sulfoxide 3.29 was obtained as a white 
solid in 17% yield along with sulfone 3.28 in 78% yield.  
1H NMR (400 MHz, CDCl3) δ ppm: 7.81–7.45 (m, 5H, CH-Ar), 5.69 (m, 1H, CH-5), 5.27–
5.02 (m, 2H, CH2-6), 3.89–3.77 (m, 6H, CH2-2,3,4). 
13C NMR (100 MHz, CDCl3) δ ppm: 154.0 (C-1), 133.2 (CH-5), 133.1 (C-Ar), 131.5 (CH-Ar), 
129.6 (CH-Ar), 125.7 (CH-Ar), 118.3 (CH2-6), 72.2 (CH2), 62.8 (CH2), 56.3 (CH2). 
IR (thin film): 2160, 2011, 2004, 1350, 1151, 906, 731 cm-1. 
HRMS (ESI): Calcd for C12H14N4NaO3S
+ [M+Na]+, 317.0679; found, 301.0677 
MP: 51°C. 
 
5-((2-(Allyloxy)ethyl)sulfinyl)-1-phenyl-1H-tetrazole (3.29) 
 
Chemical formula: C12H14N4O2S 
MW: 278.33 
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1H NMR (400 MHz, CDCl3) δ ppm: 7.76–7.55 (m, 5H, CH-Ar), 5.78 (m, 1H, CH-5), 5.28–
5.11 (m, 2H, CH2-6), 4.03–3.84 (m, 5H, CH2), 3.72 (dq, J = 7.4, 4.8 Hz, 1H, CH2-2). 
13C NMR (100 MHz, CDCl3) δ ppm: 156.4 (C-1), 133.4 (CH-5), 132.9 (C-Ar), 131.6 (CH-Ar), 
129.9 (CH-Ar), 124.9 (CH-Ar), 118.1 (CH2-6), 72.3 (CH2-4), 61.6 (CH2-3), 53.6 (CH2-2). 
IR (thin film): 1496, 1350, 1151, 1014, 910, 762 cm-1. 
HRMS (ESI): Calcd for C12H14N4NaO2S
+ [M+Na]+, 301.0730; found, 301.0723. 
MP: 88°C. 
 
5-(Hex-5-en-1-ylthio)-1-phenyl-1H-tetrazole (3.33) 
Method A 
 
Chemical formula: C13H16N4S 
MW: 260.36 
To a stirred suspension of NaH (438 mg, 10.9 mmol, 1.31 equiv) in THF (15 mL) at 0°C was 
slowly added the thiol 3.25 (1.63 g, 9.15 mmol, 1.10 equiv). The reaction mixture was stirred at 
this temperature for 30 min followed by slow addition of the tosylated alcohol 3.31 (2.11 g, 8.30 
mmol). The resulting mixture was stirred at room temperature for 3 days and water was then 
added to quench the reaction. The aqueous layer was extracted with Et2O, and the combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure to afford the sulfide 3.33 as a colourless oil (2.16 g, 8.30 
mmol, quant). 
Method B 
 
To a stirred suspension of NaH (360 mg, 9.00 mmol, 1.20 equiv) in THF (14 mL) at 0°C was 
slowly added the thiol 3.25 (1.47 g, 8.25 mmol, 1.10 equiv). The reaction mixture was stirred at 
this temperature for 30 min followed by slow addition of alkene 3.32 (1.0 mL, 7.5 mmol). The 
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resulting mixture was stirred at room temperature for 3 days and water was then added to 
quench the reaction. The aqueous layer was extracted with Et2O, and the combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure to afford the sulfide 3.33 as a colourless oil (1.98 g, 7.59 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.71–7.42 (m, 5H, CH-Ar), 5.77 (m, 1H, CH-6), 5.09–
4.87 (m, 2H, CH2-7), 3.40 (m, 2H, CH2-2), 2.09 (m, 2H, CH2-5), 1.83 (m, 2H, CH2-3), 1.54 (m, 
2H, CH2-4). 
13C NMR (100 MHz, CDCl3) δ ppm: 154.4 (C-1), 138.0 (CH-6), 133.7 (C-Ar), 130.1 (CH-Ar), 
129.8 (CH-Ar), 123.8 (CH-Ar), 115.1 (CH2-7), 33.2 (CH2-2 or 5), 33.1 (CH2-2 or 5), 28.5 
(CH2-3), 27.8 (CH2-4) 
IR (thin film): 2924, 2856, 1597, 1500, 1413, 910 cm-1. 
HRMS (ESI): Calcd for C13H16N4NaS
+ [M+Na]+, 283.0988; found, 283.0978. 
 
5-(Hex-5-en-1-ylsulfonyl)-1-phenyl-1H-tetrazole (3.34) 
 
Chemical formula: C13H16N4O2S 
MW: 276.36 
 
To a stirred solution of sulfide 3.33 (2.16 g, 8.30 mmol) in ethanol (110 mL) at 0°C was added 
(NH4)6Mo7O24·H2O (1.64 mg, 1.33 mmol, 0.160 equiv) and 30% H2O2 (5.40 mL, 47.3 mmol, 
5.7 equiv). The resulting mixture was stirred at room temperature for 3 days. Brine was added 
to quench the reaction and the aqueous layer was extracted with Et2O. The combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:EtOAc (8:2) to afford the sulfone 3.34 as a colourless oil (2.09 g, 7.55 mmol, 
91%).  
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1H NMR (400 MHz, CDCl3) δ ppm: 7.77–7.51 (m, 5H, CH-Ar), 5.76 (m, 1H, CH-6), 5.10–
4.95 (m, 2H, CH2-7), 3.74 (m, 2H, CH2-2), 2.12 (m, 2H, CH2-5), 2.03–1.89 (m, 2H, CH2-3), 
1.69–1.52 (m, 2H, CH2-4). 
13C NMR (100 MHz, CDCl3) δ ppm: 153.4 (C-1), 137.2 (CH-6), 133.0 (C-Ar), 131.4 (CH-Ar), 
129.7 (CH-Ar), 125.0 (CH-Ar), 115.7 (CH2-7), 55.8 (CH2-2), 32.9 (CH2-5), 27.3 (CH2-4), 21.4 
(CH2-3). 
IR (thin film): 3306, 2941, 2831, 1448, 1028, 734 cm-1. 
HRMS (ESI): Calcd for C13H16N4NaO2S
+ [M+Na]+, 315.0886; found, 315.0879 
(1-Methyl-2-oxocyclohexyl)methyl 2,2,2-trifluoroacetate ((±)3.36) 
 
Chemical formula: C10H13F3O3 
MW: 238.21 
To a stirred solution of 3.35 (10.0 mL, 82.5 mmol) in TFA (mL) was added p-formaldehyde (8.0 
mL, 37% in H2O, 99 mmol, 1.2 equiv) and the reaction mixture was stirred at 25°C for 24h. 
Et2O was added to dilute the resulting mixture and the organic layer was washed several times 
with an aqueous saturated solution of NaHCO3, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (95:5) to (8:2) to afford the trifluoroacetate 
(±)3.36 as a colourless oil (8.96 g, 37.6 mmol, 46%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.45 (d, J = 11.0 Hz, 1H, CH2-8), 4.29 (d, J = 11.0 Hz, 
1H, CH2-8), 2.51 (m, 1H, CH2-2), 2.34 (m, 1H, CH2-2), 2.07–1.96 (m, 1H, CH2), 1.84–1.65 (m, 
5H, CH2), 1.22 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 212.0 (CO-1), 157.3 (q, J = 40 Hz, COCF3), 114.5 (q, J 
= 290 Hz, CF3), 71.9 (CH2-8), 48.3 (C-6), 38.4 (CH2-5), 35.5 (CH2), 26.9 (CH2), 20.7 (CH2), 
20.1 (CH3-7).IR (thin film): 1782, 1697, 1209, 1161 cm-1. 
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2-(Hydroxymethyl)-2-methylcyclohexan-1-one ((±)3.37) 
 
Chemical formula: C8H14O2 
MW: 142.20 
To a stirred solution of trifluoroacetate (±)3.36 (24.5 g, 103 mmol) in a 1:1 mixture of 
MeOH:H2O (114 mL) at 0°C was added NaOH (5.80 g,  145 mmol, 1.41 equiv). The reaction 
mixture was stirred at this temperature for 2.5h and a saturated aqueous solution of NH4Cl was 
then added to quench the reaction. The aqueous layer was extracted with Et2O, and the 
combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure to afford the alcohol (±)3.37 as a pale yellow oil (14.6 g, 
mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 3.48 (d, J = 1.3 Hz, 2H, CH2-8), 2.71 (bs, 1H, OH), 
2.55–2.42 (m, 1H, CH2-2), 2.26 (m, 1H, CH2-2), 2.01 (m, 1H, CH2), 1.89–1.46 (m, 5H, CH2), 
1.17 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 218.4 (CO-1), 69.0 (CH2-8), 50.1 (C-6), 38.9 (CH2-2), 
35.5 (CH2), 27.3 (CH2), 20.7 (CH2), 20.2 (CH3-7). 
IR (thin film): 3454, 2938, 1691, 1450, 1265, 1037, 735 cm-1. 
HRMS (ESI): Calcd for C8H14NaO2
+ [M+Na]+, 165.0886; found, 165.0881.  
 
1-Methyl-2-oxocyclohexane-1-carbaldehyde ((±)3.38) 
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Chemical formula: C8H12O2 
MW: 140.18 
To a stirred solution of alcohol (±)3.37 (1.42 g, 10.0 mmol) in DMSO (30 mL) was added IBX 
(7.92 g, 30.0 mmol, 3.0 equiv). The reaction mixture was stirred at room temperature for 3h. 
The resulting mixture was then filtered and the filter cake was washed with Et2O. Water was 
added to the filtrate and the aqueous layer was extracted with Et2O. The combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure to afford the aldehyde (±)3.38 as a pale yellow oil (1.40 g, 10 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 9.50 (s, 1H, CHO-5), 2.54–2.24 (m, 3H, CH2), 2.01–
1.91 (m, 1H, CH2), 1.82–1.55 (m, 4H, CH2), 1.24 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 209.7 (CO-1), 201.0 (CHO-5), 61.3 (C-6), 40.6 (CH2), 
34.7 (CH2), 26.7 (CH2), 21.7 (CH2), 17.9 (CH3-7). 
HRMS (CI/Isobutane): Calcd for C8H13O2
+ [M+H]+, 141.0916; found, 141.0910. 
 
5-(Allyloxy)-1-phenyl-1H-tetrazole (3.56) 
 
Chemical formula: C10H10N4O 
MW: 202.22 
To a stirred solution of sulfone 3.28 (135 mg, 0.460 mmol) in THF (2.1 mL) at -78°C was added 
LiHMDS (0.92 mL, 1M in THF, 0.92 mmol, 2.0 equiv). The reaction mixture was stirred at this 
temperature for 15 min before a solution of aldehyde (±)3.38 (76 mg, 0.54 mmol, 1.2 equiv) in 
THF (1.2 mL) was added. The resulting solution was stirred at -78°C for 90 min and a saturated 
aqueous solution of NH4Cl was then added to quench the reaction. The aqueous layer was 
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extracted with Et2O, and the combined organic extracts were washed with brine, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography using petroleum ether:Et2O (7:3) to (1:1) to afford 
(±)3.56 as a colourless oil (25 mg, 0.12 mmol, 27%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.70 (m, 2H, CH-Ar), 7.47 (m, 3H, CH-Ar), 6.20–6.00 
(m, 1H, CH-3), 5.50–5.39 (m, 2H, CH2-4), 5.10 (d, J = 5.9 Hz, 2H, CH2-2). 
13C NMR (100 MHz, CDCl3) δ ppm: 159.9 (C-1), 133.3 (C-Ar), 130.4 (CH-3), 129.5 (CH-Ar), 
128.9 (CH-Ar), 121.6 (CH-Ar), 120.9 (CH2-4), 74.1 (CH2-2). 
IR (thin film): 1799, 1595, 1558, 1506, 1451 cm-1. 
HRMS (ESI): Calcd for C10H10N4NaO
+ [M+Na]+, 225.0747; found, 225.0740. 
 
(E)-2-(Hepta-1,6-dien-1-yl)-2-methylcyclohexan-1-one ((±)3.61) 
 
 
Chemical formula: C14H22O 
MW: 206.33 
To a stirred solution of sulfone 3.34 (135 mg, 0.460 mmol) in THF (2.1 mL) at -78°C was added 
LiHMDS (0.92 mL, 1M in THF, 0.92 mmol, 2.0 equiv). The reaction mixture was stirred at this 
temperature for 15 min before a solution of aldehyde (±)3.38 (132 mg, 0.94 mmol, 2.0 equiv) 
in THF (1.2 mL) was added. The resulting solution was stirred at -78°C for 2h and a saturated 
aqueous solution of NH4Cl was then added to quench the reaction. The aqueous layer was 
extracted with Et2O, and the combined organic extracts were washed with brine, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
then purified by flash chromatography using petroleum ether:CH2Cl2 (8:2) to afford the diene 
(±)3.61 as a colourless oil (95 mg, 0.46 mmol, quant). 
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1H NMR (400 MHz, CDCl3) δ ppm: 5.88–5.70 (m, 1H, CH-13), 5.56 (d, J = 15.9 Hz, 1H, 
CH-8), 5.33 (dt, J = 15.8, 6.8 Hz, 1H, CH-9), 5.07–4.86 (m, 2H, CH2-14), 2.53 (m, 1H, CH2-
2), 2.27 (m, 1H, CH2-2), 1.98 (m, 6H, CH2), 1.80–1.38 (m, 6H, CH2), 1.12 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 213.8 (CO-1), 138.6 (CH-13), 134.8 (CH-8), 130.7 (CH-
9), 114.6 (CH2-14), 51.3 (C-6), 40.4 (CH2), 39.2 (CH2), 33.1 (CH2), 32.2 (CH2), 28.4 (CH2), 
27.7 (CH2), 24.6 (CH3-7), 21.8 (CH2). 
IR (thin film): 2916, 2858, 1708, 1448, 972 cm-1. 
HRMS (ESI): Calcd for C14H22NaO
+ [M+Na]+, 229.1563; found, 229.1555. 
 
(Z)-1-(2-((E)-Hept-1-en-1-yl)-2-methylcyclohexylidene)-2-(2,4,6-
triisopropylphenyl)hydrazine ((±)3.62) 
 
Chemical formula: C29H48N2O2S 
MW: 488.78 
To a stirred solution of ketone (±)3.61 (888 mg, 4.30 mmol) in THF (25 mL) at 0°C was added 
TrisNHNH2 (1.44 g, 4.84 mmol, 1.10 equiv) and 2 drops of concentrated HCl. The reaction 
mixture was stirred at room temperature for 2 h. A saturated aqueous solution of NaHCO3 was 
added to quench the reaction. The aqueous layer was extracted with Et2O, and the combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether: CH2Cl2 (7:3) to (3:7) to afford the hydrazone (±)3.62 
as a white solid (1.73 g, 3.54 mmol, 82%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.98 (bs, 1H, NH), 7.08 (s, 2H, CH-Ar), 5.18 (d, J = 
15.8 Hz, 1H, CH-8), 4.93–4.74 (m, 1H, CH-9), 4.18 (m, 2H, CH-iPr ), 2.88–2.76 (m, 1H, CH-
iPr), 2.49 (d, J = 14.6 Hz, 1H, CH2-2), 1.88–1.79 (m, 1H, CH2-2), 1.77–1.61 (m, 4H, CH2), 
1.45 (d, J = 12.7 Hz, 3H, CH2), 1.33–1.03 (m, 25H, 7CH2, 18CH3-iPr), 0.90 (s, 3H, CH3-7), 
0.80–0.73 (m, 3H, CH3-14) 
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13C NMR (100 MHz, CDCl3) δ ppm: 161 (CN-1), 152.8 (C-Ar), 151.2 (2C-Ar), 136.8 (CH-8), 
131.7 (C-Ar), 130.1 (CH-9), 123.4 (2CH-Ar), 44.7 (C-6), 40.1 (CH2), 34.1 (CH-iPr), 32.6 (CH2-
2), 31.3 (CH2), 29.7 (2CH-iPr), 28.9 (CH2), 25.9 (CH2), 24.9 (CH3), 24.9 (CH3), 23.7 (CH2), 
23.6 (CH3), 23.5 (CH3), 22.4 (CH2), 22.0 (CH2), 14.0 (CH3-14). 
IR (thin film): 1448, 2928, 1705, 1600, 1448, 1334, 1192, 1126 cm-1. 
HRMS (ESI): Calcd for C29H48N2NaO2S
+ [M+Na]+, 511.3329; found, 511.3344. 
MP: 59°C.  
 
2-((Methoxymethoxy)methyl)-2-methylcyclohexan-1-one ((±)3.65) 
 
Chemical formula: C10H18O3 
MW: 186.25 
To a stirred solution of alcohol (±)3.37 (469 mg, 3.30 mmol) in CH2Cl2 (5.0 mL) was added 
TBAI (243 mg, 0.658 mmol, 0.20 equiv), DIPEA (4.00 mL, 23.1 mmol, 7.0 equiv) and MOMCl 
(1.00 mL,  13.2 mmol, 4.0 equiv). The reaction mixture was stirred at room temperature for 24h 
and a saturated aqueous solution of NaHCO3 was then added to quench the reaction. The 
aqueous layer was extracted with CH2Cl2, and the combined organic extracts were washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:Et2O (8:2) to 
afford the protected alcohol (±)3.65 as a colourless oil (393 mg, 2.11 mmol, 64%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.59 (qd, J = 6.5, 0.8 Hz, 2H, CH2-9), 3.57 (s, 2H, CH2-
8), 3.32 (s, 3H, CH3-10), 2.48–2.34 (m, 2H, CH2-2), 1.91–1.61 (m, 6H, CH2-3,4,5), 1.12 (s, 3H, 
CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 214.0 (CO-1), 96.7 (CH2-9), 72.9 (CH2-8), 55.2 (CH3-
10), 49.4 (C-6), 39.0 (CH2-2), 36.3 (CH2-5), 27.1 (CH2-3), 21.1 (CH2-4), 21.0 (CH3-7). 
IR (thin film): 2926, 2868, 1705, 1450, 1150, 1111, 1049, 918 cm-1. 
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HRMS (ESI): Calcd for C10H18NaO3
+ [M+Na]+, 209.1148; found, 209.1147. 
 
 
 
 
 
 
2-((Ethoxymethoxy)methyl)-2-methylcyclohexan-1-one ((±)3.67) 
 
Chemical formula: C11H20O3 
MW: 200.28 
To a stirred solution of alcohol (±)3.37 (2.13 g, 14.9 mmol) in CH2Cl2 (30 mL) was added TBAI 
(1.05 g, 2.84 mmol, 0.20 equiv), DIPEA (5.2 mL, 29.9 mmol, 2.0 equiv) and EOMCl (2.3 mL,  
29.8 mmol, 2.0 equiv). The reaction mixture was stirred at room temperature for 24h and a 
saturated aqueous solution of NaHCO3 was then added to quench the reaction. The aqueous 
layer was extracted with CH2Cl2, and the combined organic extracts were washed with brine, 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude 
mixture was then purified by flash chromatography using petroleum ether:Et2O (8:2) to afford 
the protected alcohol (±)3.67 as a colourless oil (2.45 g, 12.2 mmol, 82%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.68–4.62 (m, 2H, CH2-9), 3.57 (m, 4H, CH2-8,10), 2.44–
2.36 (m, 2H, CH2-2), 1.94–1.59 (m, 6H, CH2-3,4,5), 1.21 (t, J = 7.1 Hz, 3H, CH3-11), 1.12 (s, 
3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 214.1 (CO-1), 95.4 (CH2-9), 73.0 (CH2-8), 63.3 (CH2-
10), 49.5 (C-6), 39.0 (CH2-2), 36.3 (CH2-6), 27.1 (CH2-3 or 4), 21.1, (CH2-3 or 4) 21.0 (CH3-
7), 15.1 (CH3-11). 
IR (thin film): 2932, 2870, 1705, 1450,1115, 1099 cm-1. 
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HRMS (ESI): Calcd for C11H20NaO3
+ [M+Na]+, 223.1305; found, 223.1297 
 
 
 
 
 
(Z)-N'-(2-((Ethoxymethoxy)methyl)-2-methylcyclohexylidene)-2,4,6-
triisopropylbenzenesulfonohydrazide ((±)3.68) 
 
Chemical formula: C26H44N2O4S 
MW: 480.71 
To a stirred solution of ketone (±)3.67 (4.31 g, 21.5 mmol) in THF (125 mL) at 0°C was added 
TrisNHNH2 (7.00 g, 23.6 mmol, 1.10 equiv) and 3 drops of concentrated HCl. The reaction 
mixture was stirred at room temperature for 2 h. A saturated aqueous solution of NaHCO3 was 
added to quench the reaction. The aqueous layer was extracted with Et2O, and the combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O(8:2) to (1:1) to afford the hydrazone (±)3.68 as a 
white solid (10.3 g, 21.5 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.14 (s, 2H, CH-Ar), 4.42 (dd, J = 15.9, 6.6 Hz, 2H, 
CH2-9), 4.16 (dt, J = 13.5, 6.7 Hz, 2H, CH-iPr), 3.48–3.31 (m, 4H, CH2-8,10), 2.89 (dd, J = 
13.8, 6.9 Hz, 1H, CH-iPr), 2.20 (t, J = 5.9 Hz, 2H, CH2-2), 1.65–1.49 (m, 6H, CH2-3,4,5), 1.24 
(m, 18H, CH3-iPr), 1.13 (t, J = 7.1 Hz, 3H, CH3-11), 0.98 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 161.1 (C-1), 152.8 (C-Ar),151.0 (2C-Ar), 131.3 (C-Ar), 
123.3 (CH-Ar), 95.1 (CH2-9), 73.9 (CH2-8), 62.8 (CH2-10), 42.6 (C-6), 35.5 (CH2-3 or 5), 34.0 
(CH-iPr), 29.6 (CH-iPr), 25.2 (CH2-3 or 5), 24.7 (CH3-iPr), 24.6 (CH3-iPr), 23.4 (CH3-7), 
23.2 (CH2-2), 22.5 (CH3-iPr), 20.8 (CH2-4), 14.9 (CH3-11). 
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IR (thin film): 1598, 1163, 1114, 1035, 1014, 921 cm-1. 
HRMS (ESI): Calcd for C26H44NaN2O4S
+ [M+Na]+, 503.2914; found, 503.2917. 
MP: 87°C. 
 
 
(6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-yl)(2,2,4-trimethyl-1-
((trimethylsilyl)oxy)-3-vinylcyclohex-3-en-1-yl)methanol ((±)3.69a-b) 
 
Chemical formula: C26H46O4Si 
MW: 450.74 
To a stirred solution of hydrazone (±)3.68 (4.80 g, 10.0 mmol, 1.20 equiv) in THF (12 mL) 
at -78°C was added dropwise t-BuLi (12.4 mL, 1.60 M in hexane, 19.8 mmol, 2.40 equiv). The 
solution turned dark red. The resulting solution was stirred at this temperature for 30 min and 
warmed for a few min to room temperature and intense nitrogen bubbling occurred. The red  
reaction mixture was then cooled down to -78°C and a solution of aldehyde (±)3.18 (2.21 g, 
8.30 mmol) in THF (6.0 mL) was added. The resulting mixture was stirred at -78°C for 4 h and 
became yellow. A saturated aqueous solution of NaHCO3 was added to quench the reaction. 
The aqueous layer was extracted with Et2O, and the combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography petroleum ether:Et2O (10:0.25) to 
afford the title alcohols (±)3.69a (1.05 g, 2.33 mmol, 28%) and (±)3.69b (1.05 g, 2.33 mmol, 
28%) as highly viscous yellow oils, as well as (±)3.70 (775 mg, 4.21 mmol, 42%) as a colourless 
oil (resulting in part from the excess of hydrazone (±)3.68 employed).  
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(R*)-((R*)-6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-yl)((R*)-2,2,4-
trimethyl-1-((trimethylsilyl)oxy)-3-vinylcyclohex-3-en-1-yl)methanol ((±)3.69a) 
 
Chemical formula: C26H46O4Si 
MW: 450.74 
1H NMR (400 MHz, CDCl3) δ ppm: 6.16 (dd, J = 17.2, 11.6 Hz, 1H, CH-10), 5.99 (bs, 1H, 
CH-4), 5.24 (dd, J = 11.1, 2.6 Hz, 1H, CH2-10´), 4.91 (dd, J = 17.6, 2.6 Hz, 1H, CH2-10´), 4.65 
(s, 2H, CH2-9´), 4.61 (s, 1H, CH-2), 3.78 (bs, 1H, OH), 3.63–3.45 (m, 4H, CH2-9,9´´), 2.30 
(dd, J = 17.3, 8.2 Hz, 1H, CH2-5), 2.17–2.01 (m, 2H, CH2-13 or 14), 1.87 (dd, J = 17.6, 5.1 Hz, 
1H, CH2-5), 1.76–1.71 (m, 1H, CH2-7), 1.68 (s, 3H, CH3-18), 1.63–1.53 (m, 4H, CH2-6, CH2-
13 or 14), 1.34 (dd, J = 13.4, 6.9 Hz, 1H, CH2-7), 1.20 (t, J = 7.1 Hz, 3H, CH3-9´´´), 1.13–1.01 
(m, 9H, CH3-16,17,19), 0.12 (s, 9H, CH3-OTMS). 
13C NMR (100 MHz, CDCl3) δ ppm: 141.3 (C-3), 137.3 (C-11), 136.4 (CH-10), 130.6 (CH-4), 
127.8 (C-12), 118.7 (CH2-10´), 95.2 (CH2-9´), 76.2 (C-1), 74.0 (CH2-9), 70.9 (CH-2), 63.1 (CH2-
9´´), 43.7 (C-15), 38.1 (C-8), 33.9 (CH2-7), 29.4 (CH2-5), 28.1 (CH2-13 or 14), 26.0 (CH3-16 or 
17), 25.4 (CH2-13 or 14), 23.6 (CH3-19), 21.8 (CH3-16 or 17), 21.4 (CH3-18), 18.1 (CH2-6), 15.1 
(CH3-9´´´), 1.1 (CH3-OTMS). 
IR (thin film): 2931, 1375, 1251, 1097, 1047 cm-1. 
HRMS (ESI): Calcd for C26H46NaO4Si
+ [M+Na]+, 473.3058; found, 473.3040. 
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(R*)-((S*)-6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-yl)((R*)-2,2,4-
trimethyl-1-((trimethylsilyl)oxy)-3-vinylcyclohex-3-en-1-yl)methanol ((±)3.69b) 
 
Chemical formula: C26H46O4Si 
MW: 450.74 
1H NMR (400 MHz, CDCl3) δ ppm: 6.17 (dd, J = 17.4, 11.0 Hz, 1H, CH-10), 6.02 (bs, 1H, 
CH-4), 5.25 (dd, J = 11.0, 2.8 Hz, 1H, CH2-10´), 4.91 (dd, J = 17.6, 2.8 Hz, 1H, CH2-10´), 4.66 
(s, 1H, CH-2), 4.63 (s, 2H, CH2-9´), 3.84 (bs, 1H, OH), 3.59–3.31 (m, 4H, CH2-9,9´´ ), 2.37–
2.24 (m, 1H, CH2-5), 2.17–1.99 (m, 2H, CH2-13 or 14), 1.87 (dd, J = 17.7, 5.8 Hz, 1H, CH2-7), 
1.78–1.72 (m, 1H, CH2-7), 1.68 (s, 3H, CH3-18), 1.62–1.53 (m, 4H, CH2-6, CH2-13 or 14), 
1.47–1.39 (m, 1H, CH2-7), 1.26–1.14 (m, 6H, CH3-9´´´, 19), 1.10–1.02 (m, 6H, CH3-16, 17), 
0.13 (s, 9H, CH3-OTMS). 
13C NMR (100 MHz, CDCl3) δ ppm: 141.3 (C-3), 137.3 (C-11), 136.5 (CH-10), 131.2 (CH-4), 
127.7 (C-12), 118.7 (CH2-10´), 95.2 (CH2-9´), 76.1 (C-1), 74.2 (CH2-9), 70.4 (CH-2), 63.1 (CH2-
9´), 43.7 (C-15), 38.1 (C-8), 34.1 (CH2-7), 29.3 (CH2-5), 27.8 (CH2-13 or 14), 25.9 (CH2-13 or 
14), 24.0 (CH3-19), 23.7 (CH3-16 or 17), 21.3 (CH3-18), 18.3 (CH2-6), 15.1 (CH3-9´´´), 1.3 
(CH3-OTMS). 
IR (thin film): 2931, 2357, 1465, 1251, 1097, 910 cm-1. 
HRMS (ESI): Calcd for C26H46NaO4Si
+ [M+Na]+, 473.3058; found, 473.3052. 
 
3-((Ethoxymethoxy)methyl)-3-methylcyclohex-1-ene ((±)3.70) 
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Chemical formula: C11H20O2  
MW: 184.28 
1H NMR (400 MHz, CDCl3) δ ppm: 5.68 (dt, J = 10.1, 3.7 Hz, 1H, CH-2), 5.43 (d, J = 10.1, 
1H, CH-1), 4.66 (s, 2H, CH2-9), 3.58 (q, J = 7.1 Hz, 2H, CH2-10), 3.27 (m, 2H, CH2-8), 1.95 
(m, 2H, CH2-3), 1.67–1.52 (m, 3H, CH2-4, 5), 1.38–1.34 (m, 1H, CH2-5) 1.21 (t, J = 7.1 Hz, 
3H, CH3-11), 0.99 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 133.6 (CH-1), 127.2 (CH-2), 95.4 (CH2-9), 76.3 (CH2-
8), 63.0 (CH2-10), 35.7 (C-6), 32.2 (CH2-5), 25.2 (CH2-3), 24.9 (CH3-7), 18.9 (CH2-4), 15.2 
(CH3-11). 
IR (thin film): 1112, 1047, 910, 742 cm-1. 
HRMS (ESI): Calcd for C11H20NaO2
+ [M+Na]+, 207.1356; found, 207.1358. 
 
(1R*)-1-((1R*)-(6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-
yl)(hydroxy)methyl)-2,2,4-trimethyl-3-vinylcyclohex-3-en-1-ol ((±)3.71a-b) 
 
Chemical formula: C23H38O4 
MW: 378.55 
To a stirred solution of alcohol (±)3.69a (342 mg, 0.758 mmol ) in THF (2.7 mL) was added a 
1N aqueous solution of HCl (2.7 mL) and the resulting mixture was stirred at room temperature 
overnight. A saturated aqueous solution of NaHCO3 was added to quench the reaction. The 
aqueous layer was extracted with EtOAc, and the combined organic extracts were washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
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crude mixture was then purified by flash chromatography petroleum ether:Et2O (8:2) to (1:1) to 
afford the alcohol (±)3.71a as a colourless oil (268 mg, 0.708 mmol, 94%).  
The same experimental procedure was applied to alcohol (±)3.69b (417mg, 0.92 mmol) to 
afford the alcohol (±)3.71b as a colourless oil (348 mg, 0.92 mmol, quant).  
 
(R*)-1-((R*)-((R*)-6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-
yl)(hydroxy)methyl)-2,2,4-trimethyl-3-vinylcyclohex-3-en-1-ol ((±)3.71a) 
 
Chemical formula: C23H38O4 
MW: 378.55 
1H NMR (400 MHz, CDCl3) δ ppm: 6.56–6.45 (m, 1H, CH-4), 6.17 (dd, J = 17.3, 11.3 Hz, 
1H, CH-10), 5.25 (dd, J = 11.0, 2.7 Hz, 1H, CH2-10´), 4.91 (dd, J = 17.6, 2.6 Hz, 1H, CH2-10´), 
4.69–4.64 (m, 2H, CH2-9´), 4.23 (s, 1H, CH-2), 3.65–3.57 (m, 3H, CH2-9 , 2CH2-9´´), 3.39 (s, 
1H, OH), 3.26 (d, J = 9.6 Hz, 1H, CH2-9), 3.08 (d, J = 1.4 Hz, 1H, OH), 2.07 (dd, J = 9.0, 5.6 
Hz, 4H, CH2), 1.96–1.80 (m, 3H, CH2), 1.66 (s, 3H, CH3-18), 1.63–1.57 (m, 2H, CH2), 1.41–
1.32 (m, 1H, CH2-7), 1.25–1.15 (m, 6H, CH3-9´´´, CH3-16 or 17), 1.06 (s, 3H, CH3-19), 0.91 
(s, 3H, CH3-16 or 17). 
13C NMR (100 MHz, CDCl3) δ ppm: 142.1 (C-3), 138.1 (C-11), 136.2 (CH-10), 130.7 (CH-4), 
127.3 (C-12), 118.6 (CH2-10´), 95.5 (CH2-9´), 75.7 (C-1), 75.4 (CH2-9), 69.0 (CH-2), 63.7 (CH2-
9´´), 43.9 (C-15), 38.5 (C-8), 34.7 (CH2), 28.7 (CH2), 27.4 (CH2-13 or 14), 25.9 (CH2-13 or 14), 
24.7 (CH3-19), 23.6 (CH3-16), 23.5 (CH3-17), 21.1 (CH3-18), 18.7 (CH2), 15.1 (CH3-9´´´). 
IR (thin film): 3426, 2910, 1463, 1384, 1112 cm-1. 
HRMS (ESI): Calcd for C23H38NaO4
+ [M+Na]+, 401.2662; found, 401.2653. 
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(R*)-1-((R*)-((S*)-6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-
yl)(hydroxy)methyl)-2,2,4-trimethyl-3-vinylcyclohex-3-en-1-ol ((±)3.71b) 
 
Chemical formula: C23H38O4 
MW: 378.55 
1H NMR (400 MHz, CDCl3) δ ppm: 6.25–6.08 (m, 2H, CH-4, CH-10), 5.26 (dd, J = 11.1, 2.7 
Hz, 1H, CH2-10´), 4.92 (dd, J = 17.6, 2.7 Hz, 1H, CH2-10´), 4.64 (s, 2H, CH2-9´), 4.35 (d, J = 
4.2 Hz, 1H, CH-2), 3.57 (q, J = 7.1 Hz, 2H, CH2-9´´), 3.39–3.30 (m, 2H, CH2-9), 3.00 (s, 1H, 
OH), 2.62 (bs, 1H, OH), 2.23–2.02 (m, 3H, CH2), 1.98–1.85 (m, 1H, CH2-13 or 14), 1.80–1.72 
(m, 2H, CH2), 1.68 (s, 3H, CH3-18), 1.62–1.56 (m, 2H, CH2-6), 1.54–1.47 (m, 1H, CH2-5), 
1.42–1.35 (m, 1H, CH2-7), 1.22–1.16 (m, 9H, CH3-9´´´, CH3-16 or 17, CH3-19), 1.07 (s, 3H, 
CH3-16 or 17). 
13C NMR (100 MHz, CDCl3) δ ppm: 144.8 (C-3), 137.6 (C-11), 136.1 (CH-10), 129.7 (CH-4), 
127.6 (C-12), 118.7 (CH2-10´), 95.2 (CH2-9´), 76.0 (C-1), 75.2 (CH2-9), 72.4 (CH-2), 63.3 (CH2-
9´´), 43.7 (C-15), 38.2 (C-8), 34.8 (CH2-7), 28.7 (CH2-5), 27.7 (CH2-13 or 14), 25.6 (CH2-13 or 
14), 25.1 (CH3-16 or 17), 23.9 (CH3-16 or 17), 22.9 (CH3-19), 21.2 (CH3-18), 18.3 (CH2-6), 15.1 
(CH3-9´´´). 
IR (thin film): 3423, 2927, 1446, 1383, 1109, 1041 cm-1. 
HRMS (ESI): Calcd for C23H38NaO4
+ [M+Na]+ 401.2662; found, 401.2645 
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(4R*,5S*)-4-(6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-yl)-6,6,8-trimethyl-
7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.72a-b) 
 
Chemical formula: C24H36O5 
MW: 404.55 
To a stirred solution of diol (±)3.71a (253 mg, 0.670 mmol) in DMF (9.3 mL) was added NaH 
(60 %) (79 mg, 2.0 mmol, 3.0 equiv) and N,N-carbonyl diimidazole (541 mg, 3.34 mmol, 5.0 
equiv). The reaction mixture was stirred at room temperature for 30 min. A saturated aqueous 
solution of NH4Cl was added to quench the reaction. The aqueous layer was extracted with 
Et2O, and the combined organic extracts were washed with brine, dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (8:2) to afford the carbonate (±)3.71a  as a pale 
yellow oil (271 mg, 0.670 mmol, quant). 
The same experimental procedure was applied to alcohol (±)3.71b (262 mg, 0.690 mmol) to 
afford the carbonate (±)3.72b as a colourless oil (279 mg, 0.670 mmol, quant).  
 
(4R*,5R*)-4-((R*)-6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.72a) 
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Chemical formula: C24H36O5 
MW: 404.55 
1H NMR (400 MHz, CDCl3) δ ppm: 6.05 (dd, J = 17.4, 11.2 Hz, 1H, CH-10), 5.84 (t, J = 3.9 
Hz, 1H, CH-4), 5.26 (dd, J = 11.1, 2.4 Hz, 1H, CH2-10´), 5.03 (s, 1H, CH-2), 4.93 (dd, J = 17.6, 
2.4 Hz, 1H, CH2-10´), 4.53 (s, 2H, CH2-9´), 3.55–3.43 (m, 2H, CH2-9´´), 3.29–3.18 (m, 2H, 
CH2-9), 2.28–1.95 (m, 5H, CH2), 1.85–1.78 (m, 1H, CH2), 1.72–1.65 (m, 1H, CH2), 1.61 (s, 
3H, CH3-18), 1.60–1.52 (m, 2H, CH2), 1.32 (dd, J = 9.3, 5.0 Hz, 1H, CH2), 1.13 (t, J = 7.1 Hz, 
3H, CH3-9´´´), 1.09 (s, 3H, CH3-19), 1.06 (s, 6H, CH3-16, 17). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.2 (CO3), 137.5 (C-11), 134.7 (C-3), 134.6 (CH-10), 
133.2 (CH-4), 127.9 (C-12), 119.8 (CH2-10´), 94.9 (CH2-9´), 89.8 (C-1), 77.6 (CH-2), 72.9 
(CH2-9), 63.1 (CH2-9´´), 42.8 (C-15), 38.0 (C-8), 33.6 (CH2), 28.9 (CH2), 25.6 (CH2), 25.1 
(CH2), 24.4 (CH3-16 or 17), 23.2 (CH3-19), 20.8 (CH3-18), 20.7 (CH3-16 or 17), 17.9 (CH2), 
14.9 (CH3-9´´´). 
IR (thin film): 2974, 1797, 1458, 1386, 1178, 1043 cm-1. 
HRMS (ESI): Calcd for C24H36NaO5
+ [M+Na]+, 427.2455; found, 427.2448 
 
(4R*,5R*)-4-((S*)-6-((Ethoxymethoxy)methyl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.72b) 
 
Chemical formula: C24H36O5 
MW: 404.55 
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1H NMR (400 MHz, CDCl3) δ ppm: 6.10 (dd, J = 17.4, 11.1 Hz, 1H, CH-10), 5.87 (t, J = 3.9 
Hz, 1H, CH-4), 5.35 (s, 1H, CH-2), 5.31 (dd, J = 11.1, 2.5 Hz, 1H, CH2-10´), 4.97 (dd, J = 17.6, 
2.5 Hz, 1H, CH2-10´), 4.66 (s, 2H, CH2-9´), 3.61–3.49 (qd, 2H, CH2-9´´), 3.49–3.41 (m, 2H, 
CH2-9), 2.32–2.29 (m, 1H, CH2-5), 2.19–2.13 (m, 2H, CH2), 2.10–1.95 (m, 2H, CH2), 1.76–
1.58 (m, 4H, CH2), 1.65 (s, 3H, CH3-18), 1.40–1.35 (m, 1H, CH2), 1.20 (t, J = 7.1 Hz, 3H, CH3-
9´´), 1.13 (s, 3H, CH3-16 or 17), 1.10 (s, 3H, CH3-16 or 17), 0.98 (s, 3H, CH3-19). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.5 (CO3), 138.1 (C-11), 135.0 (C-3), 134.8 (CH-10), 
132.4 (CH-4), 128.0 (C-12), 119.9 (CH2-10´), 95.5 (CH2-9´), 89.9 (C-1), 77.8 (CH-2), 75.6 
(CH2-9), 63.4 (CH2-9´´), 43.0 (C-15), 37.7 (C-8), 34.9 (CH2), 29.1 (CH2), 25.6 (CH2), 25.2 
(CH2), 24.8 (CH3-16 or 17), 23.4 (CH3-19), 20.9 (CH3-18), 20.7 (CH3-16 or 17), 18.1 (CH2), 
15.1 (CH3-9´´). 
IR (thin film): 1789, 1463, 1386, 1346, 1178, 1047 cm-1. 
HRMS (ESI): Calcd for C24H36NaO5
+ [M+Na]+, 427.2455; found, 427.2440. 
 
(1-Methylcyclohex-2-en-1-yl)methanol ((±)3.73) 
 
Chemical formula: C8H14O 
MW: 126.20 
To a stirred solution of protected alcohol (±)3.70 (1.43 g, 7.92 mmol) in acetone (60 mL) and 
water (30 mL) was slowly added concentrated H2SO4 (7.4 mL). The reaction mixture was stirred 
at room temperature for 14 h. A saturated aqueous solution of NaHCO3 was added to quench 
the reaction and the aqueous layer was then extracted with Et2O. The combined organic extracts 
were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum 
ether:Et2O (9:1) to afford the alcohol (±)3.73 as a colourless oil (395mg, 3.13 mmol, 40%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.79 (dt, J = 10.0, 3.7 Hz, 1H, CH-2), 5.37 (d, J = 10.1 
Hz, 1H, CH-1), 3.34 (m, 2H, CH2-8), 1.95 (m, 2H, CH2-5), 1.72–1.58 (m, 3H, CH2-3, 2CH2-
4), 1.39–1.27 (m, 1H, CH2-3), 0.95 (s, 3H, CH3-7). 
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13C NMR (100 MHz, CDCl3) δ ppm: 132.8 (CH-1), 129.2 (CH-2), 71.4 (CH2-8), 37.0 (C-6), 
31.6 (CH2-5), 25.1 (CH2-3), 24.3 (CH3-7), 19.0 (CH2-4). 
IR (thin film): 3358, 2927, 2866, 1452, 1033, 910 cm-1. 
HRMS (ESI): Calcd for C8H14NaO
+ [M+Na]+, 149.0937; found, 149.0933. 
 
 
(4R*,5R*)-4-((R*)-6-(Hydroxymethyl)-6-methylcyclohex-1-en-1-yl)-6,6,8-trimethyl-7-
vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.74a) 
 
 Chemical formula: C21H30O4 
MW: 346.47 
To a stirred solution of protected alcohol (±)3.72a (278 mg, 0.680 mmol) in acetone (11 mL) 
and water (6 mL) was slowly added concentrated H2SO4 (1.5 mL). The reaction mixture was 
stirred at room temperature for 16 h. A saturated aqueous solution of NaHCO3 was added to 
quench the reaction and the aqueous layer was then extracted with Et2O. The combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (6:4) to afford the alcohol (±)3.73a as a white solid (220 mg, 0.630 mmol, 
93%). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.09 (dd, J = 17.5, 11.2 Hz, 1H, CH-10), 6.01 (t, J = 4.0 
Hz, 1H, CH-4), 5.30 (dd, J = 11.1, 2.5 Hz, 1H, CH2-10'), 5.19 (s, 1H, CH-2), 4.96 (dd, J = 17.6, 
2.5 Hz, 1H, CH2-10'), 3.60 (d, J = 11.2 Hz, 1H, CH2-9), 3.45 (d, J = 11.2 Hz, 1H, CH2-9), 2.30–
2.20 (m, 1H, CH2-5), 2.18–2.12 (m, 3H, CH2-13 or 14, OH), 2.02–1.94 (m, 1H, CH2-5), 1.81–
1.68 (m, 4H, CH2), 1.64 (s, 3H, CH3-18), 1.69–1-49 (m, 1H, CH2-6), 1.41–1.35 (m, 1H, CH2-
7), 1.10 (s, 6H, CH3-16, 17), 0.92 (s, 3H, CH3-19). 
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13C NMR (100 MHz, CDCl3) δ ppm: 155.3 (CO3), 137.3 (C-11), 135.2 (C-3), 134.6 (CH-10), 
134.2 (CH-4), 128.2 (C-12), 119.9 (CH2-10'), 89.8 (C-1), 77.3 (CH-2), 69.9 (CH2-9), 43.1 (C-
15), 39.1 (C-8), 34.1 (CH2-7), 29.0 (CH2-5), 25.7 (CH2-13 or 14), 25.0 (CH2-13 or 14), 24.1 
(CH3-16 or 17), 22.7 (CH3-19), 21.4 (CH3-16 or 17), 20.9 (CH3-18), 18.2 (CH2-6). 
IR (thin film): 3493, 2914, 1786, 1346, 1039 cm-1. 
HRMS (ESI): Calcd for C21H30NaO4
+ [M+Na]+, 369.2036; found, 369.2024. 
MP: 159°C. 
((R*)-1-Methyl-2-((4R*,5R*)-6,6,8-trimethyl-2-oxo-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-
4-yl)cyclohexan-1-yl)methyl 4-nitrobenzoate((±)3.75a) 
 
Chemical formula: C28H33NO7 
MW: 495.57 
To a stirred solution of alcohol (±)3.74a (212 mg, 0.610 mmol) in CH2Cl2 (13 mL) was added 
triethylamine (222 µL, 1.59 mmol, 2.60 equiv), DMAP (75 mg, 0.61 mmol, 1.0 equiv) and p-
nitrobenzoyl chloride (226 mg, 1.22 mmol, 2.0 equiv). The reaction mixture was stirred at room 
temperature for 16 h. A saturated aqueous solution of NaHCO3 was added to quench the 
reaction. The aqueous layer was extracted with Et2O, and the combined organic extracts were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude mixture was then purified by flash chromatography using petroleum 
ether:Et2O (6:4) to afford the ester (±)3.75a as a pale yellow solid (210 mg, 0.62 mmol, quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 8.30 (d, J = 8.6 Hz, 2H, CH-Ar), 8.17 (d, J = 8.6 Hz, 
2H, CH-Ar), 6.10 (dd, J = 17.3, 10.8 Hz, 1H, CH-10), 6.02 (s, 1H, CH-4), 5.32 (d, J = 11.0 Hz, 
1H, CH2-10'), 5.11 (s, 1H, CH-2), 4.99 (d, J = 17.7 Hz, 1H, CH2-10'), 4.17 (s, 2H, CH2-9), 
2.35–2.19 (m, 3H, CH2), 2.12–2.05 (m, 1H, CH2-13 or 14), 1.97–1.89 (m, 2H, CH2-5, 7), 1.79–
1.64 (m, 6H, 3CH2, CH3-18), 1.57–1.50 (m, 1H, CH2-7), 1.29 (s, 3H, CH3-19), 1.14 (s, J = 3.0 
Hz, 3H, CH3-16 or 17), 1.13 (s, J = 3.0 Hz, 3H, CH3-16 or 17). 
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13C NMR (100 MHz, CDCl3) δ ppm: 164.4 (C-9'), 155.0 (CO3), 150.7 (C-NO2), 136.0 (C-11), 
135.2 (C-3), 134.9 (C-Ar), 134.5 (CH-4 or 10), 134.5 (CH-4 or 10), 130.6 (CH-Ar), 128.2 (C-
12), 123.7 (CH-Ar), 120.2 (CH2-10'), 89.7 (C-1), 78.2 (CH-2), 69.7 (CH2-9), 42.9 (C-15), 37.8 
(C-8), 33.8 (CH2-7), 29.0 (CH2-5), 25.7 (CH2-13 or 14), 25.6 (CH2-13 or 14), 24.3 (CH3-16 or 
17), 23.3 (CH3-19), 21.0 (CH3-16 or 17), 20.9 (CH3-18), 17.9 (CH2-6). 
IR (thin film): 2912, 2360, 1793, 1726, 1529, 1346, 1267, 719 cm-1. 
HRMS (ESI): Calcd for C28H33NNaO7
+ [M+Na]+, 518.2149; found, 518.2150. 
(4R*,5R*)-4-((S*)-6-(Hydroxymethyl)-6-methylcyclohex-1-en-1-yl)-6,6,8-trimethyl-7-
vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.74b) 
 
Chemical formula: C21H30O4 
MW: 346.47 
To a stirred solution of protected alcohol (±)3.72b (340 mg, 0.840 mmol) in acetone (14 mL) 
and water (7 mL) was slowly added concentrated H2SO4 (1.8 mL). The reaction mixture was 
stirred at room temperature for 16 h. A saturated aqueous solution of NaHCO3 was added to 
quench the reaction and the aqueous layer was then extracted with Et2O. The combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude mixture was then purified by flash chromatography using 
petroleum ether:Et2O (6:4) to afford the alcohol (±)3.73b as a white solid (292 mg, 0.840 mmol, 
quant). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.11 (dd, J = 17.6, 11.1 Hz, 1H, CH-10), 5.91 (t, J = 4.0 
Hz, 1H, CH-4), 5.32 (dd, J = 11.1, 2.5 Hz, 1H, CH2-10'), 5.09 (s, 1H, CH-2), 4.98 (dd, J = 17.6, 
2.5 Hz, 1H, CH2-10'), 3.51 (dd, J = 10.8, 5.0 Hz, 1H, CH2-9), 3.33 (dd, J = 10.7, 4.9 Hz, 1H, 
CH2-9), 2.30–1.98 (m, 5H, 4CH2, OH), 1.85 (dd, J = 8.5, 3.8 Hz, 2H, CH2), 1.73–1.59 (m, 5H, 
CH2-6, CH3-18), 1.43–1.30 (m, 2H, CH2), 1.15–1.07 (m, 9H, CH3-16, 17, 19). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.4 (C-CO3), 137.5 (C-11), 134.9 (C-3), 134.8 (CH-
10), 133.6 (CH-4), 128.1 (C-12), 119.9 (CH2-10'), 90.1 (C-1), 78.2 (CH-2), 68.8 (CH2-9), 42.9 
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(C-15), 39.3 (C-8), 33.5 (CH2-7), 29.0 (CH2-5), 25.7 (CH2-13 or 14), 25.2 (CH2-13 or 14), 24.3 
(CH3-16 or 17), 22.8 (CH3-19), 20.9 (CH3-16 or 17), 20.8 (CH3-18), 18.1 (CH2-6). 
IR (thin film): 3477, 1795,73, 1390, 1176 cm-1. 
HRMS (ESI): Calcd for C21H30NaO4
+ [M+Na]+, 369.2036; found, 369.2023. 
MP: 155°C. 
 
(E)-1-(Allyloxy)-4,4-dimethylpent-2-ene (3.77) 
 
Chemical formula: C10H18O 
MW: 154.25 
To a stirred solution of aldehyde 3.76 (112 mg, 1.30 mmol) and sulfone 3.28 (1.14 g, 3.88 mmol, 
3.0 equiv) in DME (44 mL) at -55°C was slowly added KHMDS (5.2 mL, 1M in THF, 5.2 mmol, 
4.0 equiv). The reaction mixture stirred at this temperature for 1h and the resulting solution was 
then warmed up to room temperature and stirred for 1h. Brine was added to quench the reaction 
and the aqueous layer was extracted with Et2O. The combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:Et2O (95:5) to 
afford the diene 3.77 as a colourless oil (112 mg, 0.72 mmol, 56%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.84 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H, CH-6), 5.63 (dt, J 
= 15.7, 1.2 Hz, 1H, CH-2), 5.38 (dt, J = 15.7, 6.2 Hz, 1H, CH-3), 5.18 (ddd, J = 17.2, 3.3, 1.6 
Hz, 1H, CH2-7), 5.09 (ddd, J = 10.4, 3.0, 1.2 Hz, 1H, CH2-7), 3.92–3.80 (m, 4H, CH2-4, 5), 
0.93 (s, 9H, CH3-1'). 
13C NMR (100 MHz, CDCl3) δ ppm: 145.5 (CH-2), 134.9 (CH-6), 121.0 (CH-3), 117.0 (CH2-
7), 71.2 (CH2-4 or 5), 70.9 (CH2-4 or 5), 32.9 (C-1), 29.4 (CH3-1'). 
IR (thin film): 2956, 1462, 1361, 1259, 1070, 974 cm-1. 
HRMS (ESI): Calcd for C10H18NaO
+ [M+Na]+, 177.1250; found, 177.1246. 
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5-(3-(Allyloxy)prop-1-en-1-yl)undecane (3.79) 
 
Chemical formula: C17H32O  
MW: 252.44 
To a stirred solution of alcohol 3.78 (105 µL, 0.469 mmol) in H2O-saturated CH2Cl2 (12 mL) 
was added DMP (400 mg, 0.943 mmol, 2.0 equiv). The resulting cloudy solution stirred at room 
temperature for 2h. The reaction mixture was diluted with Et2O and then concentrated under 
reduced pressure. Et2O was then added and the organic phase was washed with a saturated 
aqueous solution of Na2S2O3 and a saturated aqueous solution of NaHCO3. The aqueous layers 
were back-extracted with Et2O and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure.  
To a stirred solution of this crude mixture and sulfone 3.28 (416 mg, 1.41 mmol, 3.0 equiv) in 
DME (16 mL) at -55°C was slowly added KHMDS (1.9 mL, 1M in THF, 1.9 mmol, 4.0 equiv). 
The reaction mixture was stirred at this temperature for 1h and the resulting solution was then 
warmed up to room temperature and stirred for 1h. Brine was added to quench the reaction 
and the aqueous layer was extracted with Et2O. The combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:Et2O (94:4) to 
afford the diene 3.79 as a colourless oil (85 mg, 0.33 mmol, 71%). 
1H NMR (400 MHz, CDCl3) δ ppm: The presence of two diastereomers was observed in the 
NMR spectra. However, it was not possible to differentiate all signals corresponding to each 
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diastereoisomer. 5.92 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H, CH-2), 5.60–5.34 (m, 2H, CH-5,6), 5.26 
(dd, J = 17.2, 1.7 Hz, 1H, CH2 trans-1), 5.16 (dd, J = 10.4, 1.7 Hz, 1H, CH2 cis-1), 3.96 –3.94 
(m, 4H, CH2-3,4), 1.94 (bs, 1H, CH-7), 1.32–1.14 (m, 16H, CH2), 0.88–0.84  (m, 6H, CH3-
13,17). 
13C NMR (100 MHz, CDCl3) δ ppm: 139.4 (CH-6), 135.0 (CH-2), 125.8 (CH-5), 116.8 (CH2-
1), 70.9 (CH2-3 or 4), 70.6 (CH2-3 or 4), 42.5 (CH-7), 35.1 (CH2), 34.8 (CH2), 31.9 (CH2), 29.5 
(CH2), 29.4 (CH2), 27.2 (CH2), 22.8 (CH2), 22.7 (CH2), 14.1 (CH3-13,17). 
IR (thin film): 2924, 2854, 1724, 1458, 1377, 1095, 972 cm-1. 
HRMS (ESI): Calcd for C17H32NaO
+ [M+Na]+, 275.2345; found, 275.2336. 
 
(4R*,5R*)-4-(6-((E)-3-(Allyloxy)prop-1-en-1-yl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.82a-b) 
 
Chemical formula: C26H36O4 
MW: 412.57 
To a stirred solution of alcohol (±)3.74a (76 mg, 0.22 mmol) in H2O-saturated CH2Cl2 (5.6 mL) 
was added DMP (187 mg, 0.44 mmol, 2.0 equiv). The resulting cloudy solution stirred at room 
temperature for 2h. The reaction mixture was diluted with Et2O and then concentrated under 
reduced pressure. Et2O was then added and the organic phase was washed with a saturated 
aqueous solution of Na2S2O3 and a saturated aqueous solution of NaHCO3. The aqueous layers 
were back-extracted with Et2O and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure.  
To a stirred solution of this crude mixture and sulfone 3.28 (194 mg, 0.66 mmol, 3.0 equiv) in 
DME (7.5 mL) at -55°C was slowly added KHMDS (0.97 mL, 0.9 M in THF, 0.88 mmol, 4.0 
equiv). The reaction mixture stirred at this temperature for 1h and the resulting solution was 
then warmed up to room temperature and stirred for 1h. Brine was added to quench the reaction 
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and the aqueous layer was extracted with Et2O. The combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:Et2O (8:2) to 
afford the E-alkene (±)3.82a as a highly viscous colourless oil (66 mg, 0.16 mmol, 73% for two 
steps). 
The same experimental procedure was applied to alcohol (±)3.74b (100 mg, 0.29 mmol) to 
afford the E-alkene (±)3.82b as a highly viscous colourless oil (46 mg, 0.11 mmol, 48% for two 
steps).  
(4R*,5R*)-4-((S*)-6-((E)-3-(Allyloxy)prop-1-en-1-yl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.82a) 
 
Chemical formula: C26H36O4 
MW: 412.57 
1H NMR (400 MHz, CDCl3) δ ppm: 6.08 (dd, J = 17.5, 11.2 Hz, 1H, CH-10), 5.96–5.83 (m, 
2H, CH-4, CH-23), 5.65–5.55 (m, 2H, CH-9, CH-20), 5.34–5.22 (m, 2H, CH2-10' and 24), 
5.17 (dd, J = 10.4, 1.5 Hz, 1H, CH2-24), 4.95 (dd, J = 17.6, 2.4 Hz, 1H, CH2-10'), 4.90 (s, 1H, 
CH-2), 4.04–3.93 (m, 4H, CH2-21,22), 2.27 (dd, J = 17.5, 9.0 Hz, 1H, CH2-5), 2.21–2.12 (m, 
2H, CH2), 2.06 (d, J = 6.2 Hz, 2H, CH2), 1.75–1.67 (m, 1H, CH2), 1.65 (s, 3H, CH3-18), 1.60–
1.47 (m, 4H, CH2), 1.13–1.00 (m, 9H, CH3-16, 17 and 19). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.4 (CO3), 140.3 (CH-9), 137.5 (C-11), 134.9 (C-3), 
134.7 (CH-4 or 10), 134.6 (CH-4 or 10), 132.2 (CH-23), 127.9 (C-12), 126.6 (CH-20), 119.9 
(CH2-10'), 117.0 (CH2-24), 89.9 (C-1), 78.9 (CH-2), 70.9 (CH2-21 or 22), 70.5 (CH2-21 or 22), 
43.0 (C-15), 40.1 (C-8), 38.0 (CH2-7), 29.1 (CH2-5), 25.6 (CH2-13 or 14), 25.4 (CH2-13 or 14), 
25.0 (CH3-16, 17 or 19), 20.9 (CH3-18), 20.6 (CH3-16, 17 or 19), 18.0 (CH2-6). 
IR (thin film): 2927, 2850, 1797, 1446, 1344, 1176 1041 cm-1. 
HRMS (ESI): Calcd for C26H36NaO4
+ [M+Na]+, 435.2506; found, 435.2500 
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(4R*,5R*)-4-((R*)-6-((E)-3-(Allyloxy)prop-1-en-1-yl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.82b) 
 
Chemical formula: C26H36O4 
MW: 412.57 
1H NMR (400 MHz, CDCl3) δ ppm: 6.08 (dd, J = 17.6, 11.1 Hz, 1H, CH-10), 5.95–5.79 (m, 
2H, CH-4, CH-23), 5.60–5.49 (m, 2H, CH-9, CH-20), 5.34–5.11 (m, 3H, CH2-24, CH2-10´), 
4.95 (dd, J = 17.6, 2.5 Hz, 1H, CH2-10´), 4.87 (s, 1H, CH-2), 4.08–3.78 (m, 4H, CH2-21, CH2-
22), 2.27 (d, J = 8.5 Hz, 1H, CH2-5), 2.21–2.13 (m, 2H, CH2), 2.13–1.95 (m, 2H, CH2), 1.72–
1.55 (m, 7H, 4CH2, CH3-18), 1.53–1.47 (m, 1H, CH2-7), 1.25 (d, J = 12.3 Hz, 3H, CH3-16,17 
or 19), 1.07 (d, J = 9.3 Hz, 3H, CH3-16,17 or 19), 0.99 (s, 3H, CH3-16,17 or 19). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.4 (CO3), 139.6 (CH-9), 138.3 (C-11), 135.0 (C-3), 
134.9 (CH-4 or 10), 134.6 (CH-4 or 10), 131.2 (CH-23), 127.6 (C-12), 125.5 (CH-20), 119.8 
(CH2-10´), 117.0 (CH2-24), 90.0 (C-1), 78.0 (CH-2), 71.4 (CH2-21 or 23), 70.6 (CH2-21 or 23), 
42.9 (C-15), 39.6 (C-8), 37.7 (CH2-7), 29.2 (CH2-5), 25.5 (CH2-13 or 14), 25.4 (CH2- 13 or 14), 
25.2 (CH3-16, 17 or 19), 23.9 (CH3-16, 17 or 19), 20.9 (CH3-18), 20.5 (CH3-16, 17 or 19), 18.0 
(CH2-6). 
IR (thin film): 3340, 2947, 1795, 1068, 1033, 862 cm-1. 
HRMS (ESI): Calcd for C26H36NaO4
+ [M+Na]+, 435.2506; found, 435.2500. 
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(4R*,5R*)-4-(6-((E)-Hepta-1,6-dien-1-yl)-6-methylcyclohex-1-en-1-yl)-6,6,8-trimethyl-
7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.83a-b) 
  
Chemical formula: C27H38O3 
MW: 410.60 
To a stirred solution of alcohol (±)3.74a (23 mg, 0.066 mmol) in H2O-saturated CH2Cl2 (1.7 
mL) was added DMP (57 mg, 0.13 mmol, 2.0 equiv). The resulting cloudy solution stirred at 
room temperature for 2h. The reaction mixture was diluted with Et2O and then concentrated 
under reduced pressure. Et2O was then added and the organic phase was washed with a 
saturated aqueous solution of Na2S2O3 and a saturated aqueous solution of NaHCO3. The 
aqueous layers were back-extracted with Et2O and the combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure.  
To a stirred solution of this crude mixture and sulfone 3.34 (58 mg, 0.20 mmol, 3.0 equiv) in 
DME (2.3 mL) at -55°C was slowly added KHMDS (0.30 mL, 0.9 M in THF, 0.27 mmol, 4.0 
equiv). The reaction mixture stirred at this temperature for 1h and the resulting solution was 
then warmed up to room temperature and stirred for 1h. Brine was added to quench the reaction 
and the aqueous layer was extracted with Et2O. The combined organic extracts were washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The 
crude mixture was then purified by flash chromatography using petroleum ether:CH2Cl2 (6:4) 
  
165 
 
to afford the E-alkene (±)3.83a as a highly viscous colourless oil (19 mg, 0.046 mmol, 70% for 
two steps). 
The same experimental procedure was applied to alcohol (±)3.74b (120 mg, 0.36 mmol) to 
afford the E-alkene (±)3.83b as a highly viscous colourless oil (75 mg, 0.18 mmol, 52% for two 
steps).  
 
 
(4R*,5R*)-4-((S*)-6-((E)-Hepta-1,6-dien-1-yl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.83a) 
 
 Chemical formula: C27H38O3 
MW: 410.60 
1H NMR (400 MHz, CDCl3) δ ppm: 6.09 (dd, J = 17.3, 11.6 Hz, 1H, CH-10), 5.88 (s, 1H, 
CH-4), 5.78 (dt, J = 16.7, 8.4 Hz, 1H, CH-9), 5.46–5.40 (m, 1H, CH-20), 5.35–5.27 (m, 2H, 
CH2-10', CH-23), 5.06–4.90 (m, 4H, CH-2, CH2-10', CH2-24), 2.28 (d, J = 13.4 Hz, 1H, CH2), 
2.17–2.10 (m, 2H, CH2), 2.10–2.02 (m, 5H, CH2), 1.79–1.68 (m, 2H, CH2), 1.66 (s, 3H, CH3), 
1.58–1.53 (m, 3H, CH2), 1.51–1.44 (m, 4H, CH2), 1.17–1.11 (m, 2H, CH2), 1.07 (s, 6H, CH3). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.5 (CO3), 138.6 (CH-9), 138.0 (C-11), 137.8 (CH-
23), 134.9 (C-3), 134.8 (CH-10), 131.9 (CH-4), 130.3 (CH-20), 128.0 (C-12), 119.9 (CH2-10'), 
114.6 (CH2-24), 89.9 (C-1), 79.0 (CH-2), 43.0 (C-15), 40.0 (C-8), 38.4 (CH2-7), 33.2 (CH2-21 
or 22), 32.1 (CH2-21 or 22), 29.1 (CH2-5), 28.8 (CH2-25), 25.7 (CH2-13 or 14), 25.4 (CH2-13 
or 14), 25.2 (CH3-16, 17 or 19), 25.1 (CH3- 16, 17 or 19), 21.0 (CH3-18), 20.5 (CH3-16, 17 or 
19), 18.1 (CH2-6). 
IR (thin film): 2954, 2922, 2852, 1805, 1456, 1174 cm-1. 
HRMS (ESI): Calcd for C27H38NaO3
+ [M+Na]+, 433.2713; found, 433.2710. 
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(4R*,5R*)-4-((R*)-6-((E)-Hepta-1,6-dien-1-yl)-6-methylcyclohex-1-en-1-yl)-6,6,8-
trimethyl-7-vinyl-1,3-dioxaspiro[4.5]dec-7-en-2-one ((±)3.83b) 
 
Chemical formula: C27H38O3 
MW: 410.60 
1H NMR (400 MHz, CDCl3) δ ppm: 6.09 (dd, J = 17.9, 11.0 Hz, 1H, CH-10), 5.83 (bs, 1H, 
CH-4), 5.81–5.71 (m, 1H, CH-9), 5.48–5.37 (m, 1H, CH-20), 5.28–5.21 (m, 2H, CH2-10', CH-
23), 5.06–4.92 (m, 3H, CH2-24, CH2-10'), 4.88 (s, 1H, CH-2), 2.35–2.23 (m, 1H, CH2), 2.21–
2.07 (m, 3H, CH2), 2.07–1.84 (m, 5H, CH2), 1.71–1.65 (m, 4H, CH2, CH3-18), 1.63–1.36 (m, 
6H, CH2), 1.24 (s, 3H, CH3-19), 1.07 (s, 3H, CH3-16 or 17), 1.00 (s, 3H, CH3-16 or 17). 
13C NMR (100 MHz, CDCl3) δ ppm: 155.5 (CO3), 138.9 (C-11), 138.5 (CH-9), 137.5 (CH-
23), 135.0 (C-3), 134.8 (CH-10), 130.8 (CH-4), 129.0 (CH-20), 127.6 (C-12), 119.8 (CH2-10'), 
114.6 (CH2-24), 89.9 (C-1), 78.0 (CH-2), 42.9 (C-15), 39.6 (C-8), 38.1 (CH2-7), 33.2 (CH2-21 
or 22), 32.3 (CH2-21 or 22), 29.2 (C-5), 28.4 (C-25), 25.5 (CH2-13 or 14), 25.4 (CH2-13 or 14), 
25.3 (CH3-16 or 17), 24.0 (CH3-19), 21.0 (CH3-18), 20.5 (CH3-16 or 17), 18.1 (CH2-6). 
IR (thin film): 2927, 1789, 1452, 1344, 1265, 1176, 1039 cm-1. 
HRMS (ESI): Calcd for C27H38NaO3
+ [M+Na]+, 433.2713; found, 433.2706. 
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(4R*,5R*)-6,6,8-Trimethyl-4-((S*)-6-methyl-6-vinylcyclohex-1-en-1-yl)-7-vinyl-1,3-
dioxaspiro[4.5]dec-7-en-2-one ((±)3.85a) 
  
Chemical formula: C22H30O3 
MW: 342.48 
To a stirred solution of the Stewart-Grubbs catalyst SG (9.0 mg, 0.015 mmol, 0.30 equiv) in dry 
and degassed DCE (23 mL) at 50°C was slowly added a solution of carbonate (±)3.82a (20 mg,  
0.048 mmol) in DCE (1.0 mL). The reaction mixture was warmed to reflux and stirred for 2 
days. The resulting mixture was cooled down to room temperature and diluted with a small 
amount of CH2Cl2. The crude mixture was dry loaded and purified by flash chromatography 
using petroleum ether:Et2O (9:1) to afford the truncated product (±)3.85a as a pale yellow oil 
(5.0 mg, 0.014 mmol, 30%). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.09 (dd, J = 17.6, 11.0 Hz, 1H, CH-10), 5.92 (t, J = 4.0 
Hz, 1H, CH-4), 5.73 (dd, J = 17.5, 10.6 Hz, 1H, CH-9), 5.31 (dd, J = 11.1, 2.5 Hz, 1H, CH2-
10'), 5.16 (dd, J = 10.6, 1.0 Hz, 1H, CH2-9'), 5.06 (dd, J = 17.5, 1.0 Hz, 1H, CH2-9'), 4.96 (dd, 
J = 17.6, 2.5 Hz, 1H, CH2-10'), 4.92 (s, 1H, CH-2), 2.32–2.26 (m, 1H, CH2-5), 2.18–2.12 (m, 
2H, CH2), 2.10–2.04 (m, 2H, CH2), 1.75–1.70 (m, 1H, CH2), 1.66 (s, 3H, CH3-18), 1.52–1.56 
(m, 3H, CH2), 1.27–1.22 (m, 1H, CH2), 1.07 (s, 6H, CH3-16, 17), 1.07 (s, 3H, CH3-19). 
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13C NMR (100 MHz, CDCl3) δ ppm: 155.5 (CO3), 145.5 (CH-9), 137.4 (C-11), 134.9 (C-3), 
134.8 (CH-10), 132.4 (CH-4), 128.0 (C-12), 120.0 (CH2-10'), 114.6 (CH2-9'), 89.9 (C-1), 78.9 
(CH-2), 43.0 (C-15), 40.9 (C-8), 38.0 (CH2-7), 29.1 (CH2-5), 25.7 (CH2-13 or 14), 25.4 (CH2-
13 or 14), 25.1 (CH3-16, 17 or 19), 24.5 (CH3-16, 17 or 19), 21.0 (CH3-18), 20.5 (CH3-16, 17 or 
19), 18.0 (CH2-6). 
IR (thin film): 2941, 2904, 1788, 1178, 1043, 912 cm-1. 
HRMS (ESI): Calcd for C22H30NaO3
+ [M+Na]+, 365.2087; found, 365.2071. 
2-Allyl-2-methylcyclohexane-1,3-dione ((±)3.91)94 
 
Chemical formula: C10H14O2  
MW: 166.22 
To a stirred solution of diketone 2.32 (30.0 g, 237 mmol) in a 1M aqueous solution of NaOH 
(240 mL) was added 3-bromopropene (41 mL, 470 mmol, 2.0 equiv). The reaction mixture was 
stirred at room temperature for 2 days. Brine was added to quench the reaction and the aqueous 
layer was extracted with Et2O, and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure to afford the diketone 
(±)3.91 as a pale yellow oil (33.0 g, 198 mmol, 84%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.63–5.49 (m, 1H, CH-9), 5.05 (m, 2H, CH2-10), 2.67–
2.59 (m, 4H, CH2-3, 5), 2.52 (d, J = 7.3 Hz, 2H, CH2-8), 2.02–1.84 (m, 2H, CH2-4), 1.23 (s, 
3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 209.8 (CO-2,6), 132.2 (CH-9), 119.2 (CH2-10), 65.2 (C-
1), 41.3 (CH2-8), 38.2 (CH2-3,5), 19.6 (CH3-7), 17.5 (CH2-4). 
IR (thin film): 3288, 2916, 2830, 1695, 1020 cm-1. 
HRMS (ESI): Calcd for C10H14NaO2
+ [M+Na]+, 189.0886; found, 189.0882. 
 
6-Allyl-6-methyl-1,4,8,11-tetraoxadispiro[4.1.47.35]tetradecane ((±)3.92)94 
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Chemical formula: C14H22O4 
MW: 254.33 
To a stirred solution of diketone (±)3.91 (395 mg, 2.38 mmol) in CH2Cl2 (8.0 mL) was added 
p-toluenesulfonic acid (46 mg, 0.24 mmol, 0.10 equiv), ethylene glycol (1.2 mL,  21 mmol, 9.0 
equiv) and triethyl orthoformate (2.9 mL, 18 mmol, 7.5 equiv). The reaction mixture was 
refluxed for 24h. The resulting solution was allowed to cool down to room temperature and a 
saturated aqueous solution of NaHCO3 was added to quench the reaction. The aqueous layer 
was extracted with CH2Cl2, and the combined organic extracts were washed with brine, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude mixture 
was then purified by flash chromatography using petroleum ether:Et2O (1:1) to afford the acetal 
(±)3.92 as a pale yellow solid (400 mg, 1.57 mmol, 66%). 
1H NMR (400 MHz, CDCl3) δ ppm: 6.04–5.91 (m, 1H, CH-9), 4.96–4.83 (m, 2H, CH2-10), 
4.02–3.84 (m, 8H, CH2-11,12), 2.35–2.32 (m, 2H, CH2-8), 1.64–1.52 (m, 6H, CH2-3, 4, 5), 1.14 
(s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 137.8 (CH-9), 114.1 (CH2-10), 113.0 (C-6,2), 65.3 (CH2-
11 or 12), 63.8 (CH2-11 or 12), 49.7 (C-1), 34.9 (CH2-8), 30.2 (CH2-3,5), 18.6 (CH2-4), 17.2 
(CH3-7). 
IR (thin film): 3396, 2937, 2883, 1722, 1444, 1066 cm-1. 
HRMS (ESI): Calcd for C14H22NaO4
+ [M+Na]+, 277.1410; found, 277.1403. 
 
(E)-6-Methyl-6-(prop-1-en-1-yl)-1,4,8,11-tetraoxadispiro[4.1.47.35]tetradecane ((±)3.93)94 
 
Chemical formula: C14H22O4 
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MW: 254.33 
To a stirred solution of (±)3.92 (8.10 g, 31.8 mmol) in benzene (81 mL) was added 
PdCl2(CH3CN)2 (81 mg, 0.31 mmol, 0.010 equiv). The reaction mixture was refluxed for 2 days 
and the solvent was then removed under reduced pressure. The resulting mixture was diluted 
with EtOAc and CH2Cl2 and filtered through a pad of Celite. The filter cake was washed with 
EtOAc and the filtrate was concentrated under reduced pressure to afford the alkene (±)3.93 
as a white solid (7.96 g, 31.3 mmol, 98%). 
1H NMR (400 MHz, CDCl3) δ ppm: 5.78 (dd, J = 15.8, 1.5 Hz, 1H, CH-8), 5.59 (dq, J = 15.7, 
6.3 Hz, 1H, CH-9), 3.95–3.83 (m, 8H, CH2-11, 12), 1.70 (dd, J = 6.3, 1.6 Hz, 3H, CH3-10), 
1.67–1.56 (m, 6H, CH2-3, 4, 5), 1.15 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 131.3 (C-8), 126.3 (CH-9), 112.6 (C-2,6), 65.2 (CH2-11 
or 12), 65.1 (CH2-11 or 12), 52.5 (C-1), 30.8 (CH2-3,5), 18.9 (CH3-10), 18.8 (CH2-4), 15.1 (CH3-
7). 
IR (thin film): 2953, 2883, 2245, 1155, 1066 cm-1. 
HRMS (ESI): Calcd for C14H22NaO4
+ [M+Na]+, 277.1410; found, 277.1404. 
MP: 66°C. 
 
(6-Methyl-1,4,8,11-tetraoxadispiro[4.1.47.35]tetradecan-6-yl)methanol ((±)3.94)94 
 
Chemical formula: C12H20O5 
MW: 244.29 
To a stirred solution of alkene (±)3.93 (1.33 g, 5.23 mmol) in MeOH (43 mL) at -78°C was 
passed a stream of O3 for 50 min. NaBH4 (417 mg, 11.0 mmol, 2.0 equiv) was added the solution 
and the resulting mixture was allowed to warm up to room temperature. The solvent was 
removed under reduced pressure and the residue was diluted with EtOAc and a saturated 
aqueous solution of NH4Cl. The aqueous layer was extracted with EtOAc, and the combined 
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
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concentrated under reduced pressure to afford the alcohol (±)3.94 as a white solid (735 mg, 
3.00 mmol, 58%). 
1H NMR (400 MHz, CDCl3) δ ppm: 4.02–3.92 (m, 8H,CH2-11,12), 3.82 (t, J = 6.0 Hz, 2H, 
CH2-8), 3.14 (t, J = 6.0 Hz, 1H, OH), 1.68–1.56 (m, 6H, CH2-3,4,5), 1.10 (d, J = 6.9 Hz, 3H, 
CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 112.9 (C-2,6), 65.0 (CH2-8), 64.9 (CH2-11 or 12), 64.6 
(CH2-11 or 12), 50.5 (C-1), 30.3 (CH2-3,5), 18.7 (CH2-4), 12.5 (CH3-7). 
 
6-((Benzyloxy)methyl)-6-methyl-1,4,8,11-tetraoxadispiro[4.1.47.35]tetradecane 
((±)3.95)94 
 
Chemical formula: C19H26O5 
MW: 334.41 
To a stirred suspension of NaH (135 mg, 3.30 mmol, 1.10 equiv) and TBAI (110 mg, 0.30 mmol, 
0.10 equiv) at 0°C in THF (6.6 mL) was added a solution of alcohol (±)3.94 (735 mg, 3.00 
mmol) in THF (2.7 mL). To the resulting mixture was added a solution of benzyl bromide in 
DMF (660 µL). The reaction mixture was allowed to warm to room temperature and stirred for 
16h. A saturated aqueous solution of NaH4Cl was added to quench the reaction. The aqueous 
layer was extracted with EtOAc, and the combined organic extracts were washed with brine, 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude 
mixture was then purified by flash chromatography using petroleum ether:EtOAc (3:1) to afford 
the ether (±)3.95 as a white solid (490 mg, 1.47 mmol, 49%). 
1H NMR (400 MHz, CDCl3) δ ppm: 7.36–7.23 (m, 5H, CH-Ar), 4.50 (s, 2H, CH2-9), 3.98–
3.85 (m, 8H, CH2-11, 12), 3.62 (s, 2H, CH2-8), 1.83 (dt, J = 12.5, 6.2 Hz, 2H, CH2), 1.66–1.54 
(m, 4H, CH2), 1.05 (s, 3H, CH3-7). 
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13C NMR (100 MHz, CDCl3) δ ppm: 138.9 (C-Ar), 128.0 (CH-Ar), 127.1 (CH-Ar), 127.0 
(CH-Ar), 112.3 (C-2,6), 73.4 (CH2-9), 72.0 (CH2-8), 65.1 (CH2-11 or 12), 64.6 (CH2-11 or 12), 
50.9 (C-1), 31.4 (CH2), 18.7 (CH2), 14.1 (CH3-7).  
IR (thin film): 2879, 1774, 1141, 1093, 1068, 1029 cm-1. 
HRMS (ESI): Calcd for C19H26NaO5
+ [M+Na]+, 357.1672; found, 357.1670. 
MP: 53°C  
2-((Benzyloxy)methyl)-2-methylcyclohexane-1,3-dione ((±)3.96)94 
 
Chemical formula: C15H18O3 
MW: 246.31 
To a stirred solution of acetal (±)3.95 (488 mg, 1.45 mmol) in THF (3.2 mL) was added a 2M 
aqueous solution of HCl and the reaction mixture was refluxed for 5h. The resulting solution 
was cooled down to room temperature and the aqueous layer was extracted with EtOAc. The 
combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was then purified by flash 
chromatography using petroleum ether:Et2O (3:1) to afford the ketone (±)3.96 as a white solid 
(192 mg, 0.782 mmol, 54%).64 
1H NMR (400 MHz, CDCl3) δ ppm: 7.38–7.16 (m, 5H, CH-Ar), 4.40 (s, 2H, CH2-9), 3.67 (s, 
2H, CH2-8), 2.79–2.53 (m, 4H, CH2-3,5), 2.10–1.82 (m, 2H, CH2-4), 1.13 (s, 3H, CH3-7). 
13C NMR (100 MHz, CDCl3) δ ppm: 210.9 (C-2,6), 137.6 (C-Ar), 128.3 (CH-Ar), 127.7 (CH-
Ar), 127.4 (2CH-Ar), 76.3 (CH2-8), 73.5 (CH2-9), 63.6 (C-1), 39.6 (CH2-3,5), 17.7 (CH3-7), 
16.9 (CH2-4). 
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Appendices 
1H NMR and 13C NMR of 2.72a 
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1H NMR and 13C NMR of 2.72b 
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1H NMR and 13C NMR of 2.85a 
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1H NMR and 13C NMR of (±)3.74b 
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1H NMR and 13C NMR of (±)3.82a 
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1H NMR and 13C NMR of (±)3.82b 
 
 
  
  
184 
 
1H NMR and 13C NMR of (±)3.83a 
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1H NMR and 13C NMR of (±)3.83b 
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Chiral HPLC for the nitro derivate 3.20 (racemic mixture) 
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Chiral HPLC for the nitro derivate 3.20 (enantio-enriched mixture) 
 
 
  
  
188 
 
Crystal data and structure refinement for (±)3.57b 
 
View showing the structure and atom labelling scheme for (±)3.57b, displacement ellipsoids 
drawn at 50% probability level. Below view showing H-bonded chain. 
 
Refinement 
Crystal data, data collection and structure refinement details are summarized in Table 1. 
Computing details 
Data collection: CrysAlis PRO 1.171.40.45a (Rigaku OD, 2019); cell refinement: CrysAlis PRO 
1.171.40.45a (Rigaku OD, 2019); data reduction: CrysAlis PRO 1.171.40.45a (Rigaku OD, 2019); 
program(s) used to solve structure: ShelXT (Sheldrick, 2015); program(s) used to refine 
structure: SHELXL (Sheldrick, 2015); molecular graphics: Olex2 (Dolomanov et al., 2009); 
software used to prepare material for publication: Olex2 (Dolomanov et al., 2009). 
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(2019ncsx0326_1a) 
Crystal data 
C21H30O4 F(000) = 752 
Mr = 346.45 Dx = 1.241 Mg m-3 
Monoclinic, P21/c Cu K radiation,  = 1.54178 Å 
a = 6.99076 (5) Å Cell parameters from 29302 reflections 
b = 21.0167 (2) Å  = 4.1–70.2° 
c = 12.63672 (9) Å  = 0.67 mm-1 
 = 92.5471 (6)° T = 100 K 
V = 1854.79 (3)  Å3 (cut) irregular plate, colourless 
Z = 4 0.24 × 0.13 × 0.03 mm 
Data collection 
XtaLAB AFC11 (RCD3): quarter-chi single  
diffractometer 
3388 independent reflections 
Radiation source: Rotating-anode X-ray tube, 
Rigaku (Cu) X-ray Source 
3179 reflections with I > 2(I) 
Mirror monochromator Rint = 0.045 
Detector resolution: 10.0000 pixels mm-1 max = 68.2°, min = 4.1° 
 scans h = -8→8 
Absorption correction: gaussian  
CrysAlis PRO 1.171.40.45a (Rigaku Oxford 
Diffraction, 2019) Numerical absorption 
correction based on gaussian integration over  
  a multifaceted crystal model 
Empirical absorption correction using spherical 
harmonics,  implemented in SCALE3 ABSPACK 
scaling algorithm. 
k = -25→25 
Tmin = 0.699, Tmax = 1.000 l = -15→15 
56106 measured reflections  
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Refinement 
Refinement on F2 Primary atom site location: dual 
Least-squares matrix: full Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2(F2)] = 0.036 H-atom parameters constrained 
wR(F2) = 0.095  w = 1/[2(Fo2) + (0.0446P)2 + 0.7019P]   
where P = (Fo2 + 2Fc2)/3 
S = 1.06 (/)max = 0.001 
3388 reflections max = 0.24 e Å-3 
237 parameters min = -0.19 e Å-3 
1 restraint  
Special details 
 Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are 
estimated using the full covariance matrix.  The cell esds are taken  into account 
individually in the estimation of esds in distances, angles  and torsion angles; 
correlations between esds in cell parameters are only  used when they are defined by 
crystal symmetry.  An approximate (isotropic)  treatment of cell esds is used for 
estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq Occ. (<1) 
O1 0.47259 (11) 0.67711 (4) 0.49509 (6) 0.0246 (2)  
O2 0.63604 (13) 0.73135 (4) 0.37938 (6) 0.0290 (2)  
O3 0.33866 (15) 0.69854 (5) 0.33514 (8) 0.0436 (3)  
O4 1.02726 (14) 0.78001 (6) 0.69421 (8) 0.0412 (4) 0.930 (3) 
H4 1.113415 0.783002 0.742445 0.062* 0.930 (3) 
C12 0.53844 (17) 0.58807 (6) 0.68921 (9) 0.0251 (3)  
C1 0.66399 (15) 0.68370 (5) 0.54826 (9) 0.0206 (2)  
C14 0.62850 (17) 0.70364 (6) 0.66096 (9) 0.0234 (3)  
H14A 0.570658 0.746639 0.660910 0.028*  
H14B 0.751671 0.705427 0.702655 0.028*  
C11 0.66043 (17) 0.57019 (6) 0.61564 (9) 0.0240 (3)  
C3 0.76672 (16) 0.80355 (6) 0.51285 (9) 0.0218 (2)  
C2 0.75763 (17) 0.73476 (6) 0.47642 (9) 0.0228 (3)  
H2 0.889597 0.720375 0.460428 0.027*  
C15 0.76292 (16) 0.61766 (6) 0.54451 (9) 0.0232 (3)  
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C8 0.96272 (17) 0.83531 (6) 0.52706 (9) 0.0252 (3)  
C1' 0.47260 (19) 0.70190 (6) 0.39842 (10) 0.0291 (3)  
C4 0.60455 (17) 0.83580 (6) 0.52291 (9) 0.0258 (3)  
H4A 0.488100 0.813388 0.509069 0.031*  
C13 0.49515 (18) 0.65663 (6) 0.71166 (9) 0.0268 (3)  
H13A 0.502518 0.663263 0.789291 0.032*  
H13B 0.362117 0.665839 0.686093 0.032*  
C10 0.70847 (18) 0.50201 (6) 0.60021 (11) 0.0304 (3)  
H10 0.681734 0.483958 0.532235 0.036*  
C18 0.42730 (19) 0.54284 (6) 0.75552 (10) 0.0311 (3)  
H18A 0.433936 0.499885 0.725731 0.047*  
H18B 0.293320 0.556532 0.755781 0.047*  
H18C 0.482319 0.542663 0.828218 0.047*  
C17 0.76085 (19) 0.59264 (6) 0.42975 (10) 0.0288 (3)  
H17A 0.628639 0.583824 0.405046 0.043*  
H17B 0.836425 0.553432 0.427354 0.043*  
H17C 0.816179 0.624752 0.383927 0.043*  
C16 0.97402 (17) 0.62258 (6) 0.58533 (10) 0.0293 (3)  
H16A 1.047634 0.645914 0.533728 0.044*  
H16B 1.027487 0.579753 0.594928 0.044*  
H16C 0.980851 0.645180 0.653224 0.044*  
C5 0.58968 (19) 0.90447 (6) 0.55421 (11) 0.0318 (3)  
H5A 0.559964 0.907318 0.629938 0.038*  
H5B 0.483711 0.924829 0.512085 0.038*  
C19 1.04864 (19) 0.84290 (7) 0.41781 (10) 0.0334 (3)  
H19A 1.062540 0.800932 0.385251 0.050*  
H19B 1.174490 0.863288 0.426149 0.050*  
H19C 0.963632 0.869334 0.372417 0.050*  
C7 0.9432 (2) 0.90095 (7) 0.58012 (11) 0.0348 (3)  
H7A 0.928982 0.894668 0.657020 0.042*  
H7B 1.062477 0.925355 0.571121 0.042*  
C6 0.7754 (2) 0.93969 (6) 0.53618 (12) 0.0368 (3)  
H6A 0.788531 0.946868 0.459415 0.044*  
  
192 
 
H6B 0.773703 0.981647 0.571740 0.044*  
C9 1.10329 (19) 0.79567 (7) 0.59644 (11) 0.0353 (3)  
H9A 1.134652 0.756076 0.558477 0.042* 0.930 (3) 
H9B 1.223417 0.819984 0.609133 0.042* 0.930 (3) 
H9BC 1.032664 0.773302 0.651539 0.042* 0.070 (3) 
H9BD 1.164255 0.763200 0.552271 0.042* 0.070 (3) 
C10' 0.7859 (2) 0.46490 (7) 0.67478 (13) 0.0411 (3)  
H10A 0.814438 0.481448 0.743632 0.049*  
H10B 0.813012 0.421644 0.659562 0.049*  
O4A 1.235 (2) 0.8318 (8) 0.6416 (14) 0.058 (6)* 0.070 (3) 
H4AA 1.289376 0.812067 0.692493 0.087* 0.070 (3) 
 
Atomic displacement parameters (Å2) 
 U11 U22 U33 U12 U13 U23 
O1 0.0207 (4) 0.0286 (4) 0.0237 (4) 0.0003 (3) -0.0071 (3) 0.0000 (3) 
O2 0.0395 (5) 0.0293 (5) 0.0174 (4) -0.0030 (4) -0.0071 (3) 0.0011 (3) 
O3 0.0494 (6) 0.0366 (5) 0.0421 (6) -0.0025 (4) -0.0297 (5) 0.0036 (4) 
O4 0.0290 (6) 0.0649 (8) 0.0287 (6) -0.0159 (5) -0.0104 (4) 0.0148 (5) 
C12 0.0264 (6) 0.0282 (6) 0.0201 (6) -0.0024 (5) -0.0043 (5) 0.0010 (5) 
C1 0.0168 (5) 0.0256 (6) 0.0190 (5) -0.0001 (4) -0.0045 (4) -0.0004 (4) 
C14 0.0244 (6) 0.0270 (6) 0.0188 (6) -0.0015 (5) 0.0002 (4) -0.0014 (4) 
C11 0.0238 (6) 0.0260 (6) 0.0216 (6) 0.0006 (5) -0.0058 (4) 0.0015 (4) 
C3 0.0231 (6) 0.0266 (6) 0.0157 (5) -0.0017 (4) -0.0009 (4) 0.0012 (4) 
C2 0.0231 (6) 0.0282 (6) 0.0169 (5) 0.0008 (5) -0.0026 (4) 0.0001 (4) 
C15 0.0219 (6) 0.0260 (6) 0.0216 (6) 0.0024 (4) -0.0016 (4) 0.0006 (5) 
C8 0.0217 (6) 0.0315 (6) 0.0221 (6) -0.0030 (5) -0.0005 (4) 0.0003 (5) 
C1' 0.0353 (7) 0.0254 (6) 0.0257 (6) 0.0019 (5) -0.0108 (5) 0.0004 (5) 
C4 0.0233 (6) 0.0283 (6) 0.0256 (6) -0.0016 (5) -0.0005 (5) -0.0002 (5) 
C13 0.0295 (6) 0.0289 (6) 0.0224 (6) -0.0029 (5) 0.0037 (5) -0.0021 (5) 
C10 0.0288 (6) 0.0281 (6) 0.0344 (7) 0.0014 (5) 0.0023 (5) 0.0009 (5) 
C18 0.0350 (7) 0.0315 (7) 0.0267 (6) -0.0046 (5) 0.0016 (5) 0.0015 (5) 
C17 0.0333 (7) 0.0286 (6) 0.0247 (6) 0.0029 (5) 0.0031 (5) -0.0023 (5) 
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C16 0.0220 (6) 0.0319 (7) 0.0337 (7) 0.0036 (5) -0.0025 (5) 0.0032 (5) 
C5 0.0306 (7) 0.0294 (7) 0.0355 (7) 0.0018 (5) 0.0035 (5) -0.0030 (5) 
C19 0.0298 (7) 0.0412 (7) 0.0295 (7) -0.0045 (5) 0.0045 (5) 0.0005 (5) 
C7 0.0321 (7) 0.0371 (7) 0.0349 (7) -0.0098 (6) 0.0009 (5) -0.0060 (6) 
C6 0.0390 (8) 0.0287 (7) 0.0432 (8) -0.0036 (6) 0.0069 (6) -0.0064 (6) 
C9 0.0256 (6) 0.0461 (8) 0.0334 (7) -0.0074 (6) -0.0084 (5) 0.0056 (6) 
C10' 0.0384 (8) 0.0337 (7) 0.0510 (9) 0.0064 (6) 0.0000 (6) 0.0083 (6) 
 
Geometric parameters (Å, º) for (2019ncsx0326_1a) 
O1—C1 1.4769 (13) C11—C10 1.4864 (17) 
O1—C1' 1.3280 (15) C3—C2 1.5176 (16) 
O2—C2 1.4624 (13) C3—C8 1.5276 (16) 
O2—C1' 1.3307 (16) C3—C4 1.3317 (17) 
O3—C1' 1.2061 (15) C15—C17 1.5421 (16) 
O4—C9 1.4056 (17) C15—C16 1.5450 (16) 
C12—C11 1.3429 (17) C8—C19 1.5382 (17) 
C12—C13 1.5019 (17) C8—C7 1.5425 (18) 
C12—C18 1.5057 (17) C8—C9 1.5335 (18) 
C1—C14 1.5156 (15) C4—C5 1.5014 (17) 
C1—C2 1.5675 (16) C10—C10' 1.321 (2) 
C1—C15 1.5523 (16) C5—C6 1.5206 (19) 
C14—C13 1.5195 (16) C7—C6 1.513 (2) 
C11—C15 1.5408 (16) C9—O4A 1.306 (14) 
    
C1'—O1—C1 110.16 (9) C11—C15—C17 110.03 (10) 
C1'—O2—C2 110.06 (9) C11—C15—C16 108.09 (9) 
C11—C12—C13 122.59 (11) C17—C15—C1 110.37 (9) 
C11—C12—C18 124.60 (11) C17—C15—C16 107.80 (10) 
C13—C12—C18 112.78 (10) C16—C15—C1 110.50 (10) 
O1—C1—C14 105.70 (9) C3—C8—C19 108.89 (10) 
O1—C1—C2 101.18 (8) C3—C8—C7 110.22 (10) 
O1—C1—C15 107.35 (9) C3—C8—C9 112.24 (10) 
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C14—C1—C2 116.42 (9) C19—C8—C7 110.06 (11) 
C14—C1—C15 111.58 (9) C9—C8—C19 107.68 (11) 
C15—C1—C2 113.35 (9) C9—C8—C7 107.71 (11) 
C1—C14—C13 110.21 (10) O1—C1'—O2 112.57 (10) 
C12—C11—C15 123.28 (11) O3—C1'—O1 123.72 (13) 
C12—C11—C10 120.98 (11) O3—C1'—O2 123.71 (12) 
C10—C11—C15 115.72 (10) C3—C4—C5 125.71 (11) 
C2—C3—C8 118.50 (10) C12—C13—C14 114.31 (10) 
C4—C3—C2 119.30 (11) C10'—C10—C11 124.30 (13) 
C4—C3—C8 121.96 (11) C4—C5—C6 111.03 (11) 
O2—C2—C1 102.12 (9) C6—C7—C8 113.83 (11) 
O2—C2—C3 108.43 (9) C7—C6—C5 109.65 (11) 
C3—C2—C1 119.30 (9) O4—C9—C8 111.84 (11) 
C11—C15—C1 109.99 (9) O4A—C9—C8 110.9 (8) 
    
O1—C1—C14—
C13 
54.62 (12) C15—C1—C14—
C13 
-61.75 (12) 
O1—C1—C2—O2 -18.82 (10) C15—C1—C2—
O2 
95.78 (10) 
O1—C1—C2—C3 100.59 (11) C15—C1—C2—C3 -144.80 (10) 
O1—C1—C15—
C11 
-68.24 (11) C15—C11—C10—
C10' 
119.62 (14) 
O1—C1—C15—
C17 
53.36 (12) C8—C3—C2—O2 -123.00 (10) 
O1—C1—C15—
C16 
172.50 (9) C8—C3—C2—C1 120.85 (11) 
C12—C11—C15—
C1 
-15.67 (15) C8—C3—C4—C5 -3.41 (19) 
C12—C11—C15—
C17 
-137.47 (12) C8—C7—C6—C5 61.33 (15) 
C12—C11—C15—
C16 
105.05 (13) C1'—O1—C1—
C14 
137.79 (10) 
C12—C11—C10—
C10' 
-58.88 (18) C1'—O1—C1—C2 16.01 (11) 
C1—O1—C1'—O2 -6.36 (13) C1'—O1—C1—
C15 
-103.00 (10) 
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C1—O1—C1'—O3 174.20 (12) C1'—O2—C2—C1 16.83 (12) 
C1—C14—C13—
C12 
42.77 (14) C1'—O2—C2—C3 -109.98 (11) 
C14—C1—C2—
O2 
-132.79 (10) C4—C3—C2—O2 51.49 (14) 
C14—C1—C2—C3 -13.37 (15) C4—C3—C2—C1 -64.66 (14) 
C14—C1—C15—
C11 
47.12 (12) C4—C3—C8—C19 -106.61 (13) 
C14—C1—C15—
C17 
168.72 (10) C4—C3—C8—C7 14.21 (16) 
C14—C1—C15—
C16 
-72.14 (12) C4—C3—C8—C9 134.27 (12) 
C11—C12—C13—
C14 
-11.61 (16) C4—C5—C6—C7 -46.69 (15) 
C3—C8—C7—C6 -43.35 (15) C13—C12—C11—
C15 
-2.08 (18) 
C3—C8—C9—O4 -53.42 (15) C13—C12—C11—
C10 
176.29 (11) 
C3—C8—C9—
O4A 
-154.9 (9) C10—C11—C15—
C1 
165.87 (10) 
C3—C4—C5—C6 19.99 (18) C10—C11—C15—
C17 
44.07 (14) 
C2—O2—C1'—O1 -7.52 (14) C10—C11—C15—
C16 
-73.41 (13) 
C2—O2—C1'—O3 171.91 (12) C18—C12—C11—
C15 
176.26 (11) 
C2—C1—C14—
C13 
166.00 (10) C18—C12—C11—
C10 
-5.36 (18) 
C2—C1—C15—
C11 
-179.10 (9) C18—C12—C13—
C14 
169.87 (10) 
C2—C1—C15—
C17 
-57.50 (12) C19—C8—C7—C6 76.77 (14) 
C2—C1—C15—
C16 
61.64 (12) C19—C8—C9—
O4 
-173.25 (11) 
C2—C3—C8—C19 67.73 (13) C19—C8—C9—
O4A 
85.3 (9) 
C2—C3—C8—C7 -171.45 (10) C7—C8—C9—O4 68.08 (14) 
C2—C3—C8—C9 -51.40 (14) C7—C8—C9—
O4A 
-33.4 (9) 
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C2—C3—C4—C5 -177.70 (11) C9—C8—C7—C6 -166.10 (11) 
 
Hydrogen-bond geometry (Å, º) for (2019ncsx0326_1a) 
 D—H···A D—H H···A D···A D—H···A 
O4—H4···O3i 0.84 1.96 2.7873 (13) 169 
O4A—
H4AA···O3i 
0.84 1.83 2.598 (18) 151 
Symmetry code:  (i) x+1, -y+3/2, z+1/2. 
Document origin: publCIF [Westrip, S. P. (2010). J. Apply. Cryst., 43, 920-925]. 
 
 
 
